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 
When I consider thy heavens, 
The work of thy fingers, 
The moon and the stars, 
Which thou hast ordained; 
What is man, that thou art mindful of him? 
And the son of man, that thou visitest him?  
- Pslam 8 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dedicated to my Homeland Hong Kong 
A Requiem for our Sacrificed Souls 
   
“The Contact”, Sunny Tsoi, 2020. Inspired by “Creation of Adam” by Michelangelo and the interacting 
Notch receptors and ligands. 
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Abstract  
Notch signaling is an evolutionary conserved contact-dependent cell-cell communication 
pathway. This “contact” spans from hydra to fruit flies to human; orchestrating 
development, homeostasis and cancer, thus the Requiem, a song of life and death. Upon 
the “contact” of Notch receptor and ligand, the intracellular domain NICD is released 
and translocates to the nucleus. NICD, together with the DNA binding protein CSL and 
other co-activators, activate downstream targets. In this thesis, I have investigated the role 
of Notch signaling in multiple contexts with a modular approach. This includes: the 
non-canonical role of CSL in breast cancer, crosstalk of Notch signaling with hypoxia 
signaling in cancer, canonical Notch signaling in blood development, a novel mouse 
model for Alagille syndrome, and the hyperactivated Notch during mammary 
development and tumourigenesis. Here I phrase them in five sections of a requiem 
(Mozart’s Requiem, 1791): 
 
Introitus: In Paper I, we found that ablation of CSL unleashed a hypoxic response in 
normoxic conditions and enhanced tumour growth in breast cancer. A large part of the 
deregulated genes in the CSL null cell line is Notch independent. We demonstrated a 
non-canonical role of CSL and the possible implication of loss of CSL in breast cancer.  
 
Kyrie: In Paper II, we established that Notch signaling can modulate hypoxia signaling in 
multiple cancer cell types. By siRNA knocked down of HIF2α, we found that Notch 
signaling requires HIF2α for regulating a subset of Notch targets in medulloblastoma 
cells. Differences in the effect of N1ICD and N2ICD were also shown in the 
medulloblastoma cells. Lastly, we presented evidence of Notch signaling contributing to 
the HIF1α-to-HIF2α switch. 
 
Dies Irae: In Paper III, we revealed that canonical Notch signaling is dispensable in adult 
steady-state and stress myelo-erythropoiesis by ablating CSL in the myeloid lineage. 
Some of the Notch targets were derepressed in some of the progenitor stages, indicating 
CSL could act as a repressor in some contexts. 
 
Rex tremendae: In Paper IV, we established and characterized a mouse model for Alagille 
syndrome in human, recapitulating defects in multiple organ-systems. We showed a 
mutation in Jag1 caused delay differentiation and structural abnormalities in the bile 
ducts. From transcriptomics of mice and patients samples, we also found some 
commonly affected genes across species. Lastly, we discovered that the mutated Jag1 
failed to bind to Notch1 and reduced the extent of Notch2 and Notch3 activation. 
 
Lacrymosa: In Paper V, we observed that hyperactive Notch in the luminal lineage during 
lactation cause defect in ductal development and led to mammary tumour development.  
Furthermore, we showed that this lineage can contribute to a large part of the mammary 
tumour.  
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Introduction 
This thesis addresses the importance of one of the most important signaling pathway – 
Notch signaling. “Balance” and “contact” are essential to Notch signaling, just as to our 
very existence. Over the billions years of our entire history of time, between lightness and 
darkness across billions light-years of our universe, there is one pale blue dot a. Everything 
on this pale blue dot was once forgettable star dust. Yet, in our pale blue dot, the star 
dust thrives as stardust crusaders bsurviving and evolving with the song of life. “Perfectly 
balanced, as all things should be.” c 'Twas the perfect balance of environmental 
conditions that made us. 'Twas also how we stand against the ever changing 
environment, to maintain a balance by reacting, regulating and relating to others, that 
made us. 
 
The Chinese word “Chung Yung” (), in English the “doctrine of mean”, (or the 
strikingly similar Swedish word “lagom”), briefly represents the wisdom of being “just 
right” - not too much; not too little. A deeper meaning of Chung Yung is to do the right 
thing as who you are and at the right time. In living organisms, one key to balance is “cell 
signaling”; the communication of cells among themselves and to its environment. If cell 
signaling is compromised, the balance will be tilted and diseases will incur. For instance, 
excessive proliferation signal at the wrong time could possibly lead to cancer. In fact, 
many oncogenes fall into the category of signaling-related proteins, such as growth 
factors, G-proteins and kinases. On the other hand, inadequate signaling could lead to 
the underdevelopment of important tissues and organs. For example, defective Notch 
signaling could lead to underdevelopment of multiple organ systems in Alagille syndrome 
(will be discussed in Paper IV). Moreover, some signals play an important role in 
maintaining cell identity and behavior. Lack of such signal could also cause cancer. Thus, 
many tumour suppressor genes are signal-related. 
 
Life has evolved complex languages of communication. Among the signaling pathways in 
the mammalian system, there is Notch signaling. It is highly evolutionary conserved, and 
involves in cancers and developmental diseases in human. This thesis contributes to the 
understanding of the roles and nature of Notch signaling in cancer and developmental 
diseases. 
Cell Signaling 
“Division of labor”, the specialization of different individuals, was one of the key factors 
that enable the advances of human civilization. Similarly, our body adopted the division 
                                               
a Pale Blue Dot is a photograph of the earth taken by the Voyager 1 space probe 6 billion  
km from earth. It inspired astronomer Carl Sagan’s book with the same name.  
b Stardust crusader is the title name of the Japanese manga “JoJo's Bizarre Adventure Part-
3” (Hirohiko Araki, 1989). 
c A signature movie line from from “Avengers: Infinity War” (2018) by the main 
antagonist Thanos, who wish to wipe out half of the lives in the universe to make 
balanced world. 
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of labor in different cells, tissue and organ systems. Yet, we are many but one. Cells have 
to communicate and coordinate to maintain an organism. As complex languages have 
developed for the communication among humans, we have also evolved various complex 
signaling pathways to serve different purposes in multiple ranges. 
 
There are multiple modes of action in signaling pathways, namely (a) intracrine: the 
signal produced and stay within the same cell; (b) autocrine: the signal secreted but act 
on the original cells; (c) juxtacrine: the signal stays on the cell membrane and signal 
adjacent cells by cell-cell contact; (d) paracrine: the secreted signal act on neighbouring 
cells; (e) endocrine: the secreted signal is released to the transport system and signal 
remote cells. Despite the diverse signaling pathways, possessing a great variety of 
properties and modes of action, each signaling pathway could be grossly categorized into 
four components: 
Signal – the external signal that triggers a signaling pathway. Typically, it is a protein, 
lipids, ions, or other small molecules. Collectively, they are called ligands. 
Receptor – the component responsible for receiving the signals.  
Signal transduction – a series of biochemical events that would relay or sometimes 
amplify the signals. Typical signal transduction involves small molecules known as 
second messengers, or a series of protein interaction termed signal cascade. 
Effector – the final component contributes to the response of the signaling pathway. It 
could be a transcription factor, a membrane channel protein or many other proteins 
responsible for different function in the cells. 
 
It is these differences in the components that determine the numerous properties and 
modes of action in various signaling pathways. Furthermore, each component on its own 
may possess non-canonical functions and properties, such as modification and cross-talk 
with other pathways, expanding our study to a vast uncharted realm. In this thesis, we 
will take a modular approach to study the roles of different components of Notch 
signaling.  
History of Notch signaling pathway 
The term “notch” stemmed from a Drosophila mutant strain characterized by notches on 
the wings, first described by Dexter in 1914 1. Because of its sexual linkage nature and 
easily observed phenotype, notch mutants were used by Sir Thomas Hunt Morgan in his 
heredity study, which led to the understanding of the role of chromosome in heredity, 
and eventually his Nobel prize in 1933 2,3. Poulson was the first to study the phenotype 
in notch null embryos, carefully described the cytological differences, such as cell fate 
lineage switch in the ectoderm, opening a new door to study notch in developmental 
biology 4. With the advances of molecular biology techniques in the 1980s, the 
Drosophila Notch gene was cloned and sequenced by Spyros Artavanis-Tsakonas’ and 
Michael Young’s  d group independently 5,6. The trans-membrane domain and the EGF-
                                               
d Michael Young was awarded the Nobel Prize in Physiology or Medicine in 2017 for his 
contribution to the understanding of the circadian rhythm. 
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repeats in the extracellular domain suggested that it is a membrane receptor. Not long 
after, Serrate and Delta, which genetically interacted with Notch, were found to be 
ligands of the Notch receptor 7–10. Meanwhile, the homologs of Drosophila Notch were 
found in C. elegans (lin-12 and glp-1) 11,12 and Xenopus (Xotch) 13, showing that Notch is 
evolutionarily conserved from invertebrates to vertebrates.  
 
In 1991, a translocated membrane protein partly resembling Notch (Translocation-
associated Notch homolog, TAN-1) , were found in multiple T-cell acute lymphoblastic 
leukemia (T-ALL) patients, suggesting the possible oncogenic role of Notch in human. 
This is also supported by the development of T-cell neoplasm in mice ectopically 
expressing TAN-1 in bone marrow progenitors 14. It was an exciting discovery, as finding 
a gene directly linked to both normal development and cancer were still novel at that 
time. This also illustrated how the study of a development gene in Drosophila could have 
great implications in human diseases. Subsequently, the molecular mechanism of Notch 
signaling was explored and the respective homologs of different components of Notch 
were found in many metazoan species (Table 1). Notch signaling is simple in principle, 
but versatile in action. Notch signaling were found to be important in development, 
homeostasis, cancer and various diseases. From stemness maintenance to promoting 
differentiation, from oncogenic to tumour suppressing, Notch plays both the black and 
white in a context dependent manner, orchestrating the Notch Signaling Requiem, a 
song of birth, rebirth and death. 

 Drosophila C. elegans Zebrafish Xenopus Mammals 
Ligands Delta 
Serrate 
lag-2 jag1a,b 
deltaA,D 
delta-like 4 
X-Serrate-1 
X-Delta-1 
Jagged1,2 
Delta-like1,3,4 
Receptors Notch lin-12 
glp-3 
notch1a,b 
notch3 
Xotch Notch1-4 
DNA-
binding 
proteins 
Suppressor of 
Hairless / 
Su(H) 
lag-1 rbpja,b X-Su(H) CSL (RBPJ) 
Canonical 
downstream 
targets 
hairy/enhance
r-of-split 
ref-1 
family 
her family Esr family Hes/Hey 
family, Nrarp 
Table 1. Orthologs of Notch signaling 
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Canonical Notch signaling pathway: Simple but Elegant 
Notch signaling is surprisingly simple given its long evolutionary history, dating back to 
cnidarian Hydra or further 15. Its basic principle and core units are highly conserved (Fig. 
1 and Fig. 2). Notch signaling is a cell-cell contact dependent signaling pathway, in 
which the membrane bound ligands, Jag1,2, Delta-like (Dll) 1,3,4 (mammalian 
homologs of Drosophila Serrate and Delta respectively), bind to and activate membrane 
bound receptors Notch1-4 (mammalian homologues of Drosophila Notch). Upon 
binding, Notch receptor undergoes a series of catalytic cleavages which lead to the 
liberation of the intracellular domain of Notch (NICD). NICD then translocates to the 
nucleus and joins the DNA-binding protein CSL (mammalian homolog of suppressor of 
hairless in Drosophila), subsequently recruits co-activators such as Mastermind-like 
(MAML, mammalian homolog of Mastermind in Drosophila) and p300, replacing the 
pre-occupying co-repressor and ultimately leads to the transcription of Notch target 
genes. Unlike many other signaling pathways, canonical Notch signaling does not involve 
direct amplification during signal transduction. 
 
 
 
While the general principle of Notch signaling is very simple, it is also highly versatile 
and most often works in a context dependent manner. How this simple mechanism 
could lead to complex outcomes is one of the most fascinating question in Notch 
signaling. Post-transcriptional modification, crosstalk with other pathways and regulation 
of the epigenetic landscape could be some of the ways Notch exerts its versatile actions 
and will be discussed further. 
Figure 1. The canonical Notch 
signaling pathway. Upon binding of 
a Notch ligand (Jag/Dll) and a Notch 
receptor, a pulling force is generated 
by endocytosis of the ligands and the 
activation of Notch receptor. The 
Notch receptor undergoes S2 cleavage 
by ADAM and S3 cleavage by 
gamma-secretase to liberate the 
Notch intracellular domain (NICD). 
The NICD then translocates to the 
nucleus and forms a complex with co-
activators such as MAML and the 
DNA binding protein CSL to switch 
from a Notch-OFF to Notch-ON 
state, activating downstream 
transcriptional targets.  
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Notch receptors  
Notch receptors are type I single-pass transmembrane proteins (Fig. 2), consist of the N-
terminal extracellular domain (ECD), the transmembrane domain and the C-terminal 
intracellular domain (ICD). Before translocation to the cell membrane, its immature 
form is cleaved by furin-like convertase in the trans-Golgi at the S1 cleavage site, 
subsequently forming a non-covalently bonded heterodimer of the extracellular domain 
and the intracellular domain 16,17. From the N-terminus, the first are the repeating EGF-
like domains. The number of repeats varies among receptors and species. In mammalian 
Notch receptors, it ranges from 29 to 36 repeats. Repeat 11-12 are responsible for ligand 
interaction, as shown in binding assay and loss-of-function experiments on Drosophila 
and mammalian Notch 10,18–21. Next follows the negative regulated region (NRR), which 
consists of 3 Lin-12-Notch repeats (LNR) and a heterodimerisation domain (HD). The 
HD is the remnant site of S1 cleavage, holding the two fragments together. The HD 
domain also contains the S2 cleavage site, which is accessed and cleaved by ADAM (a 
disintegrin and metalloproteinase) during ligand-receptor binding. The NRR is 
important to shield the S2 cleavage site from ligand independent activation. Mutations in 
the NRR compromised its inhibition and lead to auto-active Notch. This could explain 
why NRR is observed to be a mutation hotspot in leukemia patients22. Next is the 
transmembrane domain, which contains the S3 cleavage site. During ligand activation, 
S3 site is cleaved by transmembrane γ-secretase complex (γSec), subsequently releasing 
the NICD from the cell membrane 23. 
 
The NICD starts with the RBPJ-associated module (RAM) and ankyrin repeats domain 
(ANK), which interact with the DNA binding protein CSL (CBP/RBPjk, Su(H), Lag-1) 
24,25. The ANK is flanked by nuclear localization signal (NLS). RAM plays a more 
important role compared to ANK in binding to CSL26, while ANK but not RAM is 
required to bind to the co-activator MAML27. The next domain is the transactivation 
domain (TAD), which is only found in Notch1 and 2 but not in 3 and 4 in mammals. 
The C-terminus harbours a proline (P), glutamic acid (E), serine (S), and threonine (T) 
rich (PEST) domain, which is essential for rapid degradation of the NICD. Mutation in 
the PEST site would increase half-life of the NICD and thus upregulate Notch signaling 
28,29. 
Canonical Notch Ligands 
Canonical Notch ligands are also type-1 transmembrane protein (Fig. 2), classified into 
two groups – homologs to Drosophila Serrate (mammalian Jag1,2) or Delta (mammalian 
Dll1,3,4) respectively. The notch ligand ECDs consist of a Module at the N-terminus of 
Notch Ligands (MNNL) domain, followed by a cysteine rich DSL (Delta, Serrate, Lag-2) 
domain, both of which are important to the activation of Notch receptors 30–32. In a 
recent study, MNNL of Jag1, Jag2 and Dll4 was shown to react with the phospholipid of 
the cell membrane in the signal receiving cells to enhance signal transmission33,34. Then 
comes the EGF repeat domains, with the number of repeats varying among Notch 
ligands. The first two EGF repeats in Jag1,2 and Dll1 resemble the Delta/OSM-11 
(DOS) motif in C. elegans and are also involved in receptor interaction30,32. Mutation in 
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the 2nd EGF repeat of Jag1 results in the loss of ability in binding to Notch1 and 
subsequently give rise to Alagille syndrome like symptoms in mice, as discussed in Paper 
IV. The Jag family differs from the Dll family in the presence of a cysteine rich region. 
Dll-3 diverges the most from the rest of the ligands, with the degenerate form of DSL 
domain, the lack of DOS domain, and the localization to the Golgi rather than the cell 
membrane, and is believed to be an inhibitor of Notch signaling 35–38.  
 
 
Interaction of Canonical Notch Receptors and Ligands 
The most well studied Notch ligand-receptor interaction is the trans-activation, where a 
Notch ligand from a juxtaposed signaling sending cell binds to and activates the Notch 
receptors on the signal receiving cell. It has been observed that Notch ligands from the 
same cells could inhibit the Notch receptors from receiving signal, which is known as cis-
inhibition 39–41. In trans-activation, the ligand-receptor interaction creates a mechanical 
force on the NECD, initiates a conformational change of NRR, which exposes the S2 
site to ADAM metalloproteases mediated proteolytic cleavage. This is supported by 
measurement of mechanical force during interaction, and the ability of Notch induction 
even when the EGF domains are replaced by FKBP-FRB synthetic domains42. Under the 
Figure 2. Canonical Notch receptors and ligands.  
EGF, epidermal growth factor-like; NRR, negative regulatory region; LNR, Lin12-Notch repeats; 
HD, heterodimerization domain; TMD, transmembrane domain; RAM, RBP-J association module; 
ANK, ankyrin repeats; TAD, transactivation domain; NLS, nuclear localization sequence; PEST, 
proline/glutamic acid/serine/threonine-rich motifs; MNNL, Module at the N-terminus of Notch 
Ligands; DSL, Delta/Serrate/LAG-2; DOS, Delta and OSM-11-like proteins 
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endogenous condition, this force is generated by the endocytosis of the ligands 43, 
together with NECD into the signal sending cell 44.  
 
NICD and CSL 
Upon Notch receptor activation, the released NICD translocates to the nucleus and 
forms a complex with CSL (RBPj- κ) and MAML. CSL contains three domain: NTD 
(N-terminal domain), BTD (β-trefoil domain) and CTD (C-terminal domain), where 
the NTD and CTD resemble the Rel homology region. The NTD and BTD recognize 
and bind to the DNA, with a weak consensus sequence C/tGTGGGAA 45. It is believed 
that CSL, together with co-repressors (i.e. SHARP/MINT, KDM5A, and KyoT2 46), 
preoccupy Notch target sequence as a repressor of Notch targets, only until the formation 
of MAML-NICD-CSL complex, then switch from the repressive (Notch Off) state to the 
transactivation (Notch On)  state 27,47. However, there was a Chromatin 
immunoprecipitation (ChIP) study showing that NICD dynamically recruits CSL to the 
Notch targets, while CSL occupies Notch independent sites 48. This is further 
demonstrated by the fact that loss-of-function in CSL does not always initiate a 
derepressed Notch profile 49–52. Thus, the role of CSL as a default repressor of Notch 
targets is context dependent. Our results in Paper III are in line with the classical model, 
where in CSL knockout (KO) megakaryocyte (Mk) and erythroid (E) progenitor, 
classical Notch targets such as Hes1 and Hes5 were derepressed. Conversely, our results 
in Paper I support the later model in the breast cancer setting, as the CSL KO cell lines 
rarely have derepressed Notch targets. Meanwhile, majority of Notch independent genes 
were upregulated in the KO cells. This suggests that CSL may have a large array of 
actions beyond Notch signaling. A known example is its possible role as a mitotic 
bookmark 53. However, the modes of Notch independent actions of CSL remains largely 
unknown. The non-canonical roles of CSL will be further discussed below. 
 
Canonical Notch Targets 
The outcome of Notch signaling is diverse in organisms and cell types, but there is a 
limited subset of conserved Notch targets that is used as a benchmark or model to study 
Notch activation. One is the Hes family proteins (i.e. Hes1, Hes2 and Hes5 in 
mammals), named by classical Notch targets hairy and enhancer of split in Drosophila. 
Hes is a family of bHLH transcription factors, also possessing an orange domain 
responsible for dimer formation, and a WRPW domain with repressive function. Hey 
family (i.e. Hey1, Hey2 and HeyL in mammals) is a subfamily of Hes that is similar to 
the YRPW motif. Hes factors are rapidly degraded, thus they have a short half-life 54. On 
the other hand, it has been shown that Hes transcription is initiated within minutes of 
Notch activation 55, proposing that they may act as pulse transcriptional responders of 
Notch. Besides Hes/Hey, Notch-regulated ankyrin repeat protein (Nrarp) is also a 
common Notch targets in many instances in mammals 56. Although these genes are the 
most intuitive targets for initial examination when studying Notch activation, they are 
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still highly context dependent and not necessarily a guaranteed benchmark of Notch 
activation.  
Diversity in Notch Signaling 
The magnitude, modes and signaling output of the Notch ligand-receptor interaction is 
dependent on which receptors/ligands are involved, and the modifications of the 
receptors and ligands. Different Notch receptors could have opposite signaling outcome 
in the same situation 57,58. Notch1 and Notch3 were shown to be co-expressed in the 
same cell and have non-redundant functions in early intrathymic progenitor 59. One 
possible explanation of the differential outcome is the variations in the NICD. For 
instance, the significantly shorter TAD domain in Notch3 may explain its lower 
transactivation activity as compared to Notch1 and Notch2 60. However, the selectivity 
cannot be fully explained by the NICD, as mice with genetically swapped Notch1 ICD 
and Notch2 ICD showed no significant differences in development or cancer outcome 61. 
Notch4 is the least understood, as it may not be activated by ligand, but may be possible 
to cis-inhibit Notch1 in the same cell 62. The discrepancy of the reaction to the two 
different Notch ligand families is modulated by posttranslational modification of the 
Notch receptors and will be discussed below. In addition, ligands in the same family, 
such as Dll1 and Dll4, were shown to have non redundant function in the same tissue in 
vivo63.  The context dependent nature of Notch receptors remains largely unknown. 
Posttranslational modification of Notch receptors  
The ECD of Notch is modified with O-linked oligosaccharide (O-glycans). These 
alterations could modulate the response of Notch receptors to ligand activation. For 
example, O-glucose modified by Rumi is essential for Notch receptors to receive signals 
64. Modification by Fringe proteins is a typical example to show how these changes could 
structure and remodel the ligand-receptor interaction (Fig. 3). Fringe proteins are 
glycosyltransferases, first discovered in the Drosophila in 1994 as a modulator of Notch 65. 
In mammals, there are three Fringes known as: the Lunatic fringe, Manic fringe, and 
Radical fringe. They function by attaching N-acetylglucoseamine (GlncNAc) to the O-
fucose at the EGF repeats. These modifications by Fringe proteins play a role in 
regulating the response of Notch to different ligands. In mammals, Lunatic and Manic 
fringe enhance Delta-like trans-activation but inhibit Jag trans-activation, while Radical 
fringe enhances both Delta like and Jag trans-activation. It is also found that the fringe 
proteins have parallel effects on the cis-inhibition Notch ligands. These dynamics allow 
cells co-expressing Notch receptors and ligands to tweak their ability to receive and send 
different Notch signals 40.  
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Modulators of Notch receptors 
Besides Notch ligands expressed in the same cell and acting as cis-inhibitors of Notch 
receptors, there are other proteins that could inhibit Notch receptors. One classical 
example is Numb, which is a membrane associated protein negatively regulates Notch 
activity in Drosophila66. Its name comes from the loss-of-function mutation of Numb 
resulted in cell fate change and loss of sensory neurons. One of the proposed actions of 
Numb is by enhancing endocytosis of Notch, thus retaining it within the endosome 67. 
On the other hand, Bardet-Biedl syndrome proteins were found to be able to promote 
recycling of Notch receptor from the endosome to the cell surface68. The endosome-
lysosome transition is also modulated by proteins such as ESCRT and BLOS2, the loss of 
which causing accumulation of Notch receptors thereby enhancing Notch signaling 69,70. 
Other than direct interaction with Notch receptors, protein kinase C (PKC) θ could also 
enhance Notch signaling by remodeling the actin skeleton which leads to an increase of 
ADAM10 recruitment 71. 
Posttranslational modification of NICD 
As Notch signaling does not involve an amplification step as in other signaling pathways, 
the dynamics of NICD plays a key role in the signaling strength and cycle. An increase in 
half-life of NICD is sufficient to trigger hyperactive Notch signaling and outcomes such 
as cancer 28. Examples of posttranslational modification of NICD include: 
phosphorylation, methylation, hydroxylation, acetylation and ubiquitylation. NICD 
could be phosphorylated by various kinases. For example, N1ICD and N3ICD could be 
phosphorylated at the NLS by PIM kinases, which is important to their nuclear 
localization and transcriptional activity 72. PKCζ mediated phosphorylation is important 
to the trafficking of the Notch receptor, as it enhances relocalization of NOTCH from 
the late endosome to the nucleus in Notch-ON state while it facilitates Notch 
internalization in Notch-OFF state73. Glycogen synthase kinase-3 β stabilizes N1ICD but 
reduces the activity of N2ICD 74. Another kinase, CDK8, phosphorylates NICD at the 
PEST, which in turns promotes the PEST-dependent degradation by the Fbw7 ubiquitin 
ligase 75. Nemo-like kinase (NLK) phosphorylates N1ICD near the ANK domain and 
decreases the trans activation activity by interfering with the formation of the active 
transcriptional complex. Conversely, NLKphosphorylation increases N3ICD activity 76. 
Finally, a recent study identified Eya1 as a phosphatase crucial to Notch signaling. Eya 
Figure 3. Modification of Notch 
receptor by Fringe proteins 
modulate trans and cis interaction 
of Notch signaling. All Fringe 
modifications enhance trans and cis 
interaction of Dll with Notch. 
Modification by Lunatic Fringe and 
Maniac Fringe inhibits while Radical 
Fringe promotes trans and cis 
interaction of Jag with Notch. 
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was shown to dephosphorylate N1ICD and increased its stability, which in turns led to 
the maintenance of Notch activity in craniofacial morphogenesis77.

N1ICD could be methylated by CARM1 (coactivator-associated arginine 
methyltransferase 1) at the TAD domain after the formation of a NICD-coactivator 
complex. This decreases the half-life of the ICD, yet increases its signal amplitude, 
indicative that this methylation promotes full but short Notch signals78. NICD could 
also be hydroxylated by Factor Inhibiting Hypoxia-Inducible Factor (FIH), which will be 
discussed below in the crosstalk of NICD and hypoxia signaling pathway 79,80. Notch1 
ICD was stabilized by acetylation at the conserved lysine residues franking the ANK 
domain, and is deacetylated and destabilized by SIRT1 in endothelial cells81. In contrast, 
acetylation of the Notch3 ICD promotes proteasomal degradation and reduces Notch 
activity in T-ALL82. Ubiquitylation of NICD primes it for proteasomal degradation. The 
E3 ubiquitin ligase Sel-10 ubiquitylates NICD at the PEST domain and initiates its 
degradation83–85. Deltex is another E3 ubiquitin ligase that ubiquitylates NICD at the 
ANK domain and mediates degradation 86,87. In recent years, there are more studies on 
ubiquitylation and deubquitylation as a dynamic process in the control of Notch signals. 
For example, the deubiquitinase Usp28 counteracts Sel-10 and causes stabilization of the 
NICD 88,89. 
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Non-canonical Notch signaling 
Although the main principles of canonical Notch signaling are highly conserved, the long 
evolutionary history must have provided ample opportunities to develop non-canonical 
modes of actions. These could be categorized depending on which module of Notch 
signaling is altered. First is non-canonical Notch ligands that could activate Notch 
receptors and trigger the release of NICD; second is a CSL independent signal outcome, 
such as crosstalk of NICD with other signaling pathways; third is the non-canonical role 
of CSL, which is independent of NICD and the upstream Notch pathway. 
Non-canonical Notch ligands 
There have been reports of nonJag/Dll proteins that could activate Notch receptors and 
elicit “canonical” downstream output. Examples include microfibrillar proteins MAGP-1 
and MAGP-2, Y-box protein-1 (YB-1), Delta/Notch-like EGF related receptor (DNER) 
and more recently Delta-like 1 homolog (DLK1) 90–93, where most of them possess EGF-
like repeats in their extracellular domain. These proteins were shown to bind to Notch 
receptor and cause the release of NICD and subsequent downstream signaling output. 
However, there is a growing realization that we still have a lot to uncover in the Notch 
ligand-receptor complexes 94. The above studies did not explore the scenario where 
Jag/Dll ligands are absent, therefore it is difficult to conclude whether they serve as a sole 
ligand, or just as modifiers of canonical Notch signaling. 
Non-canonical roles of CSL; Notch and epigenetics 
As discussed above, the non-canonical role of CSL is largely unexplored. We have 
covered above the role of CSL in the crosstalk with other pathways; the recent views on 
the dynamic binding nature of CSL; and the vast repertoire of Notch independent CSL 
binding sites. Are these sites targets of CSL as in non-canonical Notch signaling? Are 
these sites potential Notch targets that require other co-activators or epigenetic 
bookmarks to be active? Are these sites completely irrelevant for signaling but relevant for 
the role of CSL in epigenetics? Taken together with the context dependent nature of 
Notch signaling, it is of particular interest to explore the role of CSL in epigenetics. As 
described above, CSL is hypothesized to have a role in mitotic bookmarking, as CSL 
remains bound to DNA during mitosis in an embryonal-carcinoma cell line 53. In 
addition, CCCTC-binding factor (CTCF), a protein known to have profound functions 
in DNA loop formation, 3D genome organization and enhancer/promoter insulation95, 
was found to directly interact with CSL and possess overlapping binding sites with CSL. 
Moreover, Notch signaling was found to dynamically alter the H3K4me3 signature in 
CSL binding sites, as Notch inhibition would cause an erase and Notch reactivation 
would cause a reestablishment 96. In the same study, histone demethylase KDM5A, 
which erases H3K4me3 marks, was found to directly interact with CSL. These findings 
indicate that CSL interacts with epigenetic related proteins and play a role in epigenetic 
landscape. In another study, N1ICD was found to reduce H3K27me3 signature at 
NICD binding sites in T-ALL by antagonizing polycomb repressive complex 2 (PRC2) 
97. However, how N1ICD evicts PRC2, and whether CSL was involved, remained 
unexplored. There are numerous cases that Notch activation could alter epigenetic 
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marks, such as H3K27 acetylation in long range enhancers in T-ALL98, and H3K56 
acetylation in large amount of enhancers in Drosophila 99. In Paper I, we showed that the 
ablation of CSL in the breast cancer cell line MDA-MB-231 led to a significant change 
in transcriptomics that is Notch independent, where individual CSL knockout clones 
also show subtle differences in the transcriptomics changes. Alternatively, many of the 
CSL KO clones cease to develop after a few passages (unpublished), implicating that CSL 
could have some essential function that its ablation may not be easily adapted by the cell 
line in vitro. It would not be surprising if these large scopes of changes are linked to an 
epigenetic role of CSL.  
Crosstalk with signaling pathways 
CSL independent Notch signaling has been described since the 1990s. The earliest 
examples were found in both Drosophila and mammalian Notch signaling, such as in 
embryonic dorsal closure, muscle cell fate in Drosophila, and the inhibition of muscle 
differentiation in mammals 100–102. In Paper III, we showed that CSL-dependent 
canonical Notch signaling is dispensable in adult steady-state and stress myelo-
erythropoiesis in mice. Taken together with the opposite results in mice with combined 
deletion of Notch1 and Notch2 103, a CSL-independent Notch signaling pathway is most 
likely to be involved in the myelo-erythropoiesis. A more detailed look at the crosstalk of 
Notch signaling with other signaling pathways is performed in breast cancer cell lines, 
where Notch signaling was shown to upregulate interleukin-6 (IL-6) in an NICD 
dependent but CSL independent way, as the overexpression of dominant negative CSL 
did not abrogate the upregulation 104. This study showed that NICD acts through IKKα 
and IKKβ from the NF-κB signaling pathway, while NICD does not need to enter the 
nucleus to elicit the action. Interestingly, this pathway is also independent from the 
canonical NF-κB signaling pathway, as it does not activate a κB reporter. This 
demonstrates that Notch could be versatile in terms of crosstalk with other pathways and 
that NICD does not always act as a co-activator. Here, I will describe some signaling 
pathways involved in this thesis and some to illustrate how crosstalk with other signaling 
pathways are mediated. 
Crosstalk with the hypoxia signaling pathway 
In a variety of situations (i.e. development, homeostasis and cancer), cells are exposed to a 
low oxygen environment. Even in physiological conditions, tissues are generally exposed 
to 2-9% oxygen content, far lower than the atmospheric oxygen level in in vitro culture 
systems most laboratories adopt. In some scenarios, the oxygen content could be extreme, 
where <2% is usually considered a hypoxic environment 105. For example, in the 
developing embryo before placenta formation, the oxygen content could be lower than 
2% 106. Hypoxia in cancer was examined in the 20th century, as Otto Warburg observed 
that cancer cells prefer glycolysis rather than aerobic respiration. The radioprotective 
nature of highly hypoxic or anoxic (O2 < 0.02%) environments was also reported in the 
early 20th century, that tumour reoccurrence was seen even after radiation in such 
conditions. It is only until 1990s, with the discovery of hypoxia-inducible factor (HIF), 
which paved the way to study the molecular mechanism of hypoxia signaling 107,108. HIFs 
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are basic helix-loop-helix (bHLH) transcription factors that form a heterodimer with 
ARNT (Aryl Hydrocarbon Receptor Nuclear Translocator) and binds to hypoxia 
response element (HRE) sequences to initiate transcription. In mammals, there are three 
HIFs – HIF1α, HIF2α (EPAS), and HIF3α (IPAS). Under normoxic (oxygenated) 
conditions, HIF undergoes oxygen-dependent hydroxylation by prolyl-hydroxylases 
(PHDs) and will lead to rapid degradation, while under hypoxic conditions, HIF is 
stabilized and can thus drive the expression of downstream genes. Years of research have 
proposed numerous implications of hypoxia in cancer. The reprogramming to a hypoxic 
metabolism has been described as one of the ten “hallmarks of cancer” 109. In 2019, the 
Nobel Prize in Physiology or Medicine was awarded to Gregg Semenza, William Kaelin, 
and Peter Ratcliffe for their contribution to the understanding of hypoxia signaling. 
 
The possibility of a crosstalk between Notch and hypoxia is intuitive, as cells with high 
population density is likely to have more juxtaposed interaction and consumption of 
oxygen. Hypoxia signaling could upregulate Notch by upregulation of Notch signaling 
components in many settings. For example, hypoxia signaling upregulates Notch1 in 
neuroblastoma to instigate a cell-fate change to a neural-crest like phenotype 110. Hes1 
was also upregulated, but whether it is a secondary effect of the upregulation of Notch1 
or a direct crosstalk of Notch and hypoxia remained unexplored. Jag2 was found to be 
upregulated in breast cancer and led to an increase in vasculature formation, metastasis 
and cancer stem cell renewal 111,112. Dll4 is upregulated by hypoxia signaling in vascular 
development and angiogenesis in cancer 113–115. In most of these studies, Notch signaling 
was found to be required in the hypoxia induced response. A direct interaction of HIF1α 
and Notch signaling was discovered in neuronal and myogenic progenitors, such that 
under hypoxic conditions, HIF1α stabilizes N1ICD, enhances its transactivation activity 
and accompanies it to the Notch-responsive promoters 116. Similar crosstalk is also 
observed in the context of cancer, where hypoxia induces migration and invasion of 
breast cancer cells in a Notch dependent manner, through the stabilization of NICD by 
HIF1α 117. As a negative regulator of the hypoxia signaling pathway, FIH was found to 
hydroxylate NICD in the ANK domain and decreases its transactivation activity 79,80,118. 
It has also been shown that HIF1α could directly interact with the γ-Secretase complex 
and enhance the γ-Secretase activity, leading to elevated Notch activity in breast cancer 
cell lines 119. Taken together, these observations demonstrate that the hypoxia signaling 
pathway interacts with and regulates Notch signaling. 
 
Conversely, whether Notch signaling could regulate hypoxia signaling, is less studied. 
Notch was speculated to directly or indirectly regulate the hypoxia signaling, as NICD 
overexpression could further enhance hypoxia responsive genes in mouse ES cells in 
hypoxic conditions 120. In Paper II, we showed that Notch signaling enhances HIF2α 
mRNA and protein level in multiple cancer cell lines and primary cancer cells even under 
normoxic conditions, possibly through an intermediate effector. Interestingly, HIF1α is 
downregulated in some cell lines and primary cells, indicating that Notch may contribute 
to the HIF1α to HIF2α shift. We also showed Notch signaling requires HIF2α to 
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regulate a subset of Notch targets in a medulloblastoma cell line. In Paper I, we 
produced an unexpected result, i.e. that the loss of CSL led to an increase of HIF1α 
protein level in normoxic conditions in breast cancer cell line MDA-MB-231, through 
non-transcriptional control. NICD was shown to interact with HIFα, and the level of 
HIFα decreased when a γ-secretase inhibitor (DAPT) is applied, suggesting that NICD 
could stabilize HIF1α. Our two papers strongly support the notion that Notch signaling 
could regulate hypoxia signaling. In certain circumstances, Notch creates a “pseudo 
hypoxic” response, which as previously described is one of the hallmarks of cancer.
Crosstalk with the Wnt signaling pathway 
Wnt signaling is another evolutionary conserved signaling pathway, important in both 
development and cancer settings. The name of the ligand Wnt comes from the 
combination of Drosophila gene Wingless and mammalian gene originally called Int1, as 
they were found to be homologous. Wnt signaling functions in a double inhibition 
manner. In a Wnt-Off setting, the destruction complex (containing axin APC, CK1α, 
and GSK3β) phosphorylates β-catenin, which is the transcriptional activator in Wnt 
signaling, and leads to its rapid degradation. In the Wnt-On state, the binding of Wnt to 
a Frizzle family receptor will disrupt the destruction complex, causing the inability of 
GSK3β to phosphorylate β-catenin, and thus an accumulation of β-catenin. β-catenin 
will then form a transcriptional complex leading to the transcription of Wnt targets 121. 
Notch and Wnt work closely together in many developmental, homeostasis and cancer 
settings, either in synergistic, opposing, step-wise manner, or as a feedback control of one 
another, depending on the situation 122. For example, Wnt and Notch play a 
synergistically role in cell proliferation and tumourigenesis 123, but an opposing role in 
stem cell identity in intestinal stem cells 124. One mode of their interaction is 
transcription-dependent control. For instance, Wnt signaling upregulates Jag1 expression 
and thus Notch signaling in colorectal cancer 125. Alternatively, their components could 
directly interact and regulate one another. GSK3β was found to be capable of 
phosphorylating N1ICD and decrease its proteasomal degradation in embryonic 
fibroblasts 74. On the other hand, NICD could inhibit GSK3β activity in a CSL-
independent manner during myogenesis in mice 126. Whether this is due to the direct 
interaction of NICD with GSK3β or the secondary effect of other non-canonical Notch, 
was not explored. Lastly, Notch and Wnt components could interact and work together 
as a transactivation complex. For instance, MAML could act as a co-activator of β-
catenin 95. CSL, NICD and β-catenin were found to form a complex and activate arterial 
genes in vascular progenitors in mouse embryonic and adult vessels127.
Crosstalk with the NF-κB signaling pathway  
NF-κB is a family of transcription factor first identified as a DNA binding protein in B 
lymphocyte tumour. It is later found to be involved in several processes in immunity, 
inflammation and cancer. NF-κB is ubiquitously expressed but is normally inhibited by 
“inhibitors of NF-κB”(IκB), preventing it from translocation to the nucleus. In the active 
state of NF-κB signaling, IκB is phosphorylated by the IκB kinase (IKK) complex 
(consisting IKK α, IKKβ, and IKK γ/NEMO) leading to its rapid degradation, thus 
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releasing the NF-κB to translocate to the nucleus for target gene expression. In canonical 
NF-κB signaling, the IKK complex could be activated by Toll-like receptors (TLRs), 
tumour necrosis factor receptor (TNFR) and interleukin-1 receptor (IL-1R) 128. Both 
Notch and NF-κB signaling were demonstrated to transcriptionally upregulate 
components of the other pathways, such as in immune and liver cells 129. Meanwhile, 
they could also act cooperatively, such as in the regulation of the miR-223 axis in 
leukemia 130. NICD was found to directly interact with NF-κB components, either 
activating or inhibiting them 129. More interestingly, it was also observed that NICD and 
IKK could interact and act through a CSL-independent and NF-κB independent 
pathway 104, indicating modular mix-and-match could lead to further possibilities of 
signal transduction. 
Crosstalk with the TGF-β/BMP signaling pathway  
Bone morphological proteins (BMPs) are a group of signaling proteins discovered in 
1965 as a factor with the ability to induce formation of ectopic bone structures 131,132. 
They are part of the transforming growth factor β (TGF-β) superfamily (including 
factors such as activins, inhibins, noggin), which primarily act as ligands to the TGFβ 
receptors. BMPs, together with other members in the TGF-β superfamily, have 
profound functions beyond bone induction, including gastrulation, early embryogenesis 
and development of many organs. Upon binding of ligands, the TGF-β receptors, which 
are serine/threonine kinase receptors, form a heterodimer and lead to phosphorylation of 
the type I receptors in the dimer. This subsequently causes the phosphorylation of R-
SMADs (named after the C. elegans homolog Sma and Drospholia homolog Mad), which 
could then form a heterotrimer with co-SMAD (Smad4 in mammals). The trimer then 
translocates to the nucleus and acts as a transcription factor to initiate target gene 
expression133. Notch signaling and TGF-β/BMP signaling could interact in a few ways. 
First, TGF-β signaling could regulate the expression of Notch components in various 
manners134–136. Second, SMADs were found to directly interact with NICD. For 
example, N1ICD was found to interact with Smad3, while cooperatively and 
interdependently regulate the expression of Hes1 137. Similar interactions were also found 
between N1ICD and SMAD1 138, and between N4ICD and SMAD3 139. Finally, in non-
canonical TGF-β signaling, TGF-β type I receptor could be cleaved by the same γ-
secretase component that cleaves Notch receptors 140. With co-immunoprecipitation, the 
TGF-β ICD is found to be associated with NICD, indicating new ways of how NICD 
could cross-talk with TGF-β signaling.  
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Notch in development  
Developmental biology is the study of how organisms grow and develop into an 
organized and complex individual. It emerged post-WWI and reached a golden era over 
the last decades in the 20th Century. It has played a quintessential part driving 
advancement in cell and molecular methods, as a model to study molecular mechanisms, 
and inspiring other fields such as stem cell biology, regenerative biology, cancer biology 
and evolutionary developmental biology (evo-devo). It has also contributed to medical 
implications, such as developmental diseases and regenerative medicine. In the 21st 
Century, the focus in the field has shifted from traditional developmental biology to stem 
cell and regeneration, with the aim of development in relevant translational medicine. 
However, developmental biology is still essential. To know regeneration, one must know 
generation. 
 
The study of Notch started with the end phenotype of notched wings. It stepped up a 
notch by the observation of its roles in embryogenesis by Poulson 4, which opened the 
door of genetic analysis in embryogenesis and sparkled a golden era of developmental 
biology. In many developmental processes, Notch signaling plays important roles in cell 
fate decision and maintaining stem cell identity. In certain contexts, Notch could also 
promote differentiation. Loss of function of Notch signaling often leads to embryonic 
lethality. Haploinsufficiency of Notch components often links to developmental 
syndrome in humans. Thus, it is imperative to understand Notch signaling during 
development. 
Classical modes of action of Notch in development 
How a single zygote could give rise to the complex organism with different patterns and 
cell identity has been one of the most fascinating questions in developmental biology. 
Alan Turing first proposed a mathematical description of how two “morphogens” with 
simple diffusion gradients could lead to complex biological patterns 141. This was later 
demonstrated in many developmental scenarios, such as in anterior-posterior patterning 
and digit formation. However, patterning and cellular identity determination was not 
limited to diffusible morphogens only. Notch signaling was one of the classical models 
for studying pattern mechanisms such as lateral inhibition, asymmetric cell division and 
lateral induction. 
Lateral inhibition 
The term “lateral inhibition” was borrowed from neuroscience, where an excited neuron 
suppress its neighbours’ activity. Similarly in a field of cells each with an equal potential 
of a specific lineage, certain cells might stand out to be the “chosen ones” and suppress 
neighbouring cells from going towards the same lineage. This was initially described in 
the study of Drosophila sensory organ precursor (SOP) selection, where only one cell in a 
proneural cluster (PNC) will become SOP, creating a salt-and-pepper pattern (Fig. 
4A,B,C). Notch signaling suppressed SOP determination, as loss of Notch will cause all 
PNC cells to adopt a SOP lineage. In the classical lateral inhibition model, SOP started 
as a particular cell with slightly higher proneural activity than its neighbours. This will 
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lead to a slightly elevated activity of Delta, which will activate Notch of its neighbouring 
cells, hence suppressing their proneural genes and Delta. As a result, the SOP will receive 
reduced Notch signal sent back from its neighbours, forming a feedback loop, further 
amplifying its SOP fate 142. Recent studies suggested that this is not achieved by 
downregulation of Delta expression, but rather the inhibition of Neur-mediated Delta 
signal at a protein level 143. This mode of action is conserved and found in other systems. 
For example, in mammalian angiogenesis, the tip cell of a sprout expresses Dll4 to 
activate Notch1/3 in neighbouring cells, inhibiting them from taking a tip cell lineage 144. 
Binary cell fate decision 
Asymmetric division is another classical model in Notch mediated cell fate decision (Fig. 
4F). After SOP adopts its identity, it will subsequently divide into two cells with distinct 
lineages – one being the precursor of the sensory organ internal cells (pIIb) and the other 
being precursor of the sensory organ external cells (pIIa). Notch signaling promotes the 
pIIa lineage while suppresses the pIIb lineage, as gain-of-function of Notch leads to a 
pIIa lineage while loss-of-function of Notch leads to a pIIb lineage. In addition, NICD is 
only observed in the pIIa but not in pIIb. This asymmetry started with cell polarization, 
that the Notch inhibitor Numb resides to one side of the SOP. During cell division, only 
one daughter cell inherits the Numb, causing a Notch-Off profile and thus the pIIb 
lineage 67,145. A similar mechanism is also adopted and well studied in neuroblast cell fate 
decision 146. 
Lateral induction 
Lateral induction is another classical mode of action of Notch signaling in development 
(Fig. 4D,E). Instead of a negative feedback loop of Notch signaling, lateral induction 
utilizes a positive feedback loop. The signal sending cell promotes its neighbouring cells 
to the same lineage of its own, meanwhile also upregulates Notch ligands in the 
neighbouring cells to return the same signal, forming a positive feedback loop. As lateral 
induction enhances the signal sent from the induced cells, it could act as a relay to pass 
down the signal. One example is the vascular smooth muscle cells (VSMC) in the multi-
layer arterial wall. The inner-most layer of the VSMC progenitors receive Jag1 signals 
from the endothelial cells, upregulating their Jag1 expression and promoting its VSMC 
fate. With an elevated Jag1 expression, these VSMC progenitors relay the Jag1 signal to 
the next layer, also causing their Jag1 upregulation and VSMC determination. Thus, this 
second layer of VSMC progenitors could send back the Jag1 signal to the first layer, 
strengthening its Jag1 expression and VSMC fate, forming a positive feedback loop. At 
the same time, a similar loop is formed with the subsequent layer of cells 147. Likewise, 
Jag1 mediated lateral induction is also observed in pancreas148 and lens 149 development. 
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Notch in organ and tissue development 
Given the above versatile principles of the action of Notch, it is unsurprising that it plays 
a role in almost all organ-systems. Here, we will include some tissues and organs relevant 
to this thesis, and to illustrate Notch in action in various developmental processes. 
Notch and the segmentation clock during somitogenesis 
One of the conventional role of Notch in development is its contribution to the 
segmentation clock during somitogenesis. Somites are intermediate mesoderm derived 
embryonic structures, which give rise to ribs, muscles, vertebra and dermis, along the 
rostral-caudal axis in a segmented pattern150. Somitogenesis is the formation of somites, 
which starts from the caudal unsegmented growth zone in the presomitic mesoderm 
(PSM) of the embryo, budding one pair of new somites at the rostral end each time of a 
cycle. An oscillatory cycle of clock-linked genes such as c-hairy (chicken homolog of 
Drosophila canonical Notch target hairy) was observed. In every cycle, c-hairy is observed 
Figure 4. Classical modes of actions of Notch signaling. (A,B,C) Lateral inhibition. (A) A signal-
sending cell activates Notch in an adajacent cell, suppressing the signal sent back from it. (B) The lateral 
inhibition feedback strengthen the identity of the signal sender. (C) Over time, an originally uneven 
Notch signal with lateral inhibition will lead to a salt-and-pepper pattern. (D,E) Lateral induction. (D) A 
signal-sending cell activates Notch in an adjacent cell, upregulating the Notch ligand in the receiving cell, 
allowing it to propagate Notch signal further. (E) Over time, lateral induction causes the signal and 
identity to pass down to subsequent layers of cells. (F) Binary cell fate decision by asymmetric cell 
division. An SOP undergoes asymmetric cell division, where the Notch inhibitor Numb is only inherited 
to one daughter cell. Thus, it generates one Notch-ON daughter cell pIIa progenitor and one Notch-
OFF daughter cell pIIb progenitor, leading to distinct cell lineages. 
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transiently from the caudal side to the rostral side of the unsegmented growth zone. 
Upon the expression of clock-linked genes in the rostral end, cells at the prospective 
intersomic edge will undergo mesenchymal-to-epithelial transition (MET), forming a 
cleft separating the new somite and the new rostral edge of the growth zone. A recent 
study shows that clock is not required for the segmentation but likely to be an upstream 
to control its timing 151. The Notch1, Dll1, Dll3, Lunatic fringe and Hes7 were found to 
be important in somitogenesis 152–156. Inhibition of Notch signaling by GSI led to the loss 
of synchrony of the oscillatory clock, which is recovered after washout of the inhibitor 157. 
Multiple studies confirmed that Notch signaling is important in the synchrony rather 
than the production of the oscillatory pattern 158–161. This illustrates that Notch signaling 
could also function as a coordinator in terms of spatial and temporal synchrony. 
Notch in vascular development 
Notch signaling is indispensable in many stages of vascular development. Mutations of 
the Notch components in human often lead to vascular diseases. For example, 
abnormalities in the vasculature cause early onset stroke in patients with CADASIL 
(cerebral autosomal dominant arteriopathy with subcortical infarcts and 
leukoencephalopathy), which is associated with NOTCH3 mutations. Vascular 
abnormalities in ALGS (refer to “Notch in Alagille syndrome” section) caused 34% of 
mortality among patients 162. The blood vasculature originates from the lateral plate 
mesoderm, which first undergoes vasculogenesis to form a primitive vascular network 
consisting of arteries, veins and capillaries. Next, angiogenesis is the process of secondary 
sprouting of new vessels from this network. Notch1, Notch2, Jag1, and Dll4 null mutants 
are all embryonic lethal in  mice because of vascular abnormalities 163–166, indicative of 
their importance in early vasculogenesis. Notch also plays a role in arteriovenous 
specification. Notch activity, together with Vegf, Shh and Wnt signaling, promotes 
artery specification 127,167, while Notch signaling is suppressed by COUP-TFII in the 
veins to retain the venous identity 168,169. Moreover, Notch also contributes to 
angiogenesis, by controlling the balance of specialized endothelial cells called tip cells and 
stalk cells. The Notch-Dll4 axis inhibits angiogenesis and tip cells formation, as ablation 
of Dll4 caused increased tip cells and hyperbranching 170–172. On the other hand, Jag1 
promotes angiogenesis by antagonizing the Notch-Dll4 interaction, as the trans 
activation of Jag1 is inhibited by Fringe modification of the Notch receptors 173. Notch is 
also important for the integrity of blood vessels, for example the vascular smooth muscles 
cells surrounding the vessels. Loss of Jag1 or Notch3 both led to abnormalities in the 
vascular smooth muscles cells 174,175. This could potentially be the explanation behind 
brain hemorrhage seen in some ALGS patients and the early onset stroke in CADASIL 
patients.
Notch in heart development 
Heart is muscle, but heart is more than muscle. The heart is grossly composed of three 
layers - epicardium, myocardium and endocardium, with four chambers and an outflow 
tract separated by septums. The heart originates from the lateral plate mesoderm and the 
subsequent cardiac mesoderm at E6.5 in mice. As the cardiac mesoderm (marked by 
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transient expression of Mesp1 at primitive streak stage) migrates near the head fold, it 
forms the first heart field (FHF), which moves bilaterally to form the cardiac crescent and 
eventually fuse to become the primitive heart tube (PHT) (E7.5 – E8.25). This 
progenitor pool mainly contributes to the left ventricle (LV), and partly to the atria. The 
second wave of the Mesp1+ cells forms the second heart field (SHF), which lies dorsally 
and medially to the FHF. The SHF contributes to the outflow tract (OFT), right 
ventricle (RV), atria and the inflow tract (IFT) 176. As the embryo develops, the bilateral 
crescent folds and becomes the PHT, which opens dorsally. After its closure, the SHF 
joins anteriorly to form the OFT and elongate the heart tube. As the heart tube 
elongates, heart chambers start to balloon out and the heart tube loops to the right. The 
atrial and venous pole eventually moves dorsally and cranially and is thus displaced to the 
cranial side of the ventricles (E8.5 – E10.5). The formation of the OFT cushions (truncal 
cushion and conus cushion) and atrial-ventricular (AV) cushions happens at E9.5. The 
AV cushions fuse at the midline to separate the AV canal. The truncal cushion expands 
and joins the conus cushion to form a spiral aorticopulmonary septum, separating aorta 
and pulmonary trunk. Cardiac neural crest cells (CNCC), which originate from the 
ectoderm at the boundary of the neural plate, migrate and colonize the truncal cushion at 
around E9.5 – E10. CNCC has been found to be essential for proper septation in the 
OFT and remodeling for the semi-lunar valves 177,178. The epicardium forms from the 
proepicardial organ (PEO), which could be marked by Wt1 and Tbx18, located adjacent 
to the venous pole at E9.5. The PEO could contribute to interstitial fibroblast, however 
its contribution to the coronary vasculature and myocardium remains controversial 179.  
Notch signaling plays different roles during cardiac development and has been associated 
with human CHD. JAG1 was found to be mutated in 94% of ALGS patients 180,181, of 
which 77% were reported to have CHD. Around 15% of the JAG1 mutated ALGS 
patients have Tetralogy of Fallot (TOF), a cardiac syndrome characterized by four major 
symptoms. Among the ALGS patients with CHD, 45% of them are TOF with 
pulmonary atresia (PA), a severe form of TOF. Some patients have abnormalities in both 
right and left heart, which is very uncommon. One case of ALGS was reported with 
hypoplastic left heart. However, persistent truncus arteriosus (PTA) had not been 
reported 182,183. These results imply that JAG1 may be crucial in both left and right heart 
development and that it may play similar roles as TBX1. The absence of a genotype to 
phenotype correlation, and that cardiac phenotype varies even within a family, is 
intriguing and imply there is likely to be modifiers 184. NOTCH2 mutations were also 
found in ALGS, however the percentage of patients with CHD is lower compared to the 
JAG1 mutated patients in the same cohort 185. NOTCH1 mutations were reported to be 
associated with calcified aortic valve disease (CAVD) and TOF 184,186. Homozygous Jag1 
KO is embryonic lethal in mouse, while a heterozygous mutant showed no heart 
phenotype 187. The ALGS mouse model “Nodder” in Paper IV exhibits ASD, VSD and 
hypoplastic RV. Isl1Cre/+ mediated conditional KO of Jag1 led to VSD, DORV in the 
majority, and PTA in 10% of the mutants, while Isl1Cre/+ mediated dnMAML expression 
lead to VSD and PTA 188,189. However, pulmonary stenosis was only observed in a few 
Jag1 conditional mice and none in dnMAML conditional overexpressed mice. This is 
quite different from ALGS, where PTA was not reported and pulmonary atresia appears 
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in more than 40% of the TOF patients. The PTA observed may be due to a gene dosage 
effect by the complete ablation of Jag1 or Notch signaling in the SHF lineage, while 
ALGS patients only have heterozygous mutations. However, it is still of particular 
interest to understand why the high penetrance of pulmonary stenosis or atresia in ALGS 
TOF patients was not recapitulated in these mouse models, which is one of the main 
determinant of TOF severity in clinical perspectives.It is notable that Isl1 was later 
found to be also expressed in the CNCC lineage, and that the proposed role of Notch in 
SHF and OFT have to be reexamined 190. A mouse model more resembling the TOF 
phenotype is a Hey2 homozygous KO mutant, where VSD, pulmonary atresia, overriding 
aorta and RV hypertrophy, together with a ASD phenotype, was observed 191. Similarly, a 
double heterozygous mutant for Jag1 and Notch2 (Notch2+/-; Jag+/-) also displays TOF 
like phenotypes 188. Moreover, Notch signaling was also found to be critical in 
cardiomyocyte proliferation during trabeculation and EMT in heart valve formation 
192,193. 
Notch in liver development 
The liver originates from the foregut endoderm at E8.5 in mice, divided into two main 
lineages – the hepatocyte lineage and the cholangiocyte lineage. The hepatocytes are 
responsible for most of the metabolism in the liver, while the cholagngiocytes form the 
bioducts. The hepatocytes also produce bile, which is transported through the bile ducts 
to the gall bladder for storage 194. In the developing liver, a layer of hepatoblasts 
surrounding the portal vein expresses cholangiocyte markers such as Sox9, Hnf1β, and  
specialize into cholangiocytes (the epithelial cells of the bile ducts), resulting in a 
continuous layer called the ductal plate. Afterward, some hepatocytes adjacent to the 
ductal plate also express cholangiocytes markers. Lumens were then formed between 
these bipotent cells and the ductal plate, creating the asymmetrical bile ducts. Ablation of 
CSL in the hepatoblast lineage reduces cholangiocyte differentiation, while activation of 
Notch by N1ICD expression in hepatoblast lineage promotes it 195. Cholangiocytes 
express both Notch1 and Notch2, while only ablation of Notch2 impairs bile duct 
formation196. Nevertheless, simultaneous ablation of Notch1 and Notch2 in the 
hepatoblast lineage resulted in a stronger phenotype, indicating that Notch1 partly 
compensates for the function of Notch2 197. Heterozygous mutations of Jag1 and Notch2 
lead to paucity of the bile ducts 188, revealing that the Jag1-Notch2 axis is imperative in 
the bile duct formation. Conditional knockout of Jag1 in hepatoblast lineage does not 
lead to developmental abnormalities in the bile ducts 198, denoting that the vital Jag1 
signal is likely sent from elsewhere. It was later shown that Jag1 in the smooth muscle 
cells but not the endothelial cells is important for bile duct maturation199. In Paper IV, 
we established that a missense mutated Jag1 mouse line has lower Sox9 expression in 
cholangiocytes, and recapitulate the bile duct phenotype in ALGS patients. This is 
possibly due to the inability of the mutated Jag1 to bind to Notch1 and its reduced 
ability to activate Notch2. 
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Notch in haematopoiesis  
Haematopoiesis refers to the generation of various cell types in blood, such as 
erythrocytes (red blood cells or RB), megakaryocytes (give rise to platelets), and 
immune cells. They arise from two distinct haematopoietic lineages: the lymphoid 
lineage which gives rise to T cells, B cells and natural killers; and the myeloid lineage 
which gives rise to megakaryocytes, erythroid, and granulocyte-macrophage lineages. 
Haematopoiesis occurs at different places throughout various stages of development, and 
continuously occurs at the bone marrow in adult for replenishment of blood cells. The 
first wave of haematopoiesis is called the primitive haematopoiesis, which happens at 
mouse E7.5, giving rises to only erythrocytes and myeloid progenitors but not definitive 
haematopoietic stem cells (HSCs). The definitive haematopoiesis gives rise to definitive 
HSCs, capable of self-renewal and development into all HSC lineages. It begins at the 
aorta-gonadmesonephros regions (AGM) at E9, later shifting to the fetal liver, 
subsequently to the bone marrow in adults. Notch has been found to be essential in the 
embryonic definitive haematopoiesis in the AGM, as ablation of Notch1, CSL or Delta-
Notch activating Mindbomb led to the loss of HSCs from AGM 200–202. Furthermore, a 
recent study demonstrated that the Dll4 suppresses the recruitment of surrounding 
hemogenic cells in the intra-aortic hematopoietic cluster 203. Meanwhile, primitive 
haematopoiesis seems to be Notch independent, as the loss of Notch does not lead to 
alterations in the haematopoietic progenitors from such process 200. Notch signaling is 
important in the T-cell/B-cell switch in the lymphoid lineage. Activation of Notch1 
signaling skews differentiation towards the T-cell lineage instead of the B-cell lineage 204, 
while inactivation of Notch1 or CSL inhibits T-cell development but promotes B-cell 
development 205,206. The roles of Notch signaling in the erythroid and megakaryocytes 
lineages are highly debated. Some studies showed that Notch-Dll1 favors the 
megakaryocytes lineage over the erythroid lineage 207, while other studies showing the 
opposite, i.e. that Notch signaling favors the erythroid lineage but suppresses the 
megakaryocyte differentiation 103,208. CSL null mouse embryos exhibited reduced 
apoptosis of yolk sac originated erythroid cells 209. In Paper III, we showed that canonical 
Notch signaling is dispensable in adult myelo-erythropoiesis by haematopoetic specific 
ablation of CSL. This indicates that the results in other studies, which used different 
experimental strategies including perturbation of Notch receptors and ligands, may be 
driven by non-canonical Notch signaling, which is worth reexamination. 
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Notch in Diseases 
A brief history of cancer 
Cancer is the malignant form of development, the uncontrolled growth of invasive and 
even metastatic tissues. Fossil evidence showed it might have presented in human 
ancestors as early as 1 millions years ago 210. In modern human, cancer has been known 
for a long time and described by Egyptians as early as 3000 BC 211. The word cancer 
came from the Greek word “karkinos” (crabs), which was used by Hippocratic physicians 
to describe tumours, as they were often compared to the shape of a crab 212. The long 
history of cancer does not prevent it from being a mysterious disease before the 
knowledge of mutation and oncogenes. In late 19th and early 20th Century, different 
factors were thought to be linked to cancer, ranging from chimney sweeping, virus, to 
radiation. Radiotherapy and chemotherapy were used to treat cancer, yet many cancer 
patients reacted differently and some were even insensitive to treatment. Relapse in 
cancer is often met with grave prognosis and was described as early as in the 1st Century 
211. With modern genetics and molecular biology knowledge, we now know cancer is not 
a single disease, but a collection of diseases. Different mutations can cause different 
subtypes of cancer, and mutations could progress through time. These mutations could 
lead to oncogenes, mutated genes that could potentially cause cancer, or disruption of 
tumour suppressor genes, genes that are vital in protection from cancer development. 
Even within a tumour, there is a high degree of heterogeneity. Hanahan and Weinberg 
described ten checkpoints cancer development has to go through as hallmarks of cancer 
109. As mentioned above, many oncogenes were found to be signaling-related. Among 
them, Notch signaling is one on hot pursuit. Therefore, it is imperative to investigate the 
role of Notch signaling in cancer to fully understand the underlying mechanism and 
develop relevant treatment. 
Notch as an oncogene 
The study of Notch in humans started with its association to cancer, as the truncated and 
translocated form of Notch1 (TAN-1) was first cloned in a few T-ALL patients 213. Jon 
Aster’s group later confirmed the connection from the discovery of frequent gain-of-
function mutations in Notch1 in T-ALL patients (54 out of 96) 28. These mutations are 
mostly located either in the NRR region, leading to disruption of the protection from γ-
secretase, or in the PEST domain, leading to an increased half-life of the NICD. The 
gain-of-function nature of these mutations was confirmed experimentally in the same 
study. The first evidence of the oncogenic role of Notch in solid tumours came from the 
study of how mouse mammary tumour virus (MMTV) induced breast cancer in mice, 
where one of the insertion by the virus was later found to trigger the expression of 
N4ICD 214,215. To date, Notch signaling is known to be correlated with and have 
implications for many different types of cancer, such as breast cancer, medulloblastoma, 
colorectal cancer and non–small cell lung carcinoma 216,217. Notch signaling could directly 
promote cell proliferation in cancer. For instance, the Jag1-Notch1/3 axis was found to 
directly upregulate cyclin D1 expression and subsequent cell cycle progression in human 
triple negative breast cancer cell lines and in rat cell lines 218,219. Promotion of cell 
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proliferation or survival was also reported in many cancers, such as adrenocortical 
carcinoma 220, glioma 221 and liver cancer 222. Additionally, Notch1 was observed to have 
anti-apoptotic activity in prostate cancer 223. Besides cell survival, Notch activity plays a 
role in metastasis and recurrence. Blockade of Notch signaling could inhibit EMT and 
subsequent metastasis in human breast cancer xenograft in mice, by rescuing the low E-
cadherin expression via Slug suppression 224. It has been shown that hypoxia enhanced 
cancer migration and invasion is dependent on Notch signaling. Moreover, 
overexpression of NICD in normoxia could replace hypoxia in induction of cell invasion 
117. There are also reports of correlation of high Jag1 expression to metastasis and 
recurrence in prostate cancer 225,226, which merits further studies. 
Notch as a tumour suppressor 
As described above, the outcome of Notch signaling is highly context-dependent. 
Although mutations in Notch were originally discovered to be oncogenic, and found to 
be hyperactive in many cancers, the role of Notch mutations as a tumour suppressor was 
also reported. Notch signaling typically acts as the stem cell gatekeeper in many organs, 
which could explain why hyperactive Notch could lead to tumourigenesis. However, 
Notch signaling has an opposite role in skin, i.e. it promotes differentiation and cell cycle 
arrest rather than stem cell identity 227–230. It is not surprising that loss-of-function of 
Notch is oncogenic in such settings. In many squamous cell carcinoma (SCC), recurrent 
mutations of Notch signaling components were found, such as in head and neck SCC, 
cutaneous SCC, lung SCC, oesophageal SCC and bladder SCC 231–235. Most of these 
mutations reside in functionally important domains, thus likely to be loss-of-function 
mutations. Loss of Notch1 facilitated chemically induced skin cancer in mice, possibly 
through increased Shh and Wnt signaling 236. Notch inactivation by ablation of CSL or 
expression of dnMAML in mice promotes bladder SCC progression 237. Expression of 
dnMAML also result in perturbed suppression of oesophageal cell population with 
carcinogenic mutations in p53, which could be an early event in oesophageal SCC 
development 238. Besides SCC, Notch signaling was also revealed to have tumour 
suppressing activity in forebrain tumour subtypes, as the inactivation of Notch through 
ablation of CSL enhanced glioma tumour growth and promote neuroectodermal-like 
tumours in the absence of p53. However, in these studies, Notch inactivation alone does 
not seem to directly induce cancer, but rather enhanced the progression of developed 
cancer or cancer induction by other agents.
Notch in breast cancer 
As of 2018, breast cancer has been the most commonly diagnosed cancer, and is the 
leading cause of cancer related death in over 100 countries 239. Breast cancer arises from 
the mammary system, which is responsible for milk production and secretion for the 
nurture of offspring. Unlike many other organs, morphogenesis of the mammary system 
predominantly occurs at postnatal period, puberty, and undergoes cycle of development 
and involution during pregnancy. The mammary system consists of lobular units, which 
are the primary units for milk secretion, connected by collecting ducts converging at the 
nipple. The lobules and ducts are made of a basal membrane, a myoepithelial layer, an 
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inner luminal layer, and a central lumen. During mammary development, the mammary 
stem cells activate from a quiescent state, and could specialize to become either basal 
progenitors or luminal progenitors. The basal progenitors will form the myoepithelial 
layer, while the luminal progenitors will develop into two subtypes, either double positive 
progenitors of estrogen receptor (ER) and progesterone receptor (PR) or the ER- PR- 
progenitors. The former will form the luminal cells, while the latter will form the alveolar 
cells (mammary gland development is reviewed in 240). Breast cancer arises from the 
lobular units, and can be classified into multiple subtypes, including the Luminal A (ER+, 
PR+, HER2-), Luminal B (ER+, PR+, HER2+), HER2+ (ER-, PR-, HER2+), Basal-like (ER-, 
PR-, HER2-) and Claudin-low. These could be corresponding to origins from mammary 
progenitors at different stages and lineages. In clinical settings, breast cancer with no ER, 
PR or HER2 markers is diagnosed as triple negative breast cancer (TNBC). Basal-like, 
Claudin-low and TNBC have the worst prognosis, and frequently develop resistance to 
chemotherapy 241. 
 
As mentioned above, breast cancer is the first solid tumour that was found to be linked to 
Notch signaling, by MMTV causing N1ICD and N4ICD expression and inducing 
mammary tumours 215,242. This is confirmed by luminal specific overexpression of 
N4ICD, where mammary tumours develop after transgene activation 243. In Paper V, we 
found that expression of N1ICD in luminal lineage after lactation is sufficient to cause 
mammary tumour, although in lower frequency compared to the MMTV induced ones. 
Although not as commonly found as in T-ALL, mutations of Notch receptors were 
found in breast cancer patients 244,245. High levels of NOTCH1 and JAG1 expression have 
been shown to correlate to poor survival in breast cancer patients 246. In addition, NUMB 
mediated regulation of Notch was found to be lost in ~50% of breast cancer in a study, 
and the level of NUMB is inversely correlated with tumour grade 247. Accumulating 
evidence has implicated the important role of Notch signaling in the metastasis of breast 
cancer. Inhibition of Notch signaling by the expression of N4ECD inhibited EMT and 
metastasis in xenograft of human breast cancer cells in mice, as the Jag1-Notch axis 
upregulates endogenous Slug, which then downregulates E-cadherin 224. Additionally, 
hypoxia-enhanced cell migration and invasion requires Notch signaling, where 
overexpression of NICD could replace hypoxia to induce such increase in migration and 
invasion in normoxic conditions 117. Notch signaling is also important in the glycolytic 
switch of metabolism, another hallmark of cancer, in a breast cancer xenograft model 248. 
Moreover, Notch could elicit resistance in breast cancer therapy 249. Besides canonical 
Notch signaling, non-canonical Notch signaling also plays a role in breast cancer, as the 
mammary tumours caused by N4ICD expression 243 were later found to be CSL 
independent 250. In Paper I, we found that ablation of CSL is pro-proliferation, anti-
apoptotic, pro-angiogenic and leads to higher homogeneity in xenograft of human breast 
cancer cells in mice, and that the transcriptomic change is largely distinct from canonical 
Notch signaling. This indicates that non-canonical Notch signaling could play an 
unexpected role in breast cancer.  
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Notch and Alagille syndrome 
Alagille syndrome (ALGS) is a rare autosomal dominant multisystem disorder, found in 
1 in 30,000 infants. It was initially described by French pediatrician Daniel Alagille in 
1969. The symptoms include the easiest identified cholestasis (caused by liver and bile 
duct abnormalities), followed with abnormalities in eyes, skeleton, facial muscle, kidney, 
and the heart, although different symptoms are variable in penetrance 251. Mutation 
mapping and sequencing results revealed the predominantly mutated gene in ALGS 
patients to be JAG1, which is found mutated in 94% of ALGS patients 180,181, while 
NOTCH2 mutations were found in only 1% of ALGS patients 185. Liver problems, 
including paucity in the bile ducts, are the most severe and visible phenotypes, as it 
causes cholestasis and subsequently jaundice. Liver abnormalities are found in more than 
95% of patients, where 15% of patients develop liver cirrhosis and failure, which require 
liver transplantation. Congenital heart disease is also commonly found in ALGS patients 
(77% to >90%) 251. Two-thirds of them have pulmonary stenosis and 15% of them have 
TOF, which is a severe form of heart defects with ventricular septal defect, aorta 
misalignment and possibly pulmonary stenosis and even atresia, causing difficulties to 
provide oxygenated blood to the body. These complex heart problems contribute to early 
mortality. Vascular abnormalities are prevalent in ALGS and contribute to 34% of deaths 
in one study 162. 
 
There have been numerous attempts to generate mouse models for ALGS, however most 
displayed limited phenotypes. For example, three different heterozygous Jag1 mutant 
mouse lines have the inner ear phenotype, i.e., the Headturner 252 , Slalom 253 and Ozzy 
254 (all named by their behavior due to inner ear problem). Conditional ablation of Jag1 
also help understanding the role of Jag1-Notch axis in individual organ-system affected 
in ALGS 199,255,256, however may not reflect the haploinsufficient nature of Jag1 mutations 
in ALGS. A double heterozygous mouse line for Jag1 and Notch2 reflects symptoms in 
multiple organ system as in the ALGS patients, including abnormalities in bile duct 
differentiation, kidney, heart and growth, although NOTCH2 mutations are rarely found 
in ALGS patients 188. A more recent study found that the heterozygous null mutation of 
Jag1 in C57B6 genetic background leads to a bile duct phenotype, advancing the 
understanding of the Jag1-Notch axis in bile duct development 257. Although these may 
not fully recapitulate all the ALGS phenotypes, they are valuable for the understanding of 
the role of Jag1 in development of different organ system. In Paper IV, we established a 
homozygous Jag1 missense mutant mouse line “Nodder”, which is able to reflect 
phenotypes in most organ system affected in ALGS. 
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Methods in Notch signaling 
Molecular biologists have always been the pioneers in invention and engineering in 
biological sciences. Much of today’s knowledge and tools in modern biology, 
biotechnology and pharmaceuticals came from pivotal advances in molecular biology, 
ranging from molecular cloning, recombinant DNA technology, tissue culture, cross-
species xenografts, antibody-based tools to gene editing tools. I will here provide a brief 
overview of the methods used and developed to study Notch signaling. 
Activation and inhibition of Notch 
One of the best tools in the arsenal of Notch signaling regulation is γ-secretase inhibitors 
(GSIs), such as DAPT. GSI inhibits γ-secretase from cleaving the Notch receptor, thus 
blocking all NICD mediated responses in cells. Inhibition of canonical Notch signaling 
could also be achieved by overexpression of dominant negative (dnMAML), dominant 
negative (CSL), or truncated Notch ECD as a competitive inhibitor (genetic tools will be 
discussed below).  
 
Conversely, activation of Notch can be attained by immobilized Notch ligands, as 
soluble Notch ligands have been shown unable to activate Notch signaling. In a typical in 
vitro setting, protein G is first coated on a cell culture dish, followed by IgG fragment 
(Fc) conjugated Notch ligand coated on the plate. It is also worth to note that upon cell 
dissociation by trypsin, Notch receptors will be sheared and Notch targets will be 
activated. This should be considered in experimental design. Overexpression of NICD is 
also a commonly used method. Additionally, we utilized a NICD-ERT2 fusion protein 
expression vector, where NICD only enters the nucleus upon the presence of tamoxifen 
(genetic tools will be discussed below). Similarly, co-culturing of cells expressing Notch 
ligands is another option. In some cases, Notch ligands are expressed in cells from one 
species while Notch receptors are expressed from another. With the S3-cross-specific-
sequcing method our lab have developed, one could specifically analyze transcriptomic 
results from either the sender or the receiver 258. Moreover, agonistic and antagonistic 
anti-Notch antibodies is also available as a tool to activate or inhibit Notch signaling259. 
Genetic tools: expression vectors, recombinant DNA, reporters 
Overexpression of genes is one of the most direct tool in molecular biology. It is usually 
achieved by transient expression of plasmid or stable integration. Modified RNA 
(ModRNA) is an emerging clinically relevant tool, as it is risk free of random integration, 
and the short expression time window could be ideal for therapy or temporal studies 260. 
Typically, overexpression of a transgene is driven under a ubiquitous promoter such as: 
CAG, UBC, EF1α (for mammalian expression). EF1α is one of the shortest mammalian 
ubiquitous promoter, however one should note that it may not work in all mammalian 
cells. Inducible expression is often achieved with the doxycycline inducible Teton system 
(required an expression of Tet transactivator). To express more than one transgene under 
the same promoter, a 2A peptide sequence or an internal ribosomal entry site (IRES) are 
often used. The 2A peptide sequences are peptides susceptible for spontaneous cleavage, 
therefore enable two transgenes to split into individual proteins after translation. On the 
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other hand, IRES provides an alternative site for the ribosome to start translation, thus 
two transgenes are translated separately. For stable integration, lentivirus is commonly 
used. However, since it has a cargo size limit of 4kb, and as cDNAs of many Notch 
components are larger than 4kb, lentivirus may not be optimal. We utilized a Piggybac 
transposase system, which is highly efficient, with a cargo size of up to 100kb 261. The 
integrated transgene could be silenced over time, therefore, knock-in to the AAV locus or 
ROSA26 locus is preferable for stable expression. With CRISPR Cas9 technology, it is 
considerably more feasible to achieve this with limited efforts 262,263(See “CRISPR Cas9 
Gene-editing”). Alternatively, one could introduce genetic insulators flanking the 
transgene to avoid silencing 264. The Cre-recombinase loxP system is also frequently used 
as a conditional knockout or lineage activation tool. Upon expression of Cre 
recombinase, the DNA sequence flanked by two loxP site (floxed) will be removed. In 
Paper V, we used a ROSA26-floxed-StopCassette-NICD-IRES-EGFP mouse line, in 
which NICD and EGFP will be expressed in the entire cell lineage once Cre is present. 
An effective stop cassette typically contains a few poly A signals, to ensure the mRNA is 
polyadenylated before the transgene. 
 
Besides overexpression of full length Notch receptors or Notch ligands, overexpression of 
NICD is a commonly used strategy for gain-of-function studies. Conversely, 
overexpression of dnMAML is often utilized to inhibit canonical Notch signaling. 
However in Paper III, our results with CSL ablation differed from those in previous 
studies using dnMAML, indicating that dnMAML may affect pathways other than 
Notch signaling. The use of dnMAML thus has to be carefully reexamined. Fusion 
protein is an effective technique to add or remove functions from a protein, for example 
adding florescent tags for easy visualization and possibility of live cell imaging or 
fluorescence resonance energy transfer (FRET) experiments to study protein-protein 
interaction. A V5 tag or FLAG-tag is ideal for immunoprecipitation (IP) or ChIP, 
because of their short length and availability of high-quality antibody. These tags are 
easily introduced by CRISPR to the endogenous locus, making it easy to study the 
biology of the endogenous protein, avoiding artifacts introduced by overexpression. In 
Paper II, we used a N1ICD ERT2 (NERT2) fusion protein, where NICD is prevented 
from translocating to the nucleus except in the presence of tamoxifen. Lastly, 12xCSL 
reporter is a plasmid with 12 CSL binding sites preceding a reporter gene, serving as a 
reporter of Notch signaling. We have integrated this into a Piggybac plasmid, making it 
easy to generate Notch reporter cell lines or mice. 
CRISPR Cas9 Gene-editing 
Although powerful tools such as transgenic, overexpression and gene knockdown 
methods exist, the gene-editing approach stands out in a few ways. For example, gene-
editing enables complete KO of a gene, providing a better alternative to siRNA 
knockdown approaches, which may still has remnant expression of the target gene. 
Furthermore, precise gene-editing reflects a more relevant genotype in human diseases 
(i.e. point-mutation). In introducing a tissue specific expression of a transgene, it is easier 
to knock-in the transgene of interest to an endogenous locus, compared to using an 
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exogenous promoter, which requires previous knowledge in the first place, but may not 
yield accurate tissue specificity. Traditionally, gene-editing relied heavily on homologous 
recombination, which occurs with extremely low probability. In addition, it also requires 
cloning of large donor constructs and a series of selections, rendering the process time-
consuming and tedious. Recent advances include protein-based targeting tools such as 
zinc finger nuclease and TALEN 265, which still requires substantial cloning effort. 
Therefore, it is revolutionary in gene-editing when CRISPR(clustered regularly 
interspaced short palindromic repeats)-Cas9, an RNA-guided gene-editing tool, emerged 
266.  
 
CRISPR-Cas9 is a reverse-engineered tool based on the immune system in bacteria 
Streptococcus pyogenes. In brief, the bacteria uses a Cas9 endonuclease and guide RNAs 
(gRNAs) to identify and remove viral inserts. Following reverse engineering, the 
CRISPR-Cas9 tool boils down to two main componentsthe Cas9 endonuclease 
protein, and a single gRNA (sgRNA) with a custom recognition sequence. The most 
commonly used S. pyogenes Cas9 (SpCas9), together with the presence of an sgRNA with 
a 20bp custom recognition sequence, targets matching sites at the genome, provided that 
the site precedes a PAM(protospacer adjacent motif) sequence of “NGG”. The Cas9 
endonuclease will then create a double stranded break three bp 5’ from the PAM 
sequence. This will trigger the cell to undergo DNA repair with non-homologous end 
joining (NHEJ), which in turn randomly deletes or inserts short sequences at the break, 
potentially causing a frame shift mutation. In addition, if a DNA construct is also 
provided, it may be inserted to the break site. Furthermore, if two double stranded breaks 
are made, large deletion may also occur 267, providing an alternative way to achieve gene 
knockout. Alternatively, if a donor construct with homology arms (each greater than 
50bp) is provided, the cell may undergo homology directed repair (HDR) and seamlessly 
replaced the disrupted sequence with the donor. As the sgRNA could be easily designed 
and produced within a few days, CRISPR-Cas9 is an easy and versatile tool. Its high 
efficiency make in vivo genome editing viable, both facilitating genetically engineered 
cells and animals, and the possibility of gene-editing based therapy. To date, advances are 
made by introducing other members of the CRISPR-Cas family, or by engineering the 
Cas9 endonuclease. For instance, Cas9 alternatives with different PAM recognition sites, 
Cas9 alternatives with smaller molecular size, Cas9 nickase, Cas9-based activator, RNA-
editing CRISPR and single base pair substitution tools have been developed 268. 
 
In Paper I, we successfully used CRISPR-Cas9 to knock out CSL in breast cancer cell 
line MDA-MB-231, creating a more refined version of the loss-of-function experiment as 
compared to an shRNA based CSL knockdown study. We also knocked out CSL, 
Notch1 and Notch2 in the medulloblastoma cell line DAOY in Paper II with the same 
method. Meanwhile, we developed a Cas9 based lineage tracing system (CAST) 
(unpublished), where Stop cassettes are flanked by a combination of different gRNA 
target sites. Thus, the transgene could be activated by a combination of gRNA 
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expression, allowing a logic-gate like control. The general design principles and 
recommendation for CRISPR-Cas9 gene-editing experiments are summarized in Table 2. 
 
 Design principles/ Recommendation  
Introduction of 
Cas9 protein 
DNA vector: Cas9 expression by Px458 (GFP selection) or 
Px459 (puromycin selection) from Addgene. 
Cas9 mRNA: Better for single-cell injection to avoid mosaicism. 
Introduction of 
gRNA 
DNA vector : gRNA sequence cloned into Px all-in-one vectors. 
Synthesized double stranded DNA: Gblock (IDT) with T7 
promoter and terminator. 
In vitro transcribed gRNA 
Design of gRNA Tools: CHOPCHOP v3 269,270 (more sgRNA design and 
prediction tools are reviewed by Liu et al.153). 
Criteria: Preceding a PAM sequence; high predicted efficiency 
and low predicted off-target score 269,270. 
Remarks: Cell types and epigenetics may severely affect the 
efficiency of the cutting 271 even with high predicted score. 
Benchmarking 
and 
troubleshooting 
of gRNA 
Remarks: The efficiency of the gRNA seems to be the 
determinant in most CRISPR experiments. Therefore 
benchmarking and troubleshooting of the gRNA is essential. 
Methods: T7 endonuclease assay; or PCR followed by TA 
cloning and sequencing. 
Troubleshooting: Repeat with different gRNAs. If no efficient 
sgRNA is found in a particular locus, it is recommended to try 
large deletion (0.5-3kb) approach or a large fragment knock-in 
approach, using sgRNA targeting sites distal from the original 
locus. 
Screening of 
positive cell lines 
Remarks: The most time and labor intensive part. 
Method 1: Manual picking of single cell colony. Cleanest but the 
most intensive method. 
Method 2: Introduction of a small DNA fragment with positive 
selection markers. Less demanding and easier for bulk 
production. 
Design of knock-
in construct 
Distance of homology arms from cut site: Closer to 15bp and 
no further than 50bp from the sgRNA target site 272. 
Size of homology arms: Recommended to be >800bp 272, 
although we also experienced success when knocking-in a 1kb 
construct with each homology arm of 100bp (data not shown). 
Study has shown that the efficiency of CRISPR-Cas9 mediated 
HDR with large insert increases as the length of the homology 
arm increases, while decreases as the insert size increases 273. 
In vivo generation of knock-in animals: With a homology arms 
of length 1.5kb/1kb, we successfully knock-in a 2.5kb IRES-
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CreERT2 construct to the mouse Jag1 locus to generate an F0 
mouse with pronuclear injection (data not shown), indicating a 
1:1 ratio is a practical range for CRISPR based transgenic animal 
generation. 
Remarks: Newer studies have shown that in vivo linearization of 
the homology donor by targeting the plasmid at both ends of the 
homology arms could drastically reduce the sizes of the homology 
arms to 25-100bp for large inserts, and up to 1kb-5kb in 
multiple systems 274–276, thus greatly reducing the cloning effort 
needed for homologous recombination 
Table 2. Design principles and recommendation for the design and implementation of 
CRISPR experiments. 
Transcriptomics 
Transcriptomics is the study of gene expression at the individual gene level. It is a 
powerful tool to interpret the activity of individual genes and to provide insights into 
spatial and temporal transcriptomic differences in biological processes, and functional 
perturbation in loss-of-function or gain-of-function conditions. Combined with 
functional enrichment analysis such as gene ontology (GO) and gene set enrichment 
analysis (GSEA), one could gain new insights in biological processes. Furthermore, in 
combinations with other sequencing methods such as chromatin immunoprecipitation 
(ChIP) sequencing (ChIP-seq), assay for transposase-accessible chromatin using 
sequencing (ATAC-seq) and bisulphide-sequencing, one could explore the relationship 
between the transcriptomes and DNA-binding proteins, chromatin structure, or 
epigenetic status. Transcriptomics has been extensively used to study Notch signaling, as 
many of its responses are transcriptional. As CSL is a DNA binding protein, 
transcriptomics facilitates our genome-wide understanding of its role in transcription and 
gene regulation. In Paper I, we used RNA sequencing (RNA-seq) to identify Notch 
targets and differentially expressed genes (DEG) in CSL KO breast cancer cells, and we 
discovered that many DEG in CSL are not Notch targets. In Paper II, the 
transcriptomics analysis enabled us to isolate Notch targets that are HIF2a dependent. In 
Paper IV, bulk sequencing results of ALGS mouse models and ALGS patients led to the 
discovery of the functional relevance of the DEG and a common DEG across species. 
Taken together, it demonstrated that RNA-seq is a powerful tool. 
 
The first generation of transcriptomics was the micro-array, based on hybridization of the 
oligonucleotides on chips. However, this is limited to the previous knowledge of known 
transcripts, and is subjected to high noise due to cross-hybridization. The next generation 
sequencing (NGS) is revolutionary, especially for genomics and transcriptomics. There 
are many methods of next generation RNA-seq, but in principle all function by capturing 
and reverse transcribing the sequences, breaking them down into small sequences and 
separating individual sequences, pre-amplification, and fluorescent detection during 
elongation or ligation. After the sequencing and quality control of these small reads, they 
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will be aligned to a known genome, thus allowing identification and quantity calling. 
Likewise, de novo transcriptomes could be assembled without prior genomic knowledge. 
 
R and Python are two popular scripting/programming language
 for RNA-seq 
downstream analysis and bioinformatics analysis (compared in Table 3). R277 is a 
scripting language created by statisticians, with its focus on statistics and data science. 
The advantage of R is its built-in tools and syntax for statistics, and a large repository of 
bioinformatics packages built by bioinformaticians (many accessible through 
bioconductor 278). For instance, the graph plotting package ggplot2, although comes with 
a steep learning curve, is often the go-to solution for most graph plotting tasks. 
Furthermore, RStudio is a free integrated development environment (IDE) for R, 
making R scripting and project management user-friendly. For most biologists with no 
computer science background, R with RStudio is the easiest plug-and-play tool for 
bioinformatics. However, programmers may not found themselves at home with R, as its 
syntax is significantly different from most programming languages. Moreover, it is not 
trivial to plug R scripts as a component of other applications. Still, R is definitely the 
most straightforward and useful language for biologists. 
 
In contrast, Python is a versatile scripting/programming language widely used in software 
development. It is a flexible language and is easier for debugging and maintaining 
consistency than R. It is also easier to write data science tools with python to facilitate 
communication with non-bioinformaticians collaborators. Similar to R, there is a large 
repository of data science and bioinformatics packages in python. However, there is a 
steep learning curve to get python working for data science. The easiest is to get the 
Anaconda distribution version of python, where a lot of data science packages were 
maintained. PyCharm is a recommended free IDE for python, and could also be 
downloaded with Anaconda in one-go.  
 
The most common analysis of RNA-seq is to identify differentially expressed genes 
(DEG), i.e. genes that are upregulated or downregulated when compared to samples. 
DESeq2 and edgeR are two popular R packages for DEG, using similar statistical 
methods and assumptions to calculate DEG. The frequentist approach e adopted to test 
DEG should be viewed with caution, as there will be a considerable amount of false 
positives when thousands of genes were tested (Bayesian and frequentist statistics in 
science was briefly reviewed by Puga et al. 279). The default solution in these packages is 
using Benjamini-Hochberg adjustment to create an adjusted p-value and a false discovery 
rate (FDR). Meanwhile, packages using a Bayesian approach such as MMSeq, BitSeq and 
                                               
e Frequentist statistics refers to the statistical inference framework based on observation of 
frequency of the data. It is traditionally used by scientists, featuring well-established 
methods such as statistical hypothesis testing and confidence intervals. Its main 
alternative, Bayesian statistics, instead used new information to update the probability for 
a hypothesis, featuring concepts such as prior an posterior probability and likelihood 
ratio. 
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ShrinkBayes are emerging. However, the higher computational demand and the 
difficulty to introduce Bayesian concepts to the biology community make the usage of 
Bayesian methods not as popular as frequentist methods. Gene enrichment analysis such 
as GO, GSEA, and tools like PANTHER and spring are helpful in enlightening us the 
functional meaning of the upregulated or downregulated genes. Similarly, the data could 
be visualized with dimension reduction methods such as principle component analysis 
(PCA), to see how different the transcriptomes are and what genes contribute to these 
differences.
 
 R Python 
Nature Scripting language specialized 
for data science and statistics 
A scripting or programming 
language for all-round 
development 
Ease to use An easy plug-and-play tool for 
biologist 
Not as straight forward for 
biologists. Difficult to setup for 
data science. (i.e. maintaining 
versions, preparing interpreters 
and creating virtual 
environments.) 
Versatility  Inconvenient to integrate to 
other apps 
Easy to integrate to other apps 
Coding styles/ 
features 
Procedural-code; 
No coding style convention; 
Unconventional codes (count 
from 1 instead of 0, weird 
datatypes); 
Non-standard evaluation 
Object-oriented programming; 
Generally accepted coding style 
convention. 
IDE RStudio PyCharm: good for analysis and 
app development 
Jupyter notebook: good for 
testing ideas and sharing codes 
Repository/Distribu
tion  
Bioconductor Anacoda, miniconda, pip 
Popular data 
science/bioinformat
ics packages 
dplyr: data frame processing; 
ggplot2: graph plotting; 
edgeR/DESEQ2: RNA-seq 
analysis; 
Seurat: scRNA-seq 
numpy: scientific computing; 
pandas: data frame processing; 
seaborn: graph plotting; 
scanpy: scRNA-seq 
Table 3. A comparison of R and Python for biologists 
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Single cell RNA seq 
Single cell RNA-seq (scRNA-seq) is the RNA-seq at single-cell level. The emergence of 
scRNA-seq was another huge leap in the transcriptomics field, as there are a lot of hidden 
information among the heterogeneity of a cell population. Single cell transcriptomics can 
reveal heterogeneity, common and rare cell populations, and lineage relationship among 
cells and population. There are two main camps of RNA-seq technique, one is based on 
full length sequencing (e.g. Smart-Seq2 280), the other is 3’end based with unique  
molecular identifiers (UMI) (e.g. Drop-seq 281). The former provides a higher sequencing 
depth while retaining the sequence of the full transcripts, making it ideal for allelic 
specific analysis, splicing analysis and de novo transcriptomics analysis. The latter has the 
capability to process much higher number of cells, but at the expense of lower numbers 
of captured and sequenced transcripts. This higher width but lower depth nevertheless 
gives strong gross analysis and statistical power (for more detailed comparison, please 
refer to 282,283 ). Because of higher variation, more noises and zero-inflation in scRNA-seq 
results, the typical methods for bulk sequencing may not be directly applied. Many 
scRNA-seq specific packages emerged, such as Seurat (R)284, Monocle (R)285, RaceID 
(R)286 and scanpy (python; now also provide methods to integrate Seurat into python)287, 
with different normalization and testing methods. Cell cycle scoring288 is introduced to 
remove variation caused by cell cycle differences, however should be carefully applied as 
cell cycle differences could also have biological meaning. PCA is normally not enough to 
break down the greater heterogeneity in large scRNA-seq data, therefore machine 
learning dimension reduction methods such as tSNE 289 (T-distributed Stochastic 
Neighbour Embedding) and UMAP 290 (Uniform Manifold Approximation and 
Projection) were widely used in scRNA-seq analysis, with the latter more popular as it is 
superior in illustrating global distances among clusters. 
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Present Investigations
Aims 
This thesis aims to investigate Notch signaling with a modular approach: how different 
modules in Notch signaling contributes to cancer and development, and its interaction 
with other pathways in the process.  
• Canonical and non-canonical role of CSL in breast cancer. 
• Crosstalk of NICD with hypoxia signaling. 
• Role of CSL in adult steady-state and stress myelo-erythropoiesis. 
• Role of Jag1 in Alagille syndrome  
 51  
Paper I 
CSL is the central node of canonical Notch signaling, as the whole family of Notch 
receptors relies on the binding of CSL to the DNA. Ablation of CSL or using dominant 
negative CSL is a way to abrogate Notch signaling in various studies. However, the 
Notch independent role of CSL was less considered. Here, we demonstrated that ablation 
of CSL could lead to a large change of transcriptome, and that a majority of these 
changes are Notch independent. The loss of CSL in the breast cancer cell line MDA-
MB-231 caused increase tumour growth, decreased apoptosis and enhanced angiogenesis 
in xenograft. We also found the loss of CSL led to a hypoxic response in normoxic 
condition. 
 
To study the role of CSL in breast cancer, we used CRISPR-Cas9 to generate a CSL null 
breast cancer cell line MDA-MB-231. We designed a sgRNA targeting exon 5 of CSL, 
and introduced it to the cells together with Cas9 endonuclease. Screening by western blot 
for CSL, we were able to generate multiple clones of the CSL KO cell line. Interestingly, 
we also observed a decrease in mRNA level by RT-PCR, indicating that there may be 
nonsense-mediated mRNA decay in the process. It is noteworthy that a significant 
number of these clones were lost after a few passages, hinting to a drastic change in the 
transcriptome. Despite showing signs of difficulties to be maintained in vitro, CSL null 
cell lines promote tumour growth both in xenograft model and in chorioallantoic 
membrane (CAM) tumour model (confirmed by two individual clones). Using Ki67 
staining, and cleaved caspase 3 staining, we observed increased proliferation and 
decreased apoptosis in the CSL null xenograft tumour compared to the CSL+/+ xenograft 
tumour. We also noted an increase of angiogenesis in the CSL null xenograft tumour, as 
displayed by increased vascularization stained by endothelial markers collagen IV and 
CD31. Matrigel invasion assay results illustrated an increase in invasion of the CSL null 
cell line. Taken together, the loss of CSL promotes breast cancer tumour growth and 
invasion. This is in line with the enhanced tumourigenesis observed by knocking down 
CSL in another study, and that 33% of invasive breast cancer from the Cancer Genome 
Atlas (TCGA) data has genomic loss in CSL 291.  
 
We noticed a hypoxic response in the CSL null cell line in normoxic conditions, as 
shown by the stabilization of HIF1α, which is normally degraded under normoxia. There 
were no differences in the mRNA level of HIF1α, indicating that it is a post-
transcriptional event. The effect is reversed by the reintroduction of CSL to the CSL null 
cell line. Hypoxia responsive genes such as VEGF-A, STC2 and KLF8 were elevated in 
the CSL null clones, although with variability among the clones. Angiogenesis, which is 
often enhanced in hypoxia conditions, was increased in the CSL null xenograft tumour. 
Next, we explored the molecular mechanism of the hypoxic response. The reducing agent 
DTT lowered HIF1α in CSL null cells, suggesting the stabilization of HIF1α due to 
nitrosylation of HIF1α or destabilization of the ODD domain. We also uncovered that 
N1ICD interacted directly with HIF1α in the CSL null cells. Interestingly, DAPT (a 
GSI) decreased the HIF1α protein level in the CSL null clones in both normoxic and 
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hypoxic conditions. This raises the possibility of N1ICD playing a role in the 
stabilization of HIF1 α in a non-canonical way. First, as CSL is already abrogated, and as 
our transcriptomic data have shown, canonical Notch targets were unresponsive in the 
CSL null cell line. Therefore, DAPT should not affect the canonical Notch targets in the 
CSL null cell lines. Moreover, only 11 genes were still responsive to Jag1 in the CSL null 
cell lines when compared to the control (unpublished), denoting there are limited non-
canonical Notch targets affected by DAPT in the CSL null cell line. Together with the 
fact that DAPT treatment decreases HIF1α level, it is therefore reasonable to hypothesize 
that N1ICD could stabilize HIF1α. 
 
The CSL null cell lines also exhibited a polyploid giant cancer cell (PGCC) like 
phenotype when cultured in vitro. The PGCC is reported to have cancer stem cell like 
properties and could be induced by hypoxia or CoCl2 induced pseudo-hypoxic 
conditions. In the CSL null cell line, this could be induced by the increase in HIF1α 
protein. Through live imaging, we observed a defect in mitosis in a considerable portion 
of the cells. As CSL has been shown to bind to DNA throughout mitosis 53, it may play a 
role in mitosis and mitotic bookmarking. 
 
Furthermore, we examined the transcriptomic changes in the CSL null cell line. and 
found a substantial change in the transcriptome with over 1700 DEGs in the CSL null 
cell line compared to the CSL+/+ cell line. Among them, only 47 of 139 Notch targets 
were derepressed, indicating that CSL is not by default inhibitory when Notch is 
inactive. Kulic et al. 291 argued that the tumourigenesis enhanced by loss of CSL is due to 
the derepression of 170 “Notch signature” genes. However, we only observed 5 of such 
genes derepressed in the CSL null cell line. Nevertheless, derepression of such a subset of 
Notch target genes could play a role in increased tumourigenesis. Our results from the 
large transcriptomic changes and the hypoxic response indicate that the Notch 
independent role of CSL should not be disregarded. 
 
In conclusion, we demonstrated that the loss of CSL enhanced tumourigenesis and 
unleashed a hypoxic response in normoxic conditions, accompanied by hypoxic related 
phenomena such as increased angiogenesis and PGCC. We showed that Notch signaling 
could modulate hypoxia signaling, and can have implications for tumour development. 
We also showed a largely canonical-Notch-independent role of CSL, and that the non-
canonical role of CSL is also important in tumourigenesis. 
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Paper II 
It is known that hypoxia can modulate Notch signaling and sometimes requires Notch 
signaling for regulation of its downstream targets (See “Cross-talk with hypoxia 
signaling” section). It is less explored whether Notch signaling could modulate hypoxia 
signaling. In keeping with Paper I, here we showed that Notch signaling can upregulate 
hypoxia signaling in various cancer cell lines. Notch activation promotes transcription of 
HIF2α indirectly, and contributes to a HIF1α to HIF2α shift in cancer. We also found 
that a portion of Notch targets are HIF2α dependent. All these findings provide evidence 
that Notch signaling can modulate hypoxia signaling, and requires hypoxia signaling. 
 
In paper II, we first observed from publicly available data that HIF2α mRNA level was 
increased in Notch activated conditions but decreased when Notch signaling was 
blocked. We corroborate this by expressing N1ICD in 9 cancer cell lines, where 8 out of 
9 cell lines exhibited an increase in HIF2α mRNA in the presence of N1ICD. This was 
also reflected in a more physiologically relevant experimental design of Notch activation 
with immobilized Notch ligands in the breast cancer cell line MDA-MB-231 and 
primary breast cancer cells. Both immobilized Jag1 and Dll4 increased the HIF2α 
mRNA level, which is abrogated by DAPT. This increase of mRNA level by 
overexpression NICD was also observed in primary glioblastoma cells and tumourigenic 
primary mesenchymal cells. Together, we showed that Notch can induce HIF2α mRNA 
level in various types of cancer. 
 
As NICD could function in non-canonical ways (i.e. do not involve nuclear localization), 
we next examined whether the increase in HIF2α mRNA requires nuclear localization. In 
the medulloblastoma cell line DAOY, we transiently expressed a NICD-ERT2 fusion 
protein (NERT2), where the NICD is blocked by ERT2 from entering the nucleus, unless 
tamoxifen is present. Expression of NERT2 in the absence of tamoxifen did not lead to 
increase in the mRNA level of known Notch target Nrarp, nor HIF2α. On the other 
hand, expression of NERT2 with tamoxifen led to an increase in mRNA levels of Nrarp 
and HIF2α. This increase was abrogated by the expression of dnMAML or the ablation 
of CSL. These data confirm that canonical Notch signaling is involved in the regulation 
of HIF2α mRNA level. 
 
We next investigated whether canonical Notch signaling directly regulates HIF2α 
expression. The ChIP sequencing results did not reveal any CSL binding sites in the 
HIF2α promoter region. Moreover, activation of Notch signaling using immobilized 
Jag1 did not increase the luciferase activity from HIF2 promoter reporter assay. These 
data suggest that canonical CSL does not directly regulate HIF2α expression. 
Translational blockade by cycloheximide (CHX) also obliterated the increase of HIF2α 
mRNA level by Notch activation. This suggests that canonical Notch signaling most 
probably upregulates the expression of an intermediate protein, which is essential for the 
increase in HIF2α mRNA level. 
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Protein stabilization and degradation are vital parts of the regulation of HIF protein 
levels. In normoxic conditions, HIF proteins are constantly degraded. Therefore, we 
examined whether the HIF2α protein is also upregulated by Notch. We observed an 
increase in the HIF2α protein level by overexpression of N1ICD in multiple cell lines 
(primary breast cancer cells, human medulloblastoma cell lines D324 and DAOY, VHL-
deficient 786-O renal carcinoma cell line) even in normoxic conditions. In contrast, 
ligand stimulation only led to an increase in HIF2α protein level in the hypoxic 
conditions but not in normoxic conditions. Furthermore, HIF1α protein levels were 
decreased by Notch activation in some cell types, notably at later time points after Notch 
activation. This suggests that Notch activation may contribute to the HIF1α to HIF2α 
transition, which has been reported to promote stem cell characteristics and 
aggressiveness in cancer 292.  
 
We then explored the functional aspect of the regulation of HIF2α by Notch activation. 
HIF2α targets (i.e. VEGF and AREG) were upregulated by Notch activation. To further 
understand how the interplay affected the transcriptomic outcome, we activated Notch 
by tamoxifen expression in a DAOY cell line stably expressing NERT. Meanwhile, we 
knocked down HIF1α or HIF2α by siRNA and performed transcriptomic analysis. Our 
data revealed that 21% of the Notch targets required HIF2α, while only 4.1 % required 
HIF1α. Gene enrichment analysis showed that these genes are related to GO terms in 
cell adhesion, blood vessel development, and signal transduction. Lastly, we found that 
N2ICD but not N1ICD expression enhanced tumour growth in CAM model of DAOY 
cell line. To further understand the different roles of Notch1 and Notch2, we used 
CRISPR/Cas9 to knock out Notch1 or Notch2 in DAOY cells. Ablation of Notch2 but 
not Notch1 dampened the tumour growth in CAM assay, in line with the NICD 
overexpression experiment. RNA-seq revealed that only a portion of DEG is common 
among Notch1-/- and Notch2-/- cell lines, indicating that Notch1 and Notch2 serve 
different roles in DAOY cells. To our surprise, ablation of HIF2α enhanced tumour 
growth in the CAM assay. This could be due to the increased HIF1α protein level 
observed in the HIF2α-/- cells. Further investigation are needed to understand how the 
dynamics of Notch1/2 and HIF1/2α could contribute to tumour growth. 
 
To conclude, we identified that canonical Notch signaling could indirectly upregulate 
HIF2α in a broad range of cancer cell types. We also established that a subset of Notch 
signaling requires HIF2α. We discovered that Notch could contribute to the HIF1α-to-
HIF2α switch, which is a topic that should be researched further. Collectively, these data 
are important to understand the role of Notch and its crosstalk with hypoxia signaling in 
cancer, and would provide insights for future Notch and hypoxia signaling based 
treatments. 
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Paper III 
While the role of Notch signaling in embryonic hematopoiesis and lymphoid lineage has 
been well-studied, its role in adult bone marrow myelopoiesis is still controversial. 
Studies on Notch signaling in myelopoiesis are limited and not always consistent 103,207,208. 
Most of these studies perturbed either the Notch receptors or the Notch ligands, 
therefore these results could not rule out the role of non-canonical Notch signaling. To 
understand the role of canonical Notch signaling in adult myelo-erythropoiesis, we 
specifically ablated CSL in the adult myeloid lineage by crossing either Mx1-Cre or Vav-
Cre mice with homozygously loxP site flanked (floxed) CSL mice (CSLfl/fl). We revealed 
that canonical Notch signaling is dispensable in adult steady-state and stress myelo-
erythropoiesis, and that myelo-erythropoiesis are not impaired when CSL is ablated. 
 
In Paper III, we first examined the adult myelo-erythropoiesis in the CSL ablated mice. 
No defects were observed in distinct stages of granulocyte-macrophage (GM), erythroid 
(E), or megakaryocyte (Mk) progenitors, as shown in FACS analysis. Similarly, GM, E 
and MK colonies, circulating platelet and red blood cells (RBC) counts showed no 
differences in the CSL ablated mice. Chimeric experiments of wild-type CSL cells and 
CSL ablated cells exhibited no differences in terms of contribution to various progenitor 
lineages, replenishment of myeloid cells, nor platelets in peripheral blood. 
Phenylhydrazine(PHZ)-induced hemolytic anemia experiments revealed differences in 
the RBC reduction, nor expansion of E progenitors, showing that CSL ablation caused 
no defect in the erythropoiesis response to stress. Lastly, quantitative analysis of Notch 
targets demonstrated derepression of Hes1 and Hes5 by CSL ablation in Mk progenitors, 
pre-CFU-Es, and CFU-Es, indicating that CSL may act as a repressor of these Notch 
targets. 
 
Our results revealed differences compared to other studies using other approach to 
inhibit Notch signaling 103,207,208,293. The most obvious explanation could be that non-
canonical Notch signaling is involved in those experimental settings, that either the 
Notch receptor or ligands were perturbed. A previous study demonstrated that yolk sac 
derived erythroid cells has reduced apoptosis in CSL null mouse embryos. However, the 
role of CSL in erythroid apoptosis is restricted to the embryonic erythroid cells, as the 
CSL null embryos die at E10.5 209. Some of the other studies used the deletion of 
Nicastrin, which may have an impact on signaling mechanisms other than Notch. Lastly, 
our results differ from the study using dnMAML208 is not well understood, but it is 
plausible that it relates to dnMAML’s effect on other pathways. Therefore, studies using 
dnMAML to inhibit Notch signaling have to be carefully re-interpreted. In sum, we 
showed that canonical Notch signaling is dispensable in adult steady-state and stress 
myelo-erythropoiesis. 
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Paper IV 
Alagille syndrome (ALGS) is a rare multisystem disorder mainly caused by JAG1 loss-of-
function mutation. The autosomal dominant nature of inheritance and later genetic 
mapping showed that ALGS relevant JAG1 mutations are haploinsufficient. There have 
been many attempts to generate mouse models for ALGS, however most have limited 
phenotypes displayed, or do not accurately mimic the human disease (See “Notch and 
Alagille syndrome”). Here, we established a homozygous Jag1 mutant mouse line 
“Nodder”, which is able to recapitulate relevant phenotypes in most ALGS affected organ 
system. We explored the transcriptomic changes in the liver due to Jag1 mutation, and 
found that IGF1 is a commonly affected gene in mouse and humans (although in 
humans, the control samples were derived from patients with other liver diseases). Lastly, 
we examined the molecular mechanism and showed that Jag1 with Nodder mutation 
failed to bind to Notch1, while weakening the ability to activate Notch2. 
 
In Paper IV, we characterized our previously described “Nodder” mice, which possess a 
H268Q mutation in the second EGF repeat domain in Jag1, a region found mutated in a 
portion of ALGS patients. The heterozygous mice exhibited a head-nodding phenotype, 
thus were called “Nodder” (here we refer the mutated Jag1 as Jag1Ndr). In a C3H pure 
background, Jag1Ndr/Ndr is embryonically lethal 294, however when bred into a 
C3H/C67Bl6 background, it reached a recovery rate of 10% at postnatal day 0 and 5% 
in adulthood, consequently enabled us to investigate symptoms more clinically relevant 
in human ALGS. We observed impaired growth, jaundice, ASD and VSD, iris 
deformation and craniofacial abnormalities, presenting wide range of symptoms relevant 
to ALGS in human. 
 
We next assessed one of the most common and critical symptoms of ALGS – cholestasis 
and impaired liver function, which is related to paucity of bile ducts. Jag1Ndr/Ndr mice 
displayed jaundice, a possible result of the bile duct defect. Histological examination 
demonstrated that Jag1Ndr/Ndr E18.5 embryos lacked Sox9 and Hnf1β (early cholangiocyte 
markers) expression in the cells surrounding the portal vein. At a later stage, at P0, only a 
few cells with low Sox9 expression were observed, as compared to the control which are 
already undergoing lumen formation. By P10, no bile ducts were found in the Jag1Ndr/Ndr 
pups, while the wild type mice displayed mature bile ducts. In contrast, lumenized bile 
ducts could be located in Jag1Ndr/Ndr, however with the majority abnormal and few well-
formed. Remarkably, Jag1Ndr/Ndr pups at P10 showed Sox9 expression close to the portal 
veins, indicating that at later stage, Jag1Ndr/Ndr could recovered some Sox9 expression. 
Together with the results that liver organoids from Jag1Ndr/Ndr have normal cholangiocyte 
differentiation marker expression, we validated that Jag1Ndr/Ndr causes delayed but it does 
not completely inhibit differentiation. However, Jag1Ndr/Ndr organoids collapse more often 
than the Jag1+/+ organoids, demonstrating structural instability. 
 
We compared the transcriptomes of liver samples from ALGS patients to those from 
non-cholestatic patients, and transcriptomes of liver samples from Jag1Ndr/Ndr to those 
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from Jag1+/+. GSEA analysis revealed common gene sets enriched in either ALGS or 
Jag1Ndr/Ndr samples, including DNA repair, E2F targets, G2M checkpoint and reactive 
oxygen species pathway. DEG analysis revealed 16 commonly upregulated and 2 
commonly downregulated genes in both the ALGS and the Jag1Ndr/Ndr samples. Although 
the comparison is not on par, as the control sample for the ALGS samples are not from 
healthy patients but from autoimmune hepatitis patients (due to ethical reason), these 
genes may provide insights into the biology and treatment of ALGS. The commonly 
downregulated genes include IGF1, which was confirmed in Jag1Ndr/Ndr mice with ELISA. 
It is in line with the observation that IGF1 levels in ALGS patients are not responsive to 
growth hormone 295. 
 
Lastly, with co-culture experiment with human cells expressing Jag1/Jag1Ndr and mouse 
cells expressing Notch receptors, we determined that Jag1Ndr lost the ability to bind to 
Notch1 but not Notch2 and Notch3. Even Jag1Ndr can bind to Notch2 and Notch3, but 
it exhibited a lower ability to internalize Notch2 or Notch3 ECD, while also 
contributing to less Notch activation of Notch2 and Notch3 as shown in a 12xCSL 
reporter assay. 
 
Collectively, we have established and characterized an ALGS mouse model “Nodder”. 
We showed that our mouse model faithfully recapitulates symptoms in multiple system 
seen in ALGS patients. We also revealed that the Jag1Ndr causes a delayed in 
differentiation and morphological defects in bile duct formation, possibly through the 
decrease in its ability to activate Notch2. We demonstrated clinical relevance by in 
parallel analyzing Jag1Ndr and ALGS patient samples. These data inform our 
understanding of ALGS, and provide a new model to study and develop therapy for 
ALGS.
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Paper V 
Hyperactive Notch signaling has been linked to breast cancer (See “Notch in Breast 
Cancer”), however how hyperactive Notch contributes to tumourigenesis is not fully 
understood. Virus driven NICD expression, such as in MMTV-N4ICD and MMTV-
N1ICD transgenic mice, which are active in the mammary gland prior to birth 296, led to 
mammary tumour development, though the specific roles in luminal cells were not well 
explored 215,297. Whey acidic protein (WAP) is a protein secreted in the milk. It is highly 
induced during pregnancy and lactation, but ceases to express after weaning 298–300. 
Therefore, the WAP promoter is useful to induce expression in the mammary luminal 
cells during lactation. WAP promoter driving N4ICD expression led to a moderate 
phenotype, where ductal growth was not developed but lobular differentiation was 
inhibited 301. However, in that report WAP-Cre lineage tracing showed that the tumour 
growth in the WAP-N4ICD mice were not from the WAP lineage, arguing that 
hyperactive Notch played a role in the stromal environment but not the tumour itself. It 
is worth noting that WAP expression mostly regresses after lactation. However, WAP-
Cre lineage tracing revealed that remnant cell lineage of WAP expressing cells still exist 
after ductal tree regression (designated parity identified mammary epithelial cells, i.e., PI-
MECs)302. These cells possess stem cell properties and are capable of becoming both 
luminal and myoepithelial lineage. In our study, we revisited this question but using an 
alternative transgenic approach.  
 
In Paper V, we explored the role of hyperactive Notch1 in the WAP lineage, therefore 
not restricting only to cells that transiently express WAP, but also to cells derived from 
the original WAP-expressing cells. This was achieved by crossing a WAP promoter driven 
Cre recombinase (WAP-Cre) mouse line with a ROSA26-loxP-stop-loxP-N1ICD-IRES-
EGFP (R26-N1ICD) mouse. Upon Cre expression, the floxed stop cassette will be 
removed in the genome, leading to the expression of N1ICD and EGFP, causing 
N1ICD expression and EGFP marking in the WAP cell lineage. As a control, we crossed 
the WAP-Cre with ROSA26-loxP-stop-loxP-tdTomato mice. We showed that EGFP or 
tdTomato were expressed only after pregnancy and exclusively in luminal lineage. 
 
WAP-Cre;R26-N1CID mice exhibited a drastically impaired offspring survival, where 
only 60% of pups survived after birth in the first pregnancy, but no offspring survived 
during the subsequent rounds (2nd, 3rd, 4th) of pregnancy. The offspring however survived 
with foster mothers, indicative that it is a lactation problem. Three-dimensional 
morphological analysis were performed with iDISCO, displaying unaffected ductal tree 
in virgin WAP-Cre;R26-N1CID mice, but significantly increased in branching and 
number of nodes after first round of lactation. This structural defect in ductal tree 
formation, led to the inability to nurture newborn pups. 
 
We next examined whether the hyperactive Notch1 in WAP lineage caused mammary 
tumours. We observed mammary tumours in two out of five WAP-Cre;R26-N1CID 
females, 26 weeks after lactation, whereas no tumours were observed in the WAP-
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Cre;R26-tdTomato control mice. Surprisingly, the majority of tumours were EGFP 
positive, an unusual conclusion compared to the data from the WAP-N4ICD;WAP-
Cre;R26-lacZ mice used in a previous study, where no lacZ cells were found in the 
tumours 303. In one of the mice that developed mammary tumours, we observed 
metastases to the lung. The metastases were also EGFP positive, indicating that they 
originated from the WAP lineage. The contrasting result compared with the previous 
study could be explained by the different duration of NICD expression. The WAP-
Cre;R26-N1CID mice exhibits N1ICD expression in the entire WAP lineage, even after 
regression of endogenous WAP expression, while in the WAP-N4ICD mice 303, 
expression of N4ICD was non-continuous, only occurring after each round of lactation.  
 
Lastly, we explored the heterogeneity and the transcriptomic differences in the WAP-
Cre;R26-N1CID and WAP-Cre;R26-tdTomato mice by single cell RNA-seq of EGFP or 
tdTomato sorted cells. Dimension reduction with PCA and UMAP and unsupervised 
clustering revealed that there were six subtypes of cells identified from both mouse lines. 
In some subtypes, the distribution of N1CID-EGFP or tdTomato cells were even, while 
in others, either N1CID-EGFP cells or tdTomato cells were enriched. Gene enrichment 
analysis revealed that immune system related GO terms were enriched in the N1CID-
EGFP biased subtypes. On the other hand, GO terms of metabolism and catabolic 
processes were enriched in one of the tdTomato enriched subtypes, while GO terms of 
cell adhesion is enriched in another one of such subtypes. Further studies are required to 
understand the gene expression differences and how they may contribute to the tumour 
formation. 
 
Jointly, we showed that hyperactive Notch in WAP lineage could lead to ductal 
formation defect and mammary tumour. We also demonstrated that WAP hyperactive 
Notch lineage compose mammary tumour and subsequent metastases, in contrast to a 
previous study. Lastly, we established that the heterogeneity among the luminal cells was 
perturbed by Notch activation, however more efforts are required to fully understand 
how this imbalance may lead to tumourigenesis. 
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Future Perspectives 
It is intriguing that Paper I and Paper II showed that both canonical and non-canonical 
Notch signaling can modulate hypoxia signaling. However, we have not yet elucidated 
the direct molecular mechanism, for example how the loss of CSL lead to upregulation of 
HIF1α. To address this, one could reintroduce a defective CSL (i.e. with mutated DNA 
binding domain), to test whether the observed effects are related to direct transcription of 
an intermediate protein that exerts the effect. Second, we speculated that NICD could 
stabilize HIF1α in this “pseudo-hypoxic” response induced by CSL ablation. This could 
be further investigated by overexpression of NICD in the CSL null cells. Lastly, the large 
Notch-independent transcriptomic changes in the CSL null cells remain unexplored. We 
uncovered a limited number of derepressed Notch targets in the CSL null cells. ChIP 
sequencing of CSL and other epigenetic markers could elucidate the dynamic binding of 
CSL in such contexts, and its roles in epigenetic regulation in breast cancer. In Paper II, 
we revealed that Notch upregulates HIF2α mRNA via an intermediate protein. ChIP 
sequencing of NICD and CSL, and cross comparison with the transcriptomic data may 
shed light on the identity of the intermediate protein. Similarly, we observed differences 
by expressing either N1ICD or N2ICD, or by ablating Notch1 or Notch2. It is a suitable 
model to study how the two Notch receptor paralogs in the same cell would serve 
different function, remains an unanswered question in Notch signaling. As in Paper III, 
we observed different results of the CSL ablated cells with overexpression of dnMAML in 
myelopoiesis, indicating that the commonly used dnMAML may not fully represent 
removal of canonical Notch signaling, but may also have other effects. For instance, 
MAML has been shown to be a co-activator of β-catenin 304. It will be of particular 
interest to explore what other DNA sites MAML binds to and what other signaling 
pathways MAML is associated with. In Paper IV, our transcriptomic analysis was limited 
by the heterogeneity in the liver samples. For example, being able to pinpoint differences 
in the cholangiocytes and their progenitors would be helpful in understanding cholestasis 
in Alagille patients. Therefore, the use of sc-RNA seq will be advantageous in further 
exploring the detailed transcriptomic and cell population changes in Alagille patients. 
Lastly, additional investigation is needed to piece together the opposing results of WAP-
Cre lineage activation of NICD and the WAP promoter driven NICD from a previous 
study. A more detailed time tracing (i.e. introducing a Dre or Flp system to only trace PI-
MECs), may address whether the tumour grows from a remnant WAP cell lineage with 
hyperactive Notch. 
 
The context dependent nature of Notch signaling remains one of the greatest question in 
the field. However, there is limited study on a unifying principle. Undeniably, one may 
argue that the vast differences in epigenetic landscape and interacting partners of entirely 
different contexts will unsurprisingly lead to the different outcomes. However, Notch 
signaling often exhibits opposing roles even within the same lineage development in a 
sequential manner. These could be useful models to study how Notch could quickly 
switch its role. Combining transcriptomics, CSL-, NICD ChIP-seq, chromatin structure 
determination and epigenetic landscape profiling in such context will definitely shed light 
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on the DNA side of the question. On the other hand, improved techniques in 
mammalian-2-hybrid systems 305 and genome-wide CRISPR-screening 306, combined 
with Notch reporter systems, could identify important interacting partner, interrogating 
at the protein side of the question. 
 
How different Notch receptors respond differently remains unknown. In Paper II, we 
noticed differences in Notch1 and Notch2 functions in the medulloblastoma cell line. 
The negative results of the study where the N1ICD and N2ICD in mice were genetically 
swapped illustrates that the mere sequences of ICD may not sufficiently answer the 
question in the in vivo context. An alternative explanation is a gene-dosage effect, where 
the outcome depends on the combined NICD levels generated by the different Notch 
receptors. Another hypothesis is that the NICD has specific modifications according to 
the NECD. For example, different NECD may recruit different interacting partners, 
leading to different modification in the NICD. However, this direction is largely 
unexplored. With CRISPR-Cas9, it is much easier to specifically study the Notch 
receptors one at a time by removing interference from other Notch receptors. It is also 
easier to study how mutations alter the endogenous gene-dosage, which was previously 
difficult to achieve, as most previous studies were done with overexpression. 
 62  
   
“A Simple Touch”, Sunny Tsoi, 2020. Inspired by the De Stijl (Neoplasticism) art movement and 
canonical Notch signaling. 
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Popular Science Summary 
Introduction 
Over the billions years of our entire history of time, between lightness and darkness 
across billions light-years of our universe, there is one pale blue dot f. Everything on this 
pale blue dot was once forgettable star dust. Yet, in our pale blue dot, the star dust thrives 
as stardust crusaders g, surviving and evolving with the song of life. “Perfectly balanced, as 
all things should be.” h 'Twas the perfect balance of environmental conditions that made 
us. 'Twas also how we stand against the ever-changing environment, to maintain a 
balance by reacting, regulating and relating to others, that made us. A human body is 
made up of more than 30 trillion “cells”, the basic unit of life, corresponding to various 
functions such as thinking, defense, and pumping your blood, after their kinds. “No man 
is an island”i, so is no cell. Not only do we have to balance with the environment, our 
cells have to cooperate and balance among themselves. 
 
Cellular communication: signaling 
The Chinese word “Chung Yung” (, in English the “doctrine of mean”, (or the 
strikingly similar Swedish word “lagom”), briefly represents the wisdom of being “just 
right” - not too much, not too less. A deeper meaning of Chung Yung is to do the right 
thing as who you are and at the right time. In living organisms, one key to balance is “cell 
signaling”, the communication of cells among themselves and to the environment. Just as 
a machine or a railway system needs a signaling system, our body also needs a signaling 
system. If the signaling of a railway is compromised, delay or even accidents would occur. 
Likewise, if cell signaling is compromised, the internal balance will be broken and 
diseases will occur. For instance, too much growth signal at the wrong time could 
possibly lead to cancer. In fact, many causes of cancer are signaling related. On the other 
hand, inadequate signaling could lead to the underdevelopment of important tissues and 
organs.  
 
There are a few types of signaling in machines: contact-dependent, such as a button of 
your computer; long-ranged, such as a cable sending electric signal; wireless, such as 
bluetooth on your phone. Similarly, there is a great variety of types of cell signaling: long-
ranged electric signaling in your nervous system; hormones in your blood; contact 
dependent Notch signaling, which is the key topic of our story. A functioning signal 
system must have intact components, such as an antenna or a button to receive signal, 
some cables to transmit signal, and a remote control to send signals. Comparably for 
                                               
f Pale Blue Dot is a photograph of the earth taken by Voyager 1 space probe 6 billion km 
from earth. It inspired astronomer Carl Sagan’s book with the same name. 
g Stardust crusader is the title name of the Japanese manga “JoJo's Bizarre Adventure Part-
3” (Hirohiko Araki, 1989). 
h A signature movie line from from “Avengers: Infinity War” (2018) by the main 
antagonist Thanos, who wish to wipe out half of the lives in the universe to make 
balanced world. 
iFrom the poem Meditation XVII by 17th Century British poet John Donne 
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cells, where we call a signal receiver as “receptors” and physical signals as “ligands”. If a 
door knob is a “receptor”, your hand would be a “ligand”. Equally, if a vending 
machine’s insert slot is a receptor, the coin would be a ligand. In addition, during the 
relay of the signals, there are many intermediate molecules that are very important to 
process or amplify the signals. 
 
The components of a machine is manufactured and assembled according to a blueprint, 
so are the components of our cells. The blueprint in our cells is written in a language 
called DNA. Instructions for the making of one component is called a “gene”. The whole 
book of blueprint is called a “genome”. It contains all the instructions on how you can 
develop from a sperm and an egg to a complete individual reading this thesis. Just as a 
novel series could be broken down into different volumes, our genome is divided into 
different volumes. We have two collections of books, each with 23 volumes, in total 46 
volumes. One set is from our father, the other from our mother. We call the physical 
form of these individual volume of “book” a chromosome (chroma means colour in 
latin). If there is an error in a blueprint, broken or faulty components may be produced. 
Such an error in the genome (a mutation), broken or defective cellular components may 
be constructed. This could lead to diseases such as inherited diseases and cancer. 
 
The orchestral role of Notch in life and death 
Notch signaling is the key topic of this thesis. It is a contact-dependent signaling, that a 
cell must “kiss” another cell in order to send a signal. The receiver of Notch signaling is a 
“Notch receptor”, locating on the outermost layer of a cell and facing outward, like a 
nun-chuck sticking out of the cell. Conversely, the sender of Notch signaling (including 
Jagged and Delta-like), locates also on the outermost layer but of another cell. Upon the 
“contact” of the receiver and the sender, Notch signaling is activated. This “contact” has 
a long evolutionary history. One can find Notch signaling from simple jellyfish like 
creature to insects to human. If Notch is defective in a fruit fly, there will be notches on 
their supposedly smooth wings, thus the name “Notch”. Notch plays a role in the 
development of almost all organ-systems, and is found to be related to cancer and how 
aggressive a cancer could be, orchestrating life and death. The importance of this 
“contact” often makes me think of the contact of God and Adam in “Creation of Adam” 
by Michelangelo. Therefore, I use “Notch Signaling Requiem: Orchestral Role of Notch 
Signaling in Cancer and Developmental Disease” as the title of my thesis, in order to 
investigate the roles of different components of Notch signaling in various types of 
diseases. 
 
The discovery of Notch 
The story of Notch started in fruit flies. In the beginning of the 19th Century, scientists 
were still unaware on the mechanism of inheritance. It was only speculated that 
chromosomes are responsible for inheritance. To study how chromosomes may 
contribute to inheritance, they often use fruit flies for experiments. Fruit flies are ideal 
because of their short life cycle of 10 days. Also, a fruit fly only possesses 4 pairs of 
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chromosomes, making analysis far easier. The “father of modern genetics” Thomas Hunt 
Morgan started a fruit fly experiments by pairing up flies with various traits, for example, 
red eyes or white eyes, big wings or degenerated wings, and recorded what their offspring 
look like. Morgan studied the mechanism of inheritance by chromosomes and was 
awarded the Nobel Prize in Medicine or Physiology in 1933. “Notch” is one of the traits 
he studied, since the notched wings are easily visible, making it easy for Morgan to 
observe and analyze. 
 
Notch: more than just a “notch” 
Does Notch only play a role on notched wings? Scientists discovered that male flies 
carrying the Notch mutation will die as embryos. This indicates that Notch is essential in 
life. In 1930s, Donald Frederick Poulson started his research in Yale University. During 
that time, geneticists in general only investigate the role of genes in adult traits. Poulson 
was among the first to focus on the dead fly embryos instead of the living ones. He 
discovered that these embryos cannot grow skin but grow a lot of nervous system like 
cells. If one wish to reimagine it as a human, that would be a monster with a huge brain 
but no skin! This was the first time a scientist associated genes to development. 
Unfortunately, Poulson may not have received sufficient recognition. In 1995, scientists 
were awarded the Nobel Prize for their discovery on genetic rules of early development. 
However, Poulson passed away in 1989 and could not share this honour. Nevertheless, 
Poulson’s work sparkled that glorious “developmental biology”, which later enter its 
golden era in the 1980s-90s. Many great discoveries, experimental techniques and 
molecular tools came from developmental biologists. It also gave rise to new fields such as 
stem cell biology, regenerative medicine and evolutionary developmental biology. 
Nowadays, the focus shifted to stem cells and regenerative medicine. Many people 
believed that developmental biology is in decline, as there is less funding and spotlight 
from the public or peer scientists. However, the emerging fields such as stem cells and 
regenerative medicine essentially trace back their knowledge to developmental biology. 
To know regeneration, one must know generation. 
 
Notch and human cancer 
In 1980s, with the new techniques in DNA analysis, scientists can “translate” and 
understand the instruction of the DNA. Spyros Artavanis-Tsakonas and Michael Young’s 
group separately analyzed the Notch gene. They found that it resembles a “receiver” 
(receptor) on the outermost layer of the cells. Later, Artavanis-Tsakonas also analyzed 
and confirmed many components in Notch signaling, such as the signal sender “Serrate” 
and relay component CSL. In 1991, scientists discovered a peculiar gene in three 
leukemia patients that surprisingly looked like the fruit fly Notch gene. It was very 
encouraging, as at that time, it was one of the first examples of how researching on flies 
could be informative for understanding human diseases. More than ten years later, Jon 
C. Aster found broken copies of Notch in more than half of the leukemia patients, 
confirming that Notch is important in leukemia. 
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We now know that cancer is not a homogenous disease, but rather a collection of 
different diseases. Leukemia differs from liver cancer, and breast cancer differs from lung 
cancer. Even within one type of cancer, such as breast cancer, there are many subtypes. 
This is why some cancers are relatively simple to treat, while some are difficult. Some are 
drug resistant, while some readily relapse. This is mainly because they originate from 
different cells, and have different mutations in their blueprints. As time goes by, there 
might even be more and more mutations, making them even harder to treat. 
Malfunction of Notch signaling components often relates to how bad the cancer has 
developed. 
 
How does Notch work? 
How does Notch work? As mentioned, Notch is a receiver located at the outermost layer 
of a cell. Facing the environment is the outer component of Notch, responsible for 
receiver signals. Facing inside is the inner component of Notch, responsible for relaying 
the signaling. One inside, one outside, almost like a pair of door knobs with an inside 
and an outside knob. When Notch is activated, it is like someone turning the outer door 
knob. In contrast to a real door knob, upon opening, Notch does not turn, but instead 
gets the inner knob cut and ejected into the room. (This happened to me when I was 
living in a small cabin in Huddinge in a cold winter. The door knob broke and was 
ejected! I was trapped in the kitchen!). This liberated inner component will then head to 
the “brain” of the cell – the nucleus, where all the blueprints are located. The inner 
component combines with partners such as Mastermind (such a cool name) and a 
blueprint reader called CSL. Thus, the cell knows what to do and what blueprint to use 
in response to the signal. 
 
My research: Notch and aggressive cancer 
In Paper I, I use a new technique called CRISPR-Cas9 to genetically modify some breast 
cancer cells. I destroyed the component CSL and found that the cancer grew much faster 
and grew much more blood vessels to get nutrients. This is fitting the clinical 
observation, that 30% of patients with severe breast cancer have a broken CSL. Unlike 
normal cells, cancer cells enjoy a low oxygen environment. Sometimes they can even 
become invincible to radiotherapy under environment with no oxygen. We uncovered 
that the cancer cells with broken CSL behave like they are out of oxygen, even when 
there was oxygen. It is like they are a person pretending to be drowning on land, only 
that they actually love drowning. This “pseudo-low-oxygen” state may be why they form 
a such aggressive cancer. Continued with Paper II, we discovered that actually in many 
different cancers, Notch can control this “low-oxygen” signal. These two papers are the 
first to report such a link between Notch and oxygen level. Our results help in 
understanding why cancer can adopt a “low-oxygen” state, and provide insights into how 
to treat cancer patients.  
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My research: Notch and inherited disease 
In contrast to Paper I which presented the importance of CSL in breast cancer, Paper III 
exposed that CSL is dispensable in some occasions. We removed CSL in blood cells of 
mice, and realized that the mice live happily with no problem in their blood. In normal 
conditions or in conditions that required quick blood replenishment, the mice still had 
no problem at all. On the other hand, in Paper IV, we explored more than blood cells, in 
fact the whole mouse. In the mice, we mimic the mutation of the signal sender Jagged1 
in human Alagille syndrome patients. We uncovered that these mice have similar 
symptoms to the human patients, for example having problem in the heart, the eyes, the 
face, etc. They also showed complications in the bile ducts, causing skin colorations 
(yellow hue) in babies and bile accumulation, which affect human patients the most. By 
studying these mice, we gained better understanding of the patients. We also compared 
the liver of mice to that of Alagille children in Hong Kong, discovering commonalities 
among them. This advances our understanding in the disease, and the development of 
possible treatment. 
 
My research: Notch and the origin of breast cancer  
Why do people get breast cancer? We explored one of the possibilities. In Paper V, we 
tried to create a super Notch signal in the mammary (breast) tissue of mice, to see 
whether it will lead to breast problems or even breast cancer. Distinct from many organs, 
human breasts develop mostly during the puberty. They also further develop during 
pregnancy and undergo respective regression after weaning. We tried to learn about the 
role of Notch during and after breastfeeding. We created a super Notch signal in the 
mammary cells after pregnancy, and observed that the mothers failed to feed their babies. 
(Their babies survived with foster mothers). Some of the mice even developed breast 
cancer. To trace the origin of these cells, we found the cancer came from the mammary 
cells with super Notch signal. Previously, people thought Notch only affects the 
surrounding environment. Here, we demonstrated that Notch can induce cancer in the 
same cell as it is expressed in. We collected these mammary cells, surveyed individual data 
of each single cell and analyzed them together. Using artificial intelligence techniques, we 
discovered these cells were not much different from that of normal mice. Rather, we only 
noticed imbalance among these cells. This came back to our original theme “balance”. 
Even an imbalance may cause a serious disease. 
 
Thoughts and conclusion 
Above is my research on the song of life and death of Notch. I studied how Notch is 
related to life (development) and how Notch is related to death (cancer). In my odyssey 
of this PhD, I had gains and I had losses. My research results were humbly acceptable, 
contributed to various fields and involved different techniques. Although it may not be as 
astonishing as my ambitions when I first embarked on my PhD (apparently most first 
year PhD students want to earn a Nobel prize), I still considered myself lucky to be able 
to contribute to science. With all the weekends and overnights; grit and anxiety, I earned 
the famous “Permanent Head Damage” (the true meaning of a PhD), but also willpower 
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and problem-solving abilities. Among all, the bravery to face problems head on, is the 
most precious trait I had acquired. This is not an easy task, but I am still learning and 
improving. As I always say, I am pursuing a doctor of “philosophy” (the love of 
knowledge), not a doctor of “science”. Therefore, broad knowledge and critical thinking 
weigh more than mere professional knowledge, which is of course also very important. I 
am very grateful I met many great teachers and fellows whom guided me in science, 
culture, history, language, music, fighting, and many more. I am still in the darkness of 
foolishness, but I considered this as the beginning of my journey. Now I am working on 
heart development and regeneration, hoping to find insight in heart repair by comparing 
mice, newts and human. Nevertheless, “Man is born free” (Rousseau, 1762), we are not 
bound in academia only. There are still a lot of other meaningful pursuits in life. I do not 
know how long I will stay as a full-time scientist, and of course have thought of the regret 
I would have if I made a pause in science. However, I want to conclude with this line I 
composed, “Does the science make the doctor, or does the doctor make the science?” In 
the past, I thought a title of a person is mere lip-service, vague and empty. Now I wish, 
after my proper defense, wherever I go, I could bear the name of a Doctor, to encourage 
and to constrain me to keep my development and integrity. To be a doctor who lives the 
motto of my home university; the Chinese University of Hong Kong – ‘Through 
learning and temperance to virtue' (玡෈夹因). 
 
“No. It’s Doctor Strange. Not master strange. Not mister strange. 
Doctor Strange.” - ̽Doctor Strange̾2016 
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Ւᘏ肥ፑ物篷褖ԏ䜗̾Ӿጱ萆蘊ේ7KDQRVێꔴଘᤍ物̿ਠ聅ଘᤍ牧獡Ԫ๜
䛑ইྌ牐̀3HUIHFWO\EDODQFHGDVDOOWKLQJVVKRXOGEHྋྋฎݱ圵絑हꔧկ
ጱ玚蟴ꖮଘᤍ牧ꗰ疰ԧ苭ᇔ咳ኞጱ秚괡牐ᘒ苭ᇔ阑ꖬێࣁ苭虋ጱ絑हӾݍ䛑牏
矒ګ牏ݳ֢牧ℂᘒ姘媒ଘᤍ牧ኞኞ犋௳牐౯㮉ጱ蛪꘨牧ኧӣص㮆奞胨奲౮牧ݱ
ℂٌ气牧ړૡݳ֢牧ํԶ揗揣௏ᘍ牧ํԶ揗揣ᴠ蔫牧ํԶ揗揣׀࿔牧䎿֖괚ԏ
犋哴牐̿䷱ํՈฎ疅䎦̀M牧犖䷱ํ奞胨ฎ疅䎦牐Ո气犋㻌ᥝꖮक़ኴଘᤍ牧奞胨
ԏ樌牧犖ᥝଘᤍ牐

奞胨懱蒈
蝡疰猟苉Ոଉ拻ጱ̿Ӿଽ̀牧蝢ח薹ฎ犋؇犋׳牧篷螂篷犋݊ҁታَ承犖ํ
ODJRPӞ扃牧֕ꔴଘ璂牧犋ᥝڊ唰҂牧֕犖䔶ꗙ̿抁̀牧咳Ԓॠ௔牧ᥝࣁ螕ݳ
ጱ䦒瑿狶螕ݳጱԪ牐̿抁ᘏ牧ॠԏ螇犖牐̀ҁ̽Ӿଽ̾҂牧ኞᇔኴ犖ইฎ牐奞
胨ᥝ螈ᛗଘᤍ牧Ԇᥝꘑ犢㮉ԏ樌㪔䌘क़ጱ传蝢牧౯㮉圸蝡传蝢傶̿懱蒈̀
6LJQDOLQJ牧疰ই秚瑊޾裡᪠አکጱ懱蒈牐裡᪠懱蒈ڊ梊牧ݢꖥ疩ꖬ皤藮牧綍
ᛗ敋䵼Ո犜牧ᘒ奞胨懱蒈ڊ梊牧㳷괡Ꮘ瓥ଘᤍ牧୚ꖬݱ圵綧የ牐ֺই牧螂ᰁጱ
ኞ裾懱蒈牧ݢꖥ疩ꖬ奞胨犋䥁괐ኞ牧綍ᛗ୵౮ጣዩ牐Ԫ䋿Ӥ牧盄य़蟂ղ疩ꖬጣ
ዩጱየ虋牧᮷ฎ޾奞胨懱蒈ํ橕ጱ牐ፘݍ牧螂靦ጱ咳ᙙ懱蒈牧ݢꖥ疩ꖬ咳ᙙ犋
臑牧瑊ਥۑꖥ犋؋獊牧綍ᛗ耬靦蟂ղ瑊ਥ牐

秚瑊ጱ懱蒈牧ํݱ圵气ࣳ物ํ矑藉ୗጱ牧ֺইೲೲ衔樄굆脲牪ํꗴ蚣ጱ牧ֺই
አ굆耪㯽蝑굆ৼ懱蒈牪犖ํ篷娄ꗴ矒ጱ牧ֺইአ萠舄ጱ篷娄굆蝢懱牐奞胨懱蒈
阑ฎग़露ग़᯻物ํꗴ蚣ጱ脲ᐟ妿懱蒈牧ํࣁᤅ႖Ӿ㯽懱ጱ筕ᔰҁ౲֢揷凟
茹҂牧ᘒ獊矑藉ୗጱ1RWFK 懱蒈牧疰ฎ๜玡ॊ抷෈ጱԆ薫ҁ1RWFK ฎڰ綫ጱ఺
௏牧਻஍薹朰҂牐؋獊ጱ懱蒈羬妞牧疰஠ᥝํ獊㯪ጱ襉կ牧ֺই矑硩懱蒈ጱॠ
娄牏ೲ衔牏㯽斸懱蒈ጱ굆耪牏咳ڊ懱蒈ጱꗴ矒瑊ᒵᒵ牐奞胨阑ꕍ牧矑硩懱蒈ጱ
矑硩瑊牧圸֢̿ݑ꘨̀5HFHSWRUV牧疰猟ฎ奞胨ጱॠ娄牏ೲ衔牏౲ᘏ硩կᓟ牪
گ筕ݑ꘨犥雮㵕懱蒈ጱړৼฎ懱௳咳蝑瑊牧圸֢̿蟴꘨̀/LJDQGV牧疰猟ฎೲ
                                               
j ڊᛔ܈犊Ӯ夵舣㾴扎Ոࠈ夹ᘆ(John Donne)ጱ扎Meditation XVII 
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ೲ衔ᮎ櫇ಋ瞲牏汜濠㯽괝ጱ괝מᒵ牪ᘒ괷ቘ懱蒈ጱ螂纷牧犖ၿ݊盄ग़犋ݶጱړ
ৼ牧䌘懱蒈㯽螏ꖯ᪃斕᯿牐

ྋই秚瑊ጱ襉կᥝࣁૡ皜ೲᆙ萠霎ኞ叨޾奲蕕牧奞胨ጱ襉կ牧犖襑ᥝೲ萠霎ኞ
叨޾奲蕕牐Ո气奞胨ጱ萠霎牧ฎ犥'1$䌃౮牧ྯྦྷ襉կጱ抋ก牧౯㮉圸傶चࢩ
*HQH牧ᘒ碉㮆Ո꘨ጱኞ޸萠霎牧౯㮉ݞ֢चࢩ奲*HQRPH牧懿斉ԧ֦ই֜ኧ
ᔜৼܪৼ虋౮匍ࣁṛय़শሕ౲ᘏՃՃሳ缏ጱՈ牐ྋইӞॺ괝玵ݢ犥ړڊݱ圵㲘
괚牧౯㮉ጱचࢩ奲牧犖ړ౮獋ॺوࢥ܈م㲘牧疰ฎ୎ӣ䌘ວᜋ꘨
FKURPRVRPH牧ྯॺړ獨㬵ᛔᆿꗖ޾ྮꗖ牐萠霎ڊ梊牧ᛔꕍ괡狶ڊ梊ጱ襉կ牧
ಅ犥चࢩ统虋ҁPXWDWLRQ҂犖ݢꖥ疩ꖬ奞胨襉կ梊藮牧Ꮘ瓥ԧଘᤍ牧୚ꖬ螣㯽
የ޾ጣዩᒵᒵ牐

瞲䠁ኞꖮꔱጱ127&+
1RWFK 懱蒈蝢᪠1RWFKVLJQDOLQJ牧๜玡ॊ抷෈ጱԆ薫牧ฎ藉Ᏻࣳ懱蒈蝢᪠牧
襑ᥝ奞胨޾奞胨ԏ樌̿ꗖޗ̀牧಍ݢ㯽螏懱蒈牐揗揣矑懱蒈ጱ1RWFK 矑硩瑊牧
֖ꔣ奞胨腕ҁ奞胨磧क़괒҂Ӥ牧䌘茐क़ኴ牧ํই䌘क़ጱ櫕౼祏牐ᘒ揗揣咳ڊ懱
蒈ጱ蟴꘨ҁ۱ೡ -DJJHG ޾ 'HOWDOLNH҂牧֖ꔣٌ犢奞胨ጱक़괒牐֦Ӟ藉牧౯
ӞᏳ牧疰雮㵕ԧ1RWFK 懱蒈蝢᪠牐蝡̿藉Ᏻ̀牧რ螐ꔷ裾牧ኧ磧墋㻌ጱ࿜ྮ气
ኞᇔ牧ꕭک괺꘎ጱՈ气牧᮷ݢ犥ತک1RWFK ጱ擽୽牐ຎ蔋ጱ1RWFK 统虋ጱ扖牧
괡犤ٌ๜䛑㾼ꕁጱ聰Ӥڊ匍ࣗ綫QRWFK牧ࢩᘒ괔ݷ牐1RWFK 皃Ԓ䌘ྯ㮆瑊ਥጱ
咳ᙙ᮷盄᯿ᥝ牧1RWFK ጱ虋吖犖޾盄ग़ጣዩ޾๛๗ጣዩํ橕牧ݢ拣ഩ矒ኞꖮ
ꔱ牐蝡̿藉Ᏻ̀୽段ԏ窼鹢牧犤౯ଉమ蚏ᔂṛਞ߽嬄ጱݷ向̽獺ꗰ㫎吚̾牧ฎ
姘媒ኞᇔኞꖮꔱጱ᯿ᥝ藉Ᏻ牧ํইӤଂ޾㫎吚ጱ藉Ᏻ牐硲๜玡ॊ抷෈ਧԧ̽ڰ
綫ਞ諃ใ物1RWFK 瞲䠁螣㯽የ޾ጣዩጱኞꔱ䰐ᒍ̾傶氂牧犥矐懵1RWFK 懱蒈蝢
᪠ጱݱ㮆襉կ䌘綧የํ֜薫ᜋ牐

127&+ጱ咳匍
1RWFK ጱ硲Ԫ牧ᥝኧຎ蔋抋蚏牐ԫ܈Ӯ夵ڡ牧ᑀ䋊疑螭๚盄Ⴔ༩螣㯽䋊ጱ䋿ꘉ
秚ቘ牧ݝሖ介ኞᇔᇙ搡ฎ犥ວᜋ꘨螣㯽牐傶ԧӞ缆绗ᒌ牧挨กວᜋ꘨ጱ螣㯽؃
抋牧犢㮉ֵአຎ蔋狶䋿涢牧ࢩ傶ຎ蔋ኞ裾괔盠牧܈෭䦒樌疰ݢ犥ኧ恝ܪ虋౮
恝牧犖ݝํࢥ䌘ວᜋ꘨牧ො׎ړຉ牐匍դ螣㯽䋊ԏᆿ芛凟礬7KRPDV+XQW
0RUJDQ牧䌔ํݱ圵ᇙ搡牧ֺই夺縄ጮ縄य़聰ੜ聰ጱຎ蔋牧犥ݱ圵奲ݳ԰ፘԻ
蟴牧妞懯粧㮉஍դጱᇙ搡牧ℂᘒړຉ螣㯽ጱܻቘ牐芛凟礬萞ྌ嘦藨ԧວᜋ꘨ጱ
螣㯽秚ቘ牧磧஍糷괔 ଙ蘊揔凟ኞቘ蠴䋊ꕝ牐1RWFK牧ྋྋ疰ฎ芛凟礬ړຉ
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ጱٌӾӞ㮆ᇙ搡牐ࢩ傶1RWFK统虋疩ꖬጱࣗ綫覍ଉฃ憎牧蝡य़य़䒻ۗԧ芛凟礬
ጱړຉ牐

127&+物犋㰍ฎࣗ綫
1RWFK 㰍㰍୽段聰Ӥࣗ綫㻟牫ᑀ䋊疑咳匍牧1RWFK चࢩ统虋ጱᵜ௔ຎ蔋ࣁ胤胛
䦒๗괡ॣರ牧抋ก1RWFK 䌘ኞ޸覍ଉ᯿ᥝ牐ࣁ ଙդ牧㴄ℂے癥ቘૡ䋊ᴺ
ਠ౮玡ॊጱכ祜'RQDOG)UHGHULFN3RXOVRQکԧ肍굌य़䋊疻樄ຎ蔋Ꮈ绗牐ᮎ䦒
狡牧ฦꗳ螣㯽䋊疑᮷ݝ괡Ꮈ绗चࢩꖮ౮ଙᇙ监ጱ橕狌牧㪔篷ࣁ఺चࢩ޾咳ᙙጱ
橕狌牧כ祜㶴ᵞӾᎸ绗ᮎԶॣರጱຎ蔋胤胛牐犢咳匍ܻ㬵चࢩഩ矒ԧ咳ᙙ螂
纷牧ᮎԶ1RWFK 虋圵ጱॣರ胤胛牧य़蟂ղ奞胨᮷虋౮ԧᐟ妿奞胨牧㶴咳疻犋ڊ
क़ጼ牧మ猟ฎՈጱ扖牧疰猟ฎ㮆ݝํय़脲㶴䷱ํጼꖩጱௗᇔ牦蝡ฎḒེํᑀ䋊
疑䌔चࢩ蝫媒ک胤胛咳ᙙ牧ݢఠ牧犢蝡ොᶎጱ揙糽㪔篷ݑॡय़橕ဳ牐ꕭک 
ଙ牧ٌ犢ᑀ䋊疑಍ࢩ傶Ꮈ绗胤胛咳ᙙचࢩᘒ괔ک蘊揔凟ኞቘ蠴䋊ꕝ牧ᘒכ祜෱
ࣁ ଙ疰ꖮӮ裾旴牧๚ꖥوՁ蝡ꔭꗛ牐篷抷ই֜牧蝡犖ᓒฎ咳ᙙኞᇔ䋊ጱ
ضမ牧ࣁ ଙդๅےฎ焗ᰂ䦒դ牧盄ग़᯿य़ጱ咳匍牏䋿涢ොဩ޾ړৼૡ
ٍ牧᮷ฎ㬵ᛔ咳ᙙኞᇔ䋊疑牐咳ᙙኞᇔ䋊ๅᤉኞԧ஍㬵ጱ䓄奞胨ኞᇔ䋊牏ٚኞ
蠴䋊牏ᄍ麁咳ᙙ䋊ᒵᒵ牐ই犡牧ᑀ䋊ኴጱᆌ讨૪旉ک䓄奞胨޾ٚኞ蠴䋊Ӥᶎ牐
篷ॱ牧盄ग़Ո᮷藨ݶ牧ᛔଙդ஍咳ᙙኞᇔ䋊疰૪ୗ盏牧觓ط犋ٚ牧䷱ํ
唰ग़ጱᎸ绗괿ᰂ牧犖괔犋کᑀ䋊ኴ޾क़ኴጱ袧ط籗牐ٌ䋿牧咳ᙙኞᇔ䋊Ֆꕍ᯿
ᥝ牧๚Ꭳኞ牧ᆃᎣٚኞ牐7RNQRZUHJHQHUDWLRQRQHPXVWNQRZJHQHUDWLRQ

127&+ꖮՈ气ጣዩ
 ଙդ牧ꘊ茐'1$ଧڜړຉጱฦ݊牧ᑀ䋊疑ݢ犥樄ত̿ᘉ捌̀޾̿薹ꗜ̀
ኞ޸ጱ萠霎牐礚㴄೭ҁ6S\URV$UWDYDQLV7VDNRQDV҂޾䮉ᔂṛҁ0LFKDHO
<RXQJ҂ݱᛔጱ㿁褧ړ獨ړຉԧ1RWFK चࢩ牧咳匍1RWFK 盄ํݢꖥฎ֖ꔣ奞胨
क़괒ጱ矑硩瑊ҁݑ꘨҂牐ӞἩ֢䶷牧礚㴄೭犖ړຉ㪔挨䋿ԧ盄ग़ຎ蔋ꕗ๜ጱ
1RWFK 懱蒈蝢᪠ጱ奲կ牧ֺই咳蝑懱蒈ጱ-DJJHGҁ桓煼ጱ఺௏҂牧蝢᪠襉կ
&6/ᒵᒵ牐ࣁ  ଙ牧ᑀ䋊疑咳匍ํӣ֖ᤅጣየՈ᮷ํӞ㮆ௗ吖ጱचࢩ牧౮
ղ޾ຎ蔋ጱ1RWFK 盄猟牧஍㬵咳匍ฎՈ气๜㬵ྋଉጱ1RWFK 统虋஍ጱꖬጣच
ࢩ牧抋ก1RWFK 盄ํݢꖥ䌘Ո气ጣዩ覍ଉ᯿ᥝ牐ܻ㬵牧Ꮈ绗ຎ蔋चࢩ牧ฎݢ犥
ቘ薹Ո气綧የጱ牧蝡犤吚䦒ጱᑀ䋊ኴ覍ଉഄ䅕牐܈ग़ଙ஍牧褷ॊᇙ-RQ&
$VWHUࣁ᩻螂Բ౮ᤅጣየՈ獉ತک1RWFK ጱ统虋牧㪔挨กԧ1RWFK 䌘ᤅጣጱ᯿
ᥝ௔牐

 72  
ܻ㬵牧ጣዩ㪔犋ฎӞ圵የዩ牧ฎ盄ग़圵犋ݶጱየዩ牧ᤅጣ޾ԥጣ犋ݶ牧胁ጣ޾
ᙤጣ݈犋ݶ牧綍ᛗݶӞ圵ጣዩ牧ֺইԥጣ牧᮷ړ盄ग़㫎圵牐蝡疰ฎ傶֜ํԶԥ
ጣꖥ蠴牧ํԶԥጣ盄櫞蠴牧ํԶ괡ํಯꗇ௔牧ํԶ괡਻ฃ괕咳牐圵圵犋ݶ牧᮷
ฎრꔣํ犋ݶጱचࢩ统虋牧犥݊蚏რᛔ犋ݶጱ奞胨牐綍ᛗꘊ茐䦒樌വᑏ牧统虋
괡᩼㬵᩼ग़牧螕ᘏኞਂ牧磧䘣ྰጱጣ奞胨ၚӥ㬵牧疩ꖬጣዩ᩼㬵᩼䘣௔牐ᘒ
1RWFK 懱蒈蝢᪠ጱ襉կڊ梊牧盄ग़䦒狡᮷޾ጣዩጱ䘣௔ፘ橕牧ࣁ౯ጱᎸ绗犖ํ
ಅၿ݊牐

127&+ጱܻቘ
1RWFK ฎই֜螀֢ጱ牫ইӤ蝄ಅ᥺牧1RWFK ฎ֖ꔣ奞胨磧क़괒ጱ矑硩瑊牐
1RWFK ํक़襷ጱ蟂ղҁ꘨क़奾䯤(&'҂牧ฎ揗揣矑硩懱௳ጱ蟂ղ牧୵ই櫕౼
祏牧犖ํ奞胨獉ጱ蟂ղҁ꘨獉奾䯤,&'҂牧揗揣ࣁ奞胨獉㯽螏懱蒈牐Ӟक़Ӟ
獉牧疰অ猟಄槹ጱ槹ຢ牐吚1RWFK ᤩ懱௳咳蝑瑊雮㵕牧疰অ猟ํՈ㬵ൎಋ಩樄
槹牧雮㵕Ӟ蝫Ԁጱ秚ቘ牐޾槹ຢ犋ݶጱฎ牧1RWFK ጱݍ䛑犋ฎ෤旉牧ᘒฎ䥁
樄牐雮㵕䦒牧1RWFK ጱ꘨獉奾䯤,&'괡ᤩ猟ۄڏጱ䩚ᥜ獥樄牧మ猟֦Ӟ瞓क़ᶎ
槹ຢ牧಄樌獉ጱ槹ຢ疰统ꕍ蕈樄㪔汜ڊ݄ҁ౯ࣁ犥ڹ֘ጱ຋Ӿੜ੻Ӿꗖ蛪妿稲
螂牦螭ࢩྌᤩࢯࣁ䓻಄愊牐҂牐蝡꘨獉奾䯤ℂ奞胨蔭괒朰硯ԧ牧疰괡᪒ک奞胨
ጱӾ秅ҁ奞胨໐҂牧ܨ'1$ጱಅࣁ瑿牧㪔޾ٌ犢ړৼمᐟݳ꘨牧۱ೡ
0DVWHUPLQGҁḒ脲牐䌘牧चࢩݷਁํ䦒盄䒉ጱ牐҂牧޾揗揣褂ꗜኞ޸萠霎ጱ褂
ꗜ瑊&6/牧ℂᘒ雮㵕瞲ਧጱӥ჋ፓ䰤ᤈ㵕牐

౯ጱᎸ绗物1RWFK ꖮ䘣௔ጣዩ
౯ࣁḒᓤ抷෈Ӿ牧౯አ蜱ଙጱꔢದ蔩&5,635&DVN牧चࢩ硬ꗰԧԥጣ奞胨牧
Ꮘ瓥ԧ褂ꗜ瑊&6/牐౯㮉咳匍Ꮘ瓥褂ꗜ瑊&6/괡疩ꖬԥጣኞ裾ጱๅ盠牧㪔Ӭ
ๅ਻ฃኞ괐ᤅᓕޕ玲籧訅牐蝡޾屷ଥጱᎸ绗ޗݳ牧ࢩ傶ࣁӣ౮ጱԥጣየՈ䰬๜
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k አ蝖ݻૡ纷牧䌔奞芭ᴠ蔫羬妞硬ꗰ౮ᑀ䋊疑ጱૡٍ牧ݢ犥盠蝧狕硬चࢩ牐
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奾承޾眤᥺
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气ጱஞ膇牧፡፡ꖥ玽ತڊஞ膇ٚኞጱ槄ۺ牐ꕍᘒ牧Ոኞᘒᛔኧ緶ꔨ牧牧
Ոኞ㪔犋ੴ褖ࣁ䋊蔩ኴጱࢻৼ牧犖ํॡग़பԪᥝ蝍ꔴ牧౯犋Ꭳ괡ٚℂԪᑀ䋊Ꮈ
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we were younger. Also thank my Grandma, for your endless love and support. Everyone 
in my extended family community, without your financial support I would not be able 
to be here.  
 
眤蘛ᆿྮ訅ᙙ牧௮᯿ইઊ牧㱑ᓕኞၚଘ獡牧Ֆ獊ێඪ೮౯蝍ꔴቘమ牐蘛蘛֦㮉
䌘౯篷褖מ犨牧櫒౯ᔋꕥय़఺牧Ֆꕍמ犨吚෭ጱੜ犮ৼꖥ加ᛔ橏菑࿯괥牐眤蘛
ᆿྮ犥蛪֢㳷牧硽疩伩泿臑珿牧㱑ᓕ౯௔盪굌芟牧ଉ०因०᥺牧֕Ֆꖥ夹犥ྋ
螇牧疧᯿ᛔꕯ牧಍ꖥ蚎ک犡෭牧ظ૩牧㴄䔶牧磭ํ෭ꖥ傶抁ԏᘏ牐̿ᆿྮࣁ牧
犋螐蝿牐̀਎㱾䋿ࣁํ蒎牧氎犡஍ێ凗Ӥ჋牧蝱盓狕䮣牧䁭ᒼꗖ௮牐犖஠ᥝ眤
蘛甬甬ग़ଙᆙ氝牧ֵ౯؋皐౮裾牧ই犡疆㱾ࣁ螐ො牧䋿ࣁํ蒎牧氎ꖥ䁭ᒼ牐眤
蘛ᐙᆿᐙྮ犥݊ݱ֖裾蜇ܹ௮牧괿ۗ౯㬵ታَ牧犖ᇙ獨眤蘛ԫᛠᆿ狶౯䋊蔩Ӥ
ጱག䰬牧ࢥᛠᆿጱᆙ氝牧޾Բᛠᆿ䌘౯ܹےጱඪ೮牐眤蘛胨୞䌘౯ጱמ犨ꖮܹ
䙄牧س裾犋಍牧๚ꖥ狶অག䰬牧犖๚ꖥ癲֦ࢥ괷蝿稲牧֕Ֆቊఠ靦ํꖥꖮ֦橏
菑蝿ሻԏ䦒牧ଙ靦䦒準ํ秚괡牧犡෭稭ࡅ篷犨牐氎犡஍౯ꖥ犥蛪֢㳷牧ꖮ֦԰
ۣ԰玎牧玄ꔣ瞚砾牧ᆙ氝ᆿྮ牧Ӟݶۘێ牧و獺ṛ痷牐  
 80  
References 
1. Dexter, J. S. The Analysis of a Case of Continuous Variation in Drosophila by a Study of Its 
Linkage Relations. Am. Nat. 48, 712–758 (1914). 
2. Bridges, C. B. & Morgan, T. H. Sex-linked inheritance in Drosophila,. Sex-linked inheritance in 
Drosophila, (Carnegie Institution of Washington, 1916). doi:10.5962/bhl.title.54326 
3. Morgan, T. H. The Theory of the Gene. Am. Nat. 51, 513–544 (1917). 
4. Poulson, D. F. The effects of certain X-chromosome deficiencies on the embryonic development of 
Drosophila melanogaster. J. Exp. Zool. 83, 271–325 (1940). 
5. Wharton, K. A., Johansen, K. M., Xu, T. & Artavanis-Tsakonas, S. Nucleotide sequence from the 
neurogenic locus Notch implies a gene product that shares homology with proteins containing 
EGF-like repeats. Cell 43, 567–581 (1985). 
6. Kidd, S., Kelley, M. R. & Young, M. W. Sequence of the notch locus of Drosophila melanogaster: 
relationship of the encoded protein to mammalian clotting and growth factors. Mol. Cell. Biol. 6, 
3094–3108 (1986). 
7. Kopczynski, C. C., Alton, A. K., Fechtel, K., Kooh, P. J. & Muskavitch, M. A. Delta, a 
Drosophila neurogenic gene, is transcriptionally complex and encodes a protein related to blood 
coagulation factors and epidermal growth factor of vertebrates. Genes Dev. 2, 1723–1735 (1988). 
8. Thomas, U., Speicher, S. & Knust, E. The Drosophila gene Serrate encodes an EGF-like 
transmembrane protein with a complex expression pattern in embryos and wing discs. Development 
111, 749–761 (1991). 
9. Fleming, R. J., Scottgale, T. N., Diederich, R. J. & Artavanis-Tsakonas, S. The gene Serrate 
encodes a putative EGF-like transmembrane protein essential for proper ectodermal development 
in Drosophila melanogaster. Genes Dev. 4, 2188–2201 (1990). 
10. Rebay, I. et al. Specific EGF repeats of Notch mediate interactions with Delta and serrate: 
Implications for notch as a multifunctional receptor. Cell 67, 687–699 (1991). 
11. Yochem, J., Weston, K. & Greenwald, I. The Caenorhabditis elegans lin-12 gene encodes a 
transmembrane protein with overall similarity to Drosophila Notch. Nature 335, 547–550 (1988). 
12. Yochem, J. & Greenwald, I. glp-1 and lin-12, genes implicated in distinct cell-cell interactions in 
C. elegans, encode similar transmembrane proteins. Cell 58, 553–563 (1989). 
13. Coffman, C., Harris, W. & Kintner, C. Xotch, the Xenopus homolog of Drosophila Notch. 
Science (80-. ). 249, 1438–1441 (1990). 
14. Pear, W. S. et al. Exclusive development of T cell neoplasms in mice transplanted with bone 
marrow expressing activated Notch alleles. J. Exp. Med. 183, 2283–2291 (1996). 
15. Käsbauer, T. et al. The Notch signaling pathway in the cnidarian Hydra. Dev. Biol. 303, 376–390 
(2007). 
16. Logeat, F. et al. The Notch1 receptor is cleaved constitutively by a furin-like convertase. Proc. Natl. 
Acad. Sci. U. S. A. 95, 8108–8112 (1998). 
17. Blaumueller, C. M., Qi, H., Zagouras, P. & Artavanis-Tsakonas, S. Intracellular cleavage of Notch 
leads to a heterodimeric receptor on the plasma membrane. Cell 90, 281–291 (1997). 
18. Fehon, R. G. et al. Molecular interactions between the protein products of the neurogenic loci 
Notch and Delta, two EGF-homologous genes in Drosophila. Cell 61, 523–534 (1990). 
19. Ge, C., Liu, T., Hou, X. & Stanley, P. In vivo consequences of deleting EGF repeats 8-12 
including the ligand binding domain of mouse Notch1. BMC Dev. Biol. 8, (2008). 
20. Hambleton, S., Valeyev, N., Muranyi, A., Structure, V. K.- & 2004,  undefined. Structural and 
functional properties of the human notch-1 ligand binding region. Elsevier 
21. Cordle, J. et al. Localization of the delta-like-1-binding site in human Notch-1 and its modulation 
by calcium affinity. J. Biol. Chem. 283, 11785–11793 (2008). 
22. Malecki, M. J. et al. Leukemia-Associated Mutations within the NOTCH1 Heterodimerization 
Domain Fall into at Least Two Distinct Mechanistic Classes. Mol. Cell. Biol. 26, 4642–4651 
(2006). 
23. Brown, M. S., Ye, J., Rawson, R. B. & Goldstein, J. L. Regulated intramembrane proteolysis: A 
control mechanism conserved from bacteria to humans. Cell 100, 391–398 (2000). 
24. Tamura, K. et al. Physical interaction between a novel domain of the receptor Notch and the 
transcription factor RBP-J kappa/Su(H). Curr. Biol. 5, 1416–23 (1995). 
25. Nam, Y., Weng, A. P., Aster, J. C. & Blacklow, S. C. Structural requirements for assembly of the 
CSL·intracellular Notch1·Mastermind-like 1 transcriptional activation complex. J. Biol. Chem. 
278, 21232–21239 (2003). 
26. Lubman, O. Y., Ilagan, M. X. G., Kopan, R. & Barrick, D. Quantitative Dissection of the 
Notch:CSL Interaction: Insights into the Notch-mediated Transcriptional Switch. J. Mol. Biol. 
365, 577–589 (2007). 
27. Nam, Y., Sliz, P., Song, L., Aster, J. C. & Blacklow, S. C. Structural basis for cooperativity in 
recruitment of MAML coactivators to Notch transcription complexes. Cell 124, 973–983 (2006). 
 81  
28. Weng, A. P. et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic 
leukemia. Science (80-. ). 306, 269–271 (2004). 
29. Chiang, M. Y. et al. Identification of a Conserved Negative Regulatory Sequence That Influences 
the Leukemogenic Activity of NOTCH1. Mol. Cell. Biol. 26, 6261–6271 (2006). 
30. Shimizu, K. et al. Mouse Jagged1 physically interacts with Notch2 and other Notch receptors. 
Assessment by quantitative methods. J. Biol. Chem. 274, 32961–32969 (1999). 
31. Andrawes, M. B. et al. Intrinsic selectivity of notch 1 for delta-like 4 over delta-like 1. J. Biol. 
Chem. 288, 25477–25489 (2013). 
32. Parks, A. L. et al. Structure-function analysis of delta trafficking, receptor binding and signaling in 
Drosophila. Genetics 174, 1947–1961 (2006). 
33. Suckling, R. J. et al. Structural and functional dissection of the interplay between lipid and Notch 
binding by human Notch ligands. EMBO J. 36, 2204–2215 (2017). 
34. Shilo, B. & Sprinzak, D. The lipid‐binding side of Notch ligands. EMBO J. 36, 2182–2183 
(2017). 
35. Ladi, E. et al. The divergent DSL ligand Dll3 does not activate Notch signaling but cell 
autonomously attenuates signaling induced by other DSL ligands. J. Cell Biol. 170, 983–992 
(2005). 
36. Geffers, I. et al. Divergent functions and distinct localization of the Notch ligands DLL1 and 
DLL3 in vivo. J. Cell Biol. 178, 465–476 (2007). 
37. D’Souza, B., Meloty-Kapella, L. & Weinmaster, G. Canonical and non-canonical notch ligands. 
Current Topics in Developmental Biology 92, (Academic Press, 2010). 
38. Dunwoodie, S., Henrique, D., … S. H.- & 1997,  undefined. Mouse Dll3: a novel divergent Delta 
gene which may complement the function of other Delta homologues during early pattern formation in 
the mouse embryo. dev.biologists.org (1997). 
39. Sprinzak, D. et al. Cis-interactions between Notch and Delta generate mutually exclusive 
signalling states. Nature 465, 86–90 (2010). 
40. LeBon, L., Lee, T. V., Sprinzak, D., Jafar-Nejad, H. & Elowitz, M. B. Fringe proteins modulate 
Notch-ligand cis and trans interactions to specify signaling states. Elife 3, e02950 (2014). 
41. Jacobsen, T. L., Brennan, K., Arias, A. M. & Muskavitch, M. A. Cis-interactions between Delta 
and Notch modulate neurogenic signalling in Drosophila. Development 125, 4531 LP – 4540 
(1998). 
42. Gordon, W. R. et al. Mechanical Allostery: Evidence for a Force Requirement in the Proteolytic 
Activation of Notch. Dev. Cell 33, 729–736 (2015). 
43. Meloty-Kapella, L., Shergill, B., Kuon, J., Botvinick, E. & Weinmaster, G. Notch Ligand 
Endocytosis Generates Mechanical Pulling Force Dependent on Dynamin, Epsins, and Actin. Dev. 
Cell 22, 1299–1312 (2012). 
44. Parks, A. L., Klueg, K. M., Stout, J. R. & Muskavitch, M. A. Ligand endocytosis drives receptor 
dissociation and activation in the Notch pathway. Development 127, 1373 LP – 1385 (2000). 
45. Kovall, R. A. & Hendrickson, W. A. Crystal structure of the nuclear effector of Notch signaling, 
CSL, bound to DNA. EMBO J. 23, 3441–3451 (2004). 
46. Borggrefe, T. & Oswald, F. Keeping notch target genes off: A CSL corepressor caught in the act. 
Structure 22, 3–5 (2014). 
47. Wilson, J. J. & Kovall, R. A. Crystal structure of the CSL-Notch-Mastermind Ternary complex 
bound to DNA. Cell 124, 985–996 (2006). 
48. Castel, D. et al. Dynamic binding of RBPJ is determined by notch signaling status. Genes Dev. 27, 
1059–1071 (2013). 
49. Ghai, V. & Gaudet, J. The CSL transcription factor LAG-1 directly represses hlh-6 expression in 
C. elegans. Dev. Biol. 322, 334–344 (2008). 
50. Neves, A., English, K. & Priess, J. R. Notch-GATA synergy promotes endoderm-specific 
expression of ref-1 in C. elegans. Development 134, 4459–4468 (2007). 
51. Krejčí, A. & Bray, S. Notch activation stimulates transient and selective binding of Su(H)/CSL to 
target enhancers. Genes Dev. 21, 1322–1327 (2007). 
52. Li, Y. & Baker, N. E. Proneural enhancement by Notch overcomes suppressor-of-hairless repressor 
function in the developing Drosophila eye. Curr. Biol. 11, 330–338 (2001). 
53. Lake, R. J., Tsai, P.-F., Choi, I., Won, K.-J. & Fan, H.-Y. RBPJ, the Major Transcriptional 
Effector of Notch Signaling, Remains Associated with Chromatin throughout Mitosis, Suggesting 
a Role in Mitotic Bookmarking. PLoS Genet. 10, e1004204 (2014). 
54. Kageyama, R., Ohtsuka, T. & Kobayashi, T. The Hes gene family: Repressors and oscillators that 
orchestrate embryogenesis. Development 134, 1243–1251 (2007). 
55. Housden, B. E. et al. Transcriptional Dynamics Elicited by a Short Pulse of Notch Activation 
Involves Feed-Forward Regulation by E(spl)/Hes Genes. PLoS Genet. 9, e1003162 (2013). 
56. Bray, S. & Bernard, F. Notch targets and their regulation. Current Topics in Developmental Biology 
92, (Academic Press, 2010). 
 82  
57. Sun, Y. et al. Differential Notchl and Notch2 expression and frequent activation of Notch 
signaling in gastric cancers. Arch. Pathol. Lab. Med. 135, 451–458 (2011). 
58. Fan, X. et al. Notch1 and Notch2 have opposite effects on embryonal brain tumor growth. Cancer 
Res. 64, 7787–7793 (2004). 
59. Shi, J., Fallahi, M., Luo, J. L. & Petrie, H. T. Nonoverlapping functions for Notch1 and Notch3 
during murine steady-state thymic lymphopoiesis. Blood 118, 2511–2519 (2011). 
60. Beatus, P., Lundkvist, J., Öberg, C., Pedersen, K. & Lendahl, U. The origin of the ankyrin repeat 
region in Notch intracellular domains is critical for regulation of HES promoter activity. Mech. 
Dev. 104, 3–20 (2001). 
61. Liu, Z. et al. The intracellular domains of Notch1 and Notch2 are functionally equivalent during 
development and carcinogenesis. Dev. 142, 2452–2463 (2015). 
62. James, A. C. et al. Notch4 reveals a novel mechanism regulating Notch signal transduction. 
Biochim. Biophys. Acta - Mol. Cell Res. 1843, 1272–1284 (2014). 
63. Preuße, K. et al. Context-Dependent Functional Divergence of the Notch Ligands DLL1 and 
DLL4 In Vivo. PLoS Genet. 11, (2015). 
64. Acar, M. et al. Rumi Is a CAP10 Domain Glycosyltransferase that Modifies Notch and Is 
Required for Notch Signaling. Cell 132, 247–258 (2008). 
65. Irvine, K. D. & Wieschaus, E. Cell intercalation during Drosophila germband extension and its 
regulation by pair-rule segmentation genes. Development 120, 827 LP – 841 (1994). 
66. Uemura, T., Shepherd, S., Ackerman, L., Jan, L. Y. & Jan, Y. N. numb, a gene required in 
determination of cell fate during sensory organ formation in Drosophila embryos. Cell 58, 349–
360 (1989). 
67. Couturier, L., Mazouni, K. & Schweisguth, F. Numb localizes at endosomes and controls the 
endosomal sorting of notch after asymmetric division in drosophila. Curr. Biol. 23, 588–593 
(2013). 
68. Leitch, C. C., Lodh, S., Prieto-Echagüe, V., Badano, J. L. & Zaghloul, N. A. Basal body proteins 
regulate Notch signaling through endosomal trafficking. J. Cell Sci. 127, 2407–2419 (2014). 
69. Gomez-Lamarca, M. J., Snowdon, L. A., Seib, E., Klein, T. & Bray, S. J. Rme-8 depletion 
perturbs Notch recycling and predisposes to pathogenic signaling. J. Cell Biol. 210, 303–318 
(2015). 
70. Zhou, W. et al. BLOS2 negatively regulates notch signaling during neural and hematopoietic stem 
and progenitor cell development. Elife 5, (2016). 
71. Britton, G. J. et al. PKCθ links proximal T cell and notch signaling through localized regulation of 
the actin cytoskeleton. Elife 6, (2017). 
72. Santio, N. M. et al. Phosphorylation of Notch1 by Pim kinases promotes oncogenic signaling in 
breast and  prostate cancer cells. Oncotarget 7, 43220–43238 (2016). 
73. Sjöqvist, M. et al. PKCζ regulates Notch receptor routing and activity in a Notch signaling-
dependent  manner. Cell Res. 24, 433–450 (2014). 
74. Foltz, D. R., Santiago, M. C., Berechid, B. E. & Nye, J. S. Glycogen synthase kinase-3β 
modulates notch signaling and stability. Curr. Biol. 12, 1006–1011 (2002). 
75. Fryer, C. J., White, J. B. & Jones, K. A. Mastermind recruits CycC:CDK8 to phosphorylate the 
Notch ICD and coordinate activation with turnover. Mol. Cell 16, 509–520 (2004). 
76. Ishitani, T. et al. Nemo-like kinase suppresses Notch signalling by interfering with formation of 
the Notch active transcriptional complex. Nat. Cell Biol. 12, 278–285 (2010). 
77. Zhang, H. et al. An Eya1-Notch axis specifies bipotential epibranchial differentiation in 
mammalian  craniofacial morphogenesis. Elife 6, (2017). 
78. Hein, K. et al. Site-specific methylation of Notch1 controls the amplitude and duration of the 
Notch1 response. Sci. Signal. 8, (2015). 
79. Coleman, M. L. et al. Asparaginyl hydroxylation of the notch ankyrin repeat domain by factor 
inhibiting hypoxia-inducible factor. J. Biol. Chem. 282, 24027–24038 (2007). 
80. Zheng, X. et al. Interaction with factor inhibiting HIF-1 defines an additional mode of cross-
coupling between the Notch and hypoxia signaling pathways. Proc. Natl. Acad. Sci. U. S. A. 105, 
3368–3373 (2008). 
81. Guarani, V. et al. Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 
deacetylase. Nature 473, 234–238 (2011). 
82. Palermo, R. et al. Acetylation controls Notch3 stability and function in T-cell leukemia. Oncogene 
31, 3807–3817 (2012). 
83. Gupta-Rossi, N. et al. Functional Interaction between SEL-10, an F-box Protein, and the Nuclear 
Form of Activated Notch1 Receptor. J. Biol. Chem. 276, 34371–34378 (2001). 
84. Wu, G. et al. SEL-10 Is an Inhibitor of Notch Signaling That Targets Notch for Ubiquitin-
Mediated Protein Degradation. Mol. Cell. Biol. 21, 7403–7415 (2001). 
 83  
85. Öberg, C. et al. The Notch Intracellular Domain is Ubiquitinated and Negatively Regulated by 
the Mammalian Sel-10 Homolog. J. Biol. Chem. 276, 35847–35853 (2001). 
86. Fortini, M. E. & Artavanis-Tsakonas, S. The suppressor of hairless protein participates in notch 
receptor signaling. Cell 79, 273–282 (1994). 
87. Mukherjee, A. et al. Regulation of Notch signalling by non-visual β-arrestin. Nat. Cell Biol. 7, 
1091–1101 (2005). 
88. Diefenbacher, M. E. et al. The deubiquitinase USP28 controls intestinal homeostasis and 
promotes Colorectal cancer. J. Clin. Invest. 124, 3407–3418 (2014). 
89. Diefenbacher, M. E. et al. Usp28 counteracts Fbw7 in intestinal homeostasis and cancer. Cancer 
Res. 75, 1181–1186 (2015). 
90. Traustadóttir, G. Á. et al. Evidence of non-canonical NOTCH signaling: Delta-like 1 homolog 
(DLK1) directly interacts with the NOTCH1 receptor in mammals. Cell. Signal. 28, 246–254 
(2016). 
91. Rauen, T. et al. YB-1 acts as a ligand for notch-3 receptors and modulates receptor activation. J. 
Biol. Chem. 284, 26928–26940 (2009). 
92. Miyamoto, A., Lau, R., Hein, P. W., Shipley, J. M. & Weinmaster, G. Microfibrillar proteins 
MAGP-1 and MAGP-2 induce Notch1 extracellular domain dissociation and receptor activation. 
J. Biol. Chem. 281, 10089–10097 (2006). 
93. Eiraku, M., Hirata, Y., Takeshima, H., Hirano, T. & Kengaku, M. Delta/Notch-like epidermal 
growth factor (EGF)-related receptor, a novel EGF-like repeat-containing protein targeted to 
dendrites of developing and adult central nervous system neurons. J. Biol. Chem. 277, 25400–
25407 (2002). 
94. Luca, V. C. et al. Structural biology. Structural basis for Notch1 engagement of Delta-like 4. 
Science 347, 847–853 (2015). 
95. Alves-Guerra, M. C., Ronchini, C. & Capobianco, A. J. Mastermind-like 1 is a specific coactivator 
of β-catenin transcription activation and is essential for colon carcinoma cell survival. Cancer Res. 
67, 8690–8698 (2007). 
96. Liefke, R. et al. Histone demethylase KDM5A is an integral part of the core Notch-RBP-J 
repressor complex. Genes Dev. 24, 590–601 (2010). 
97. Ntziachristos, P. et al. Genetic inactivation of the polycomb repressive complex 2 in T cell acute 
lymphoblastic leukemia. Nat. Med. 18, 296–301 (2012). 
98. Yashiro-Ohtani, Y. et al. Long-range enhancer activity determines Myc sensitivity to Notch 
inhibitors in T cell leukemia. Proc. Natl. Acad. Sci. U. S. A. 111, E4946–E4953 (2014). 
99. Skalska, L. et al. Chromatin signatures at Notch‐regulated enhancers reveal large‐scale changes in 
H3K56ac upon activation. EMBO J. 34, 1889–1904 (2015). 
100. Shawber, C. et al. Notch signaling inhibits muscle cell differentiation through a CBF1-
independent pathway. Development 122, 3765 LP – 3773 (1996). 
101. Zecchini, V., Brennan, K. & Martinez-Arias, A. An activity of Notch regulates JNK signalling and 
affects dorsal closure in Drosophila. Curr. Biol. 9, 460–469 (1999). 
102. Rusconi, J. C. & Corbin, V. Evidence for a novel Notch pathway required for muscle precursor 
selection in Drosophila. Mech. Dev. 79, 39–50 (1998). 
103. Oh, P. et al. In vivo mapping of notch pathway activity in normal and stress hematopoiesis. Cell 
Stem Cell 13, 190–204 (2013). 
104. Jin, S. et al. Non-canonical Notch signaling activates IL-6/JAK/STAT signaling in breast tumor 
cells and is controlled by p53 and IKKα/IKKβ. Oncogene 32, 4892–4902 (2013). 
105. Bertout, J. A., Patel, S. A. & Simon, M. C. The impact of O2 availability on human cancer. 
Nature Reviews Cancer 8, 967–975 (2008). 
106. YM, L. et al. Determination of Hypoxic Region by Hypoxia Marker in Developing Mouse 
Embryos in Vivo: A Possible Signal for Vessel Development. Dev. Dyn. 220, (2001). 
107. Semenza, G. L., Nejfelt, M. K., Chi, S. M. & Antonarakis, S. E. Hypoxia-inducible nuclear factors 
bind to an enhancer element located 3′ to the human erythropoietin gene. Proc. Natl. Acad. Sci. U. 
S. A. 88, 5680–5684 (1991). 
108. Wang, G. L., Jiang, B. H., Rue, E. A. & Semenza, G. L. Hypoxia-inducible factor 1 is a basic-
helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. U. S. A. 
92, 5510–5514 (1995). 
109. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: The next generation. Cell 144, 646–674 
(2011). 
110. Jögi, A. et al. Hypoxia alters gene expression in human neuroblastoma cells toward an immature 
and neural crest-like phenotype. Proc. Natl. Acad. Sci. U. S. A. 99, 7021–7026 (2002). 
111. Pietras, A., Von Stedingk, K., Lindgren, D., Påhlman, S. & Axelson, H. JAG2 induction in 
hypoxic tumor cells alters notch signaling and enhances endothelial cell tube formation. Mol. 
Cancer Res. 9, 626–636 (2011). 
 84  
112. Xing, F. et al. Hypoxia-induced Jagged2 promotes breast cancer metastasis and self-renewal of 
cancer stem-like cells. Oncogene 30, 4075–4086 (2011). 
113. Skuli, N. et al. Endothelial HIF-2α regulates murine pathological angiogenesis and 
revascularization processes. J. Clin. Invest. 122, 1427–1443 (2012). 
114. Patel, N. S. et al. Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of 
basal expression in endothelial cell function. Cancer Res. 65, 8690–8697 (2005). 
115. Lanner, F. et al. Hypoxia-Induced Arterial Differentiation Requires Adrenomedullin and Notch 
Signaling. Stem Cells Dev. 22, 1360–1369 (2013). 
116. Gustafsson, M. V. et al. Hypoxia requires Notch signaling to maintain the undifferentiated cell 
state. Dev. Cell 9, 617–628 (2005). 
117. Sahlgren, C., Gustafsson, M. V., Jin, S., Poellinger, L. & Lendahl, U. Notch signaling mediates 
hypoxia-induced tumor cell migration and invasion. Proc. Natl. Acad. Sci. U. S. A. 105, 6392–
6397 (2008). 
118. Wilkins, S. E. et al. Differences in hydroxylation and binding of Notch and HIF-1α demonstrate 
substrate selectivity for factor inhibiting HIF-1 (FIH-1). Int. J. Biochem. Cell Biol. 41, 1563–1571 
(2009). 
119. Villa, J. C. et al. Nontranscriptional role of hif-1α in activation of γ-secretase and notch signaling 
in breast cancer. Cell Rep. 8, 1077–1092 (2014). 
120. Main, H. et al. Interactions between Notch- and hypoxia-induced transcriptomes in embryonic 
stem cells. Exp. Cell Res. 316, 1610–1624 (2010). 
121. Pai, S. G. et al. Wnt/beta-catenin pathway: Modulating anticancer immune response. Journal of 
Hematology and Oncology 10, 101 (2017). 
122. Collu, G. M., Hidalgo-Sastre, A. & Brennan, K. Wnt-Notch signalling crosstalk in development 
and disease. Cellular and Molecular Life Sciences 71, 3553–3567 (2014). 
123. Fre, S. et al. Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in 
the intestine. Proc. Natl. Acad. Sci. U. S. A. 106, 6309–6314 (2009). 
124. Tian, H. et al. Opposing activities of notch and wnt signaling regulate intestinal stem cells and gut 
homeostasis. Cell Rep. 11, 33–42 (2015). 
125. Rodilla, V. et al. Jagged1 is the pathological link between Wnt and Notch pathways in colorectal 
cancer. Proc. Natl. Acad. Sci. U. S. A. 106, 6315–6320 (2009). 
126. Sieiro, D., Rios, A. C., Hirst, C. E. & Marcelle, C. Cytoplasmic NOTCH and membrane-derived β-catenin link cell fate choice to epithelial-mesenchymal transition during myogenesis. Elife 5, 
(2016). 
127. Yamamizu, K. et al. Convergence of Notch and β-catenin signaling induces arterial fate in vascular 
progenitors. J. Cell Biol. 189, 325–338 (2010). 
128. Napetschnig, J. & Wu, H. Molecular Basis of NF-κB Signaling. Annu. Rev. Biophys. 42, 443–468 
(2013). 
129. Osipo, C., Golde, T. E., Osborne, B. A. & Miele, L. A. Off the beaten pathway: The complex 
cross talk between Notch and NF-κB. Laboratory Investigation 88, 11–17 (2008). 
130. Kumar, V. et al. Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell 
acute lymphoblastic leukemia. Leukemia 28, 2324–2335 (2014). 
131. Grgurevic, L., Pecina, M. & Vukicevic, S. Marshall R. Urist and the discovery of bone 
morphogenetic proteins. Int. Orthop. 41, 1065–1069 (2017). 
132. Urist, M. R. Bone: Formation by autoinduction. Science (80-. ). 150, 893–899 (1965). 
133. Wang, R. N. et al. Bone Morphogenetic Protein (BMP) signaling in development and human 
diseases. Genes and Diseases 1, 87–105 (2014). 
134. Zavadil, J., Cermak, L., Soto-Nieves, N. & Böttinger, E. P. Integration of TGF-β/Smad and 
Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J. 23, 1155–1165 
(2004). 
135. Hudson, C. & Yasuo, H. A signalling relay involving Nodal and Delta ligands acts during 
secondary notochord induction in &lt;em&gt;Ciona&lt;/em&gt; embryos. Development 133, 
2855 LP – 2864 (2006). 
136. Hudson, C., Lotito, S. & Yasuo, H. Sequential and combinatorial inputs from Nodal, 
Delta2/Notch and FGF/MEK/ERK signalling pathways establish a grid-like organisation of 
distinct cell identities in the ascidian neural plate. Development 134, 3527 LP – 3537 (2007). 
137. Blokzijl, A. et al. Cross-talk between the Notch and TGF-β signaling pathways mediated by 
interaction of the Notch intracellular domain with Smad3. J. Cell Biol. 163, 723–728 (2003). 
138. Dahlqvist, C. et al. Functional Notch signaling is required for BMP4-induced inhibition of 
myogenic differentiation. Development 130, 6089–6099 (2003). 
139. Sun, Y. et al. Notch4 intracellular domain binding to Smad3 and inhibition of the TGF-beta; 
signaling. Oncogene 24, 5365–5374 (2005). 
 85  
140. Gudey, S. K. et al. TRAF6 stimulates the tumor-promoting effects of TGFβ type I receptor 
through polyubiquitination and activation of presenilin. Sci. Signal. 7, ra2–ra2 (2014). 
141. The chemical basis of morphogenesis. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 237, 37–72 (1952). 
142. Troost, T., Schneider, M. & Klein, T. A Re-examination of the Selection of the Sensory Organ 
Precursor of the Bristle Sensilla of Drosophila melanogaster. PLoS Genet. 11, e1004911 (2015). 
143. Chanet, S., Vodovar, N., Mayau, V. & Schweisguth, F. Genome engineering-based analysis of 
Bearded family genes reveals both functional redundancy and a nonessential function in lateral 
inhibition in drosophila. Genetics 182, 1101–1108 (2009). 
144. Blanco, R. & Gerhardt, H. VEGF and Notch in tip and stalk cell selection. Cold Spring Harb. 
Perspect. Med. 3, (2013). 
145. Schweisguth, F. Asymmetric cell division in the Drosophila bristle lineage: from the polarization of 
sensory organ precursor cells to Notch-mediated binary fate decision. Wiley Interdiscip. Rev. Dev. 
Biol. 4, 299–309 (2015). 
146. Rossi, A. M. & Desplan, C. Asymmetric Notch Amplification to Secure Stem Cell Identity. 
Developmental Cell 40, 513–514 (2017). 
147. Hoglund, V. J. & Majesky, M. W. Patterning the artery wall by lateral induction of Notch 
signaling. Circulation 125, 212–215 (2012). 
148. Golson, M. L. et al. Jagged1 is a competitive inhibitor of Notch signaling in the embryonic 
pancreas. Mech. Dev. 126, 687–699 (2009). 
149. Le, T. T., Conley, K. W. & Brown, N. L. Jagged 1 is necessary for normal mouse lens formation. 
Dev. Biol. 328, 118–126 (2009). 
150. Christ, B., Huang, R. & Scaal, M. Amniote somite derivatives. Dev. Dyn. 236, 2382–2396 
(2007). 
151. Dias, A. S., De Almeida, I., Belmonte, J. M., Glazier, J. A. & Stern, C. D. Somites without a 
clock. Science (80-. ). 343, 791–795 (2014). 
152. Conlon, R. A., Reaume, A. G. & Rossant, J. Notch1 is required for the coordinate segmentation 
of somites. Development 121, 1533 LP – 1545 (1995). 
153. Shifley, E. T. et al. Oscillatory lunatic fringe activity is crucial for segmentation of the anterior but 
not posterior skeleton. Development 135, 899 LP – 908 (2008). 
154. Evrard, Y. A., Lun, Y., Aulehla, A., Gan, L. & Johnson, R. L. Lunatic fringe is an essential 
mediator of somite segmentation and patterning. Nature 394, 377–381 (1998). 
155. Bessho, Y. et al. Dynamic expression and essential functions of Hes7 in somite segmentation. 
Genes Dev. 15, 2642–2647 (2001). 
156. Kusumi, K. et al. The mouse pudgy mutation disrupts Delta homologue DII3 and initiation of 
early somite boundaries. Nat. Genet. 19, 274–278 (1998). 
157. Riedel-Kruse, I. H., Müller, C. & Oates, A. C. Synchrony dynamics during initiation, failure, and 
rescue of the segmentation clock. Science (80-. ). 317, 1911–1915 (2007). 
158. Soza-Ried, C., Öztürk, E., Ish-Horowicz, D. & Lewis, J. Pulses of Notch activation synchronise 
oscillating somite cells and entrain the zebrafish segmentation clock. Dev. 141, 1780–1788 (2014). 
159. Delaune, E. A., François, P., Shih, N. P. & Amacher, S. L. Single-Cell-Resolution Imaging of the 
Impact of Notch Signaling and Mitosis on Segmentation Clock Dynamics. Dev. Cell 23, 995–
1005 (2012). 
160. Jiang, Y. J. et al. Notch signalling and the synchronization of the somite segmentation clock. 
Nature 408, 475–479 (2000). 
161. Mara, A., Schroeder, J., Chalouni, C. & Holley, S. A. Priming, initiation and synchronization of 
the segmentation clock by deltaD and deltaC. Nat. Cell Biol. 9, 523–530 (2007). 
162. Kamath, B. M. et al. Vascular anomalies in Alagille syndrome: a significant cause of morbidity and  
mortality. Circulation 109, 1354–1358 (2004). 
163. Krebs, L. T. et al. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 14, 
1343–1352 (2000). 
164. McCright, B. et al. Defects in development of the kidney, heart and eye vasculature in mice 
homozygous  for a hypomorphic Notch2 mutation. Development 128, 491–502 (2001). 
165. Xue, Y. et al. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. 
Hum. Mol. Genet. 8, 723–730 (1999). 
166. Gale, N. W. et al. Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to 
major defects in arterial and vascular development. Proc. Natl. Acad. Sci. U. S. A. 101, 15949–
15954 (2004). 
167. Lawson, N. D., Vogel, A. M. & Weinstein, B. M. Sonic hedgehog and vascular endothelial growth 
factor act upstream of the Notch pathway during arterial endothelial differentiation. Dev. Cell 3, 
127–136 (2002). 
168. You, L. R. et al. Suppression of Notch signalling by the COUP-TFII transcription factor regulates 
vein identity. Nature 435, 98–104 (2005). 
 86  
169. Pereira, F. A., Yuhong, Q., Zhou, G., Tsai, M. J. & Tsai, S. Y. The orphan nuclear receptor 
COUP-TFII is required for angiogenesis and heart development. Genes Dev. 13, 1037–1049 
(1999). 
170. Lobov, I. B. et al. Delta-like ligand 4 (DII4) is induced by VEGF as a negative regulator of 
angiogenic sprouting. Proc. Natl. Acad. Sci. U. S. A. 104, 3219–3224 (2007). 
171. Suchting, S. et al. The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation 
and vessel branching. Proc. Natl. Acad. Sci. U. S. A. 104, 3225–3230 (2007). 
172. Hellström, M. et al. Dll4 signalling through Notch1 regulates formation of tip cells during 
angiogenesis. Nature 445, 776–780 (2007). 
173. Benedito, R. et al. The Notch Ligands Dll4 and Jagged1 Have Opposing Effects on Angiogenesis. 
Cell 137, 1124–1135 (2009). 
174. High, F. A. et al. Endothelial expression of the Notch ligand Jagged1 is required for vascular 
smooth muscle development. Proc. Natl. Acad. Sci. U. S. A. 105, 1955–1959 (2008). 
175. Henshall, T. L. et al. Notch3 is necessary for blood vessel integrity in the central nervous system. 
Arterioscler. Thromb. Vasc. Biol. 35, 409–420 (2015). 
176. Harvey, R. P. Organogenesis: Patterning the vertebrate heart. Nat. Rev. Genet. 3, 544–556 (2002). 
177. Ward, C., Stadt, H., Hutson, M. & Kirby, M. L. Ablation of the secondary heart field leads to 
tetralogy of Fallot and pulmonary atresia. Dev. Biol. 284, 72–83 (2005). 
178. Neeb, Z., Lajiness, J. D., Bolanis, E. & Conway, S. J. Cardiac outflow tract anomalies. Wiley 
Interdiscip. Rev. Dev. Biol. 2, 499–530 (2013). 
179. Meilhac, S. M., Lescroart, F., Blanpain, C. & Buckingham, M. E. Cardiac cell lineages that form 
the heart. Cold Spring Harb. Perspect. Med. 4, a013888 (2014). 
180. Oda, T. et al. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat. 
Genet. 16, 235–242 (1997). 
181. Li, L. et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand  
for Notch1. Nat. Genet. 16, 243–251 (1997). 
182. McElhinney, D. B. et al. Analysis of cardiovascular phenotype and genotype-phenotype correlation 
in individuals with a JAG1 mutation and/or Alagille syndrome. Circulation 106, 2567–74 (2002). 
183. Robert, M. L. P. et al. Alagille syndrome with deletion 20p12.2–p12.3 and hypoplastic left heart. 
Clin. Dysmorphol. 16, 241–246 (2007). 
184. MacGrogan, D., Nus, M. & Pompa, J. L. de la. Notch Signaling in Cardiac Development and 
Disease. Curr. Top. Dev. Biol. 92, 333–365 (2010). 
185. Kamath, B. M. et al. NOTCH2 mutations in Alagille syndrome. J. Med. Genet. 49, 138–44 
(2012). 
186. Greenway, S. C. et al. De novo copy number variants identify new genes and loci in isolated 
sporadic tetralogy of Fallot. Nat. Genet. 41, 931–5 (2009). 
187. Xue, Y. et al. Embryonic Lethality and Vascular Defects in Mice Lacking the Notch Ligand 
Jagged1. Hum. Mol. Genet. 8, 723–730 (1999). 
188. McCright, B., Lozier, J. & Gridley, T. A mouse model of Alagille syndrome: 
&lt;em&gt;Notch2&lt;/em&gt; as a genetic modifier of &lt;em&gt;Jag1&lt;/em&gt; 
haploinsufficiency. Development 129, 1075 LP – 1082 (2002). 
189. Andersson, E. R. et al. Mouse Model of Alagille Syndrome and Mechanisms of Jagged1 Missense 
Mutations. Gastroenterology 154, 1080–1095 (2018). 
190. Engleka, K. A. et al. Islet1 derivatives in the heart are of both neural crest and second heart field 
origin. Circ. Res. 110, 922–6 (2012). 
191. Donovan, J., Kordylewska, A., Jan, Y. N. & Utset, M. F. Tetralogy of fallot and other congenital 
heart defects in Hey2 mutant mice. Curr. Biol. 12, 1605–10 (2002). 
192. Grego-Bessa, J. et al. Notch Signaling Is Essential for Ventricular Chamber Development. Dev. 
Cell 12, 415–429 (2007). 
193. Timmerman, L. A. et al. Notch promotes epithelial-mesenchymal transition during cardiac 
development and oncogenic transformation. Genes Dev. 18, 99–115 (2004). 
194. Miyajima, A., Tanaka, M. & Itoh, T. Stem/progenitor cells in liver development, homeostasis, 
regeneration, and  reprogramming. Cell Stem Cell 14, 561–574 (2014). 
195. Zong, Y. et al. Notch signaling controls liver development by regulating biliary differentiation. 
Development 136, 1727–1739 (2009). 
196. Geisler, F. et al. Liver-specific inactivation of Notch2, but not Notch1, compromises intrahepatic 
bile duct development in mice. Hepatology 48, 607–616 (2008). 
197. Sparks, E. E., Huppert, K. A., Brown, M. A., Washington, M. K. & Huppert, S. S. Notch 
signaling regulates formation of the three-dimensional architecture of intrahepatic bile ducts in 
mice. Hepatology 51, 1391–1400 (2010). 
198. Loomes, K. M. et al. Bile duct proliferation in liver-specific Jag1 conditional knockout mice: 
Effects of gene dosage. Hepatology 45, 323–330 (2007). 
 87  
199. Hofmann, J. J. et al. Jagged1 in the portal vein mesenchyme regulates intrahepatic bile duct 
development: Insights into Alagille syndrome. Development 137, 4061–4072 (2010). 
200. Kumano, K. et al. Notch1 but not Notch2 is essential for generating hematopoietic stem cells from  
endothelial cells. Immunity 18, 699–711 (2003). 
201. Robert-Moreno, A., Espinosa, L., de la Pompa, J. L. & Bigas, A. RBPjkappa-dependent Notch 
function regulates Gata2 and is essential for the  formation of intra-embryonic hematopoietic cells. 
Development 132, 1117–1126 (2005). 
202. Burns, C. E., Traver, D., Mayhall, E., Shepard, J. L. & Zon, L. I. Hematopoietic stem cell fate is 
established by the Notch-Runx pathway. Genes Dev. 19, 2331–2342 (2005). 
203. Porcheri, C. et al. Notch ligand Dll4 impairs cell recruitment to aortic clusters and limits blood 
stem cell generation. EMBO J. 39, e104270 (2020). 
204. Pui, J. C. et al. Notch1 expression in early lymphopoiesis influences B versus T lineage  
determination. Immunity 11, 299–308 (1999). 
205. Radtke, F. et al. Deficient T cell fate specification in mice with an induced inactivation of Notch1. 
Immunity 10, 547–558 (1999). 
206. Han, H. et al. Inducible gene knockout of transcription factor recombination signal binding  
protein-J reveals its essential role in T versus B lineage decision. Int. Immunol. 14, 637–645 
(2002). 
207. Mercher, T. et al. Notch Signaling Specifies Megakaryocyte Development from Hematopoietic 
Stem Cells. Cell Stem Cell 3, 314–326 (2008). 
208. Poirault-Chassac, S. et al. Notch/Delta4 signaling inhibits human megakaryocytic terminal 
differentiation. Blood 116, 5670–5678 (2010). 
209. Robert-Moreno, À., Espinosa, L., Sanchez, M. J., de la Pompa, J. L. & Bigas, A. The notch 
pathway positively regulates programmed cell death during erythroid differentiation. Leukemia 21, 
1496–1503 (2007). 
210. Odes, E. J. et al. Earliest hominin cancer: 1.7-million-year-old osteosarcoma from Swartkrans 
Cave, South Africa. S. Afr. J. Sci. 112, 5–5 (2016). 
211. Faguet, G. B. A brief history of cancer: Age-old milestones underlying our current knowledge 
database. Int. J. Cancer 136, 2022–2036 (2015). 
212. Papavramidou, N., Papavramidis, T. & Demetriou, T. Ancient greek and greco-Roman methods 
in modern surgical treatment of cancer. Annals of Surgical Oncology 17, 665–667 (2010). 
213. Ellisen, L. W. et al. TAN-1, the human homolog of the Drosophila Notch gene, is broken by 
chromosomal translocations in T lymphoblastic neoplasms. Cell 66, 649–661 (1991). 
214. Gallahan, D. & Callahan, R. Mammary tumorigenesis in feral mice: identification of a new int 
locus in mouse  mammary tumor virus (Czech II)-induced mammary tumors. J. Virol. 61, 66–74 
(1987). 
215. Uyttendaele, H. et al. Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific 
mammalian  Notch gene. Development 122, 2251–2259 (1996). 
216. Siebel, C. & Lendahl, U. Notch signaling in development, tissue homeostasis, and disease. Physiol. 
Rev. 97, 1235–1294 (2017). 
217. Brzozowa-Zasada, M. et al. Notch signalling pathway as an oncogenic factor involved in cancer 
development. Wspolczesna Onkologia 20, 267–272 (2016). 
218. Cohen, B. et al. Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer. 
Breast Cancer Res. Treat. 123, 113–124 (2010). 
219. Ronchini, C. & Capobianco, A. J. Induction of cyclin D1 transcription and CDK2 activity by 
Notch(ic): implication for  cell cycle disruption in transformation by Notch(ic). Mol. Cell. Biol. 
21, 5925–5934 (2001). 
220. Simon, D. P., Giordano, T. J. & Hammer, G. D. Upregulated JAG1 enhances cell proliferation in 
adrenocortical carcinoma. Clin. Cancer Res. 18, 2452–2464 (2012). 
221. Giachino, C. et al. A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor 
Subtypes. Cancer Cell 28, 730–742 (2015). 
222. Zender, S. et al. A critical role for notch signaling in the formation of cholangiocellular  
carcinomas. Cancer Cell 23, 784–795 (2013). 
223. Ye, Q.-F. et al. Silencing Notch-1 induces apoptosis and increases the chemosensitivity of prostate  
cancer cells to docetaxel through Bcl-2 and Bax. Oncol. Lett. 3, 879–884 (2012). 
224. Leong, K. G. et al. Jagged1-mediated Notch activation induces epithelial-to-mesenchymal 
transition through Slug-induced repression of E-cadherin. J. Exp. Med. 204, 2935–2948 (2007). 
225. Santagata, S. et al. JAGGED1 expression is associated with prostate cancer metastasis and 
recurrence. Cancer Res. 64, 6854–6857 (2004). 
226. Zhu, H., Zhou, X., Redfield, S., Lewin, J. & Miele, L. Elevated Jagged-1 and Notch-1 expression 
in high grade and metastatic prostate  cancers. Am. J. Transl. Res. 5, 368–378 (2013). 
227. Nowell, C. & Radtke, F. Cutaneous notch signaling in health and disease. Cold Spring Harb. 
Perspect. Med. 3, (2013). 
 88  
228. Rangarajan, A. et al. Notch signaling is a direct determinant of keratinocyte growth arrest and 
entry into  differentiation. EMBO J. 20, 3427–3436 (2001). 
229. Nguyen, B.-C. et al. Cross-regulation between Notch and p63 in keratinocyte commitment to  
differentiation. Genes Dev. 20, 1028–1042 (2006). 
230. Lowell, S., Jones, P., Le Roux, I., Dunne, J. & Watt, F. M. Stimulation of human epidermal 
differentiation by Delta-Notch signalling at the boundaries of stem-cell clusters. Curr. Biol. 10, 
491–500 (2000). 
231. Stransky, N. et al. The mutational landscape of head and neck squamous cell carcinoma. Science 
333, 1157–1160 (2011). 
232. Agrawal, N. et al. Exome sequencing of head and neck squamous cell carcinoma reveals 
inactivating  mutations in NOTCH1. Science 333, 1154–1157 (2011). 
233. Gao, Y.-B. et al. Genetic landscape of esophageal squamous cell carcinoma. Nat. Genet. 46, 1097–
1102 (2014). 
234. Song, Y. et al. Identification of genomic alterations in oesophageal squamous cell cancer. Nature 
509, 91–95 (2014). 
235. Wang, N. J. et al. Loss-of-function mutations in Notch receptors in cutaneous and lung squamous 
cell  carcinoma. Proc. Natl. Acad. Sci. U. S. A. 108, 17761–17766 (2011). 
236. Nicolas, M. et al. Notch1 functions as a tumor suppressor in mouse skin. Nat. Genet. 33, 416–421 
(2003). 
237. Maraver, A. et al. NOTCH pathway inactivation promotes bladder cancer progression. J. Clin. 
Invest. 125, 824–830 (2015). 
238. Alcolea, M. P. et al. Differentiation imbalance in single oesophageal progenitor cells causes clonal  
immortalization and field change. Nat. Cell Biol. 16, 615–622 (2014). 
239. Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality 
worldwide for 36 cancers in 185 countries. CA. Cancer J. Clin. 68, 394–424 (2018). 
240. Fu, N. Y., Nolan, E., Lindeman, G. J. & Visvader, J. E. Stem cells and the differentiation 
hierarchy in mammary gland development. Physiol. Rev. 100, 489–523 (2020). 
241. Harbeck, N. et al. Breast cancer. Nat. Rev. Dis. Prim. 5, 1–31 (2019). 
242. Hu, C. et al. Overexpression of activated murine Notch1 and Notch3 in transgenic mice blocks 
mammary gland development and induces mammary tumors. Am. J. Pathol. 168, 973–990 
(2006). 
243. Raafat, A., Bargo, S., Anver, M. R. & Callahan, R. Mammary development and tumorigenesis in 
mice expressing a truncated human Notch4/Int3 intracellular domain (h-Int3sh). Oncogene 23, 
9401–9407 (2004). 
244. Wang, K. et al. PEST domain mutations in Notch receptors comprise an oncogenic driver segment 
in triple-negative breast cancer sensitive to a γ-secretase inhibitor. Clin. Cancer Res. 21, 1487–1496 
(2015). 
245. Robinson, D. R. et al. Functionally recurrent rearrangements of the MAST kinase and Notch gene 
families in  breast cancer. Nat. Med. 17, 1646–1651 (2011). 
246. Reedijk, M. et al. High-level coexpression of JAG1 and NOTCH1 is observed in human breast 
cancer and is associated with poor overall survival. Cancer Res. 65, 8530–8537 (2005). 
247. Pece, S. et al. Loss of negative regulation by Numb over Notch is relevant to human breast 
carcinogenesis. J. Cell Biol. 167, 215–221 (2004). 
248. Landor, S. K.-J. et al. Hypo- and hyperactivated Notch signaling induce a glycolytic switch 
through distinct  mechanisms. Proc. Natl. Acad. Sci. U. S. A. 108, 18814–18819 (2011). 
249. Simões, B. M. et al. Anti-estrogen Resistance in Human Breast Tumors Is Driven by JAG1-
NOTCH4-Dependent Cancer Stem Cell Activity. Cell Rep. 12, 1968–1977 (2015). 
250. Raafat, A. et al. Rbpj conditional knockout reveals distinct functions of Notch4/Int3 in mammary 
gland development and tumorigenesis. Oncogene 28, 219–230 (2009). 
251. Turnpenny, P. D. & Ellard, S. Alagille syndrome: Pathogenesis, diagnosis and management. 
European Journal of Human Genetics 20, 251–257 (2012). 
252. Kiernan, A. E. et al. The Notch ligand Jagged1 is required for inner ear sensory development. Proc. 
Natl. Acad. Sci. U. S. A. 98, 3873–3878 (2001). 
253. Tsai, H. et al. The mouse slalom mutant demonstrates a role for Jagged1 in neuroepithelial  
patterning in the organ of Corti. Hum. Mol. Genet. 10, 507–512 (2001). 
254. Vrijens, K. et al. Ozzy, a Jag1 vestibular mouse mutant, displays characteristics of Alagille 
syndrome. Neurobiol. Dis. 24, 28–40 (2006). 
255. Hofmann, J. J. et al. Endothelial deletion of murine Jag1 leads to valve calcification and congenital  
heart defects associated with Alagille syndrome. Development 139, 4449–4460 (2012). 
256. Humphreys, R. et al. Cranial neural crest ablation of Jagged1 recapitulates the craniofacial 
phenotype of  Alagille syndrome patients. Hum. Mol. Genet. 21, 1374–1383 (2012). 
 89  
257. Thakurdas, S. M. et al. Jagged1 heterozygosity in mice results in a congenital cholangiopathy 
which is  reversed by concomitant deletion of one copy of Poglut1 (Rumi). Hepatology 63, 550–
565 (2016). 
258. Chivukula, I. V et al. Decoding breast cancer tissue-stroma interactions using species-specific 
sequencing. Breast Cancer Res. 17, 109 (2015). 
259. Gordon, W. R. & Aster, J. C. Application and evaluation of anti-Notch antibodies to modulate 
Notch signaling. Methods Mol. Biol. 1187, 323–333 (2014). 
260. Chien, K. R., Zangi, L. & Lui, K. O. Synthetic chemically modified mRNA (modRNA): toward a 
new technology platform for  cardiovascular biology and medicine. Cold Spring Harb. Perspect. 
Med. 5, a014035 (2014). 
261. Zhao, S. et al. PiggyBac transposon vectors: the tools of the human gene encoding. Transl. lung 
cancer Res. 5, 120–125 (2016). 
262. Bak, R. O. & Porteus, M. H. CRISPR-Mediated Integration of Large Gene Cassettes Using AAV 
Donor Vectors. Cell Rep. 20, 750–756 (2017). 
263. Chu, V. T. et al. Efficient generation of Rosa26 knock-in mice using CRISPR/Cas9 in C57BL/6 
zygotes. BMC Biotechnol. 16, 4 (2016). 
264. Emery, D. W. The use of chromatin insulators to improve the expression and safety of integrating  
gene transfer vectors. Hum. Gene Ther. 22, 761–774 (2011). 
265. Chandrasegaran, S. & Carroll, D. Origins of Programmable Nucleases for Genome Engineering. 
Journal of Molecular Biology 428, 963–989 (2016). 
266. Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281–2308 
(2013). 
267. Chen, X. et al. Dual sgRNA-directed gene knockout using CRISPR/Cas9 technology in 
Caenorhabditis elegans. Sci. Rep. 4, 1–7 (2014). 
268. Pickar-Oliver, A. & Gersbach, C. A. The next generation of CRISPR–Cas technologies and 
applications. Nature Reviews Molecular Cell Biology 20, 490–507 (2019). 
269. Labun, K. et al. CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing. 
Nucleic Acids Res. 47, W171–W174 (2019). 
270. Liu, G., Zhang, Y. & Zhang, T. Computational approaches for effective CRISPR guide RNA 
design and evaluation. Computational and Structural Biotechnology Journal 18, 35–44 (2020). 
271. Xu, H. et al. Sequence determinants of improved CRISPR sgRNA design. Genome Res. 25, 1147–
1157 (2015). 
272. Wang, H. et al. One-step generation of mice carrying mutations in multiple genes by CRISPR/cas-
mediated genome engineering. Cell 153, 910–918 (2013). 
273. Li, K., Wang, G., Andersen, T., Zhou, P. & Pu, W. T. Optimization of Genome Engineering 
Approaches with the CRISPR/Cas9 System. PLoS One 9, e105779 (2014). 
274. Sakuma, T., Nakade, S., Sakane, Y., Suzuki, K. I. T. & Yamamoto, T. MMEJ-Assisted gene 
knock-in using TALENs and CRISPR-Cas9 with the PITCh systems. Nat. Protoc. 11, 118–133 
(2016). 
275. Salazar, J. L. & Yamamoto, S. Integration of Drosophila and human genetics to understand notch 
signaling related diseases. in Advances in Experimental Medicine and Biology 1066, 141–185 
(Springer New York LLC, 2018). 
276. Kanca, O. et al. An efficient CRISPR-based strategy to insert small and large fragments of DNA 
using short homology arms. Elife 8, (2019). 
277. R Core Team. R: A Language and Environment for Statistical Computing. (2019). 
278. Huber, W. et al. {O}rchestrating high-throughput genomic analysis with {B}ioconductor. Nat. 
Methods 12, 115–121 (2015). 
279. Puga, J. L., Krzywinski, M. & Altman, N. Bayesian statistics. Nat. Methods 12, 377–378 (2015). 
280. Picelli, S. et al. Smart-seq2 for sensitive full-length transcriptome profiling in single cells. Nat. 
Methods 10, 1096–1100 (2013). 
281. Macosko, E. Z. et al. Highly parallel genome-wide expression profiling of individual cells using 
nanoliter droplets. Cell 161, 1202–1214 (2015). 
282. Chen, G., Ning, B. & Shi, T. Single-cell RNA-seq technologies and related computational data 
analysis. Frontiers in Genetics 10, 317 (2019). 
283. Phipson, B., Zappia, L. & Oshlack, A. Gene length and detection bias in single cell RNA 
sequencing protocols. F1000Research 6, (2017). 
284. Stuart, T. et al. Comprehensive Integration of Single-Cell Data. Cell 177, 1888-1902.e21 (2019). 
285. Trapnell, C. et al. The dynamics and regulators of cell fate decisions are revealed by 
pseudotemporal ordering of single cells. Nat. Biotechnol. 32, 381–386 (2014). 
286. Grün, D. et al. De Novo Prediction of Stem Cell Identity using Single-Cell Transcriptome Data. 
Cell Stem Cell 19, 266–277 (2016). 
287. Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY: Large-scale single-cell gene expression data 
analysis. Genome Biol. 19, 15 (2018). 
 90  
288. Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-
seq. Science (80-. ). 352, 189–196 (2016). 
289. Kobak, D. & Berens, P. The art of using t-SNE for single-cell transcriptomics. Nat. Commun. 10, 
1–14 (2019). 
290. Becht, E. et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat. 
Biotechnol. 37, 38–47 (2019). 
291. Kulic, I. et al. Loss of the Notch effector RBPJ promotes tumorigenesis. J. Exp. Med. 212, 37–52 
(2015). 
292. Koh, M. Y., Lemos, R., Liu, X. & Powis, G. The hypoxia-associated factor switches cells from 
HIF-1α- to HIF-2α-dependent signaling promoting stem cell characteristics, aggressive tumor 
growth and invasion. Cancer Res. 71, 4015–4027 (2011). 
293. Klinakis, A. et al. A novel tumour-suppressor function for the Notch pathway in myeloid 
leukaemia. Nature 473, 230–233 (2011). 
294. Hansson, E. M. et al. Control of Notch-ligand endocytosis by ligand-receptor interaction. J. Cell 
Sci. 123, 2931–2942 (2010). 
295. Bucuvalas, J. C., Horn, J. A., Carlsson, L., Balistreri, W. F. & Chernausek, S. D. Growth 
hormone insensitivity associated with elevated circulating growth  hormone-binding protein in 
children with Alagille syndrome and short stature. J. Clin. Endocrinol. Metab. 76, 1477–1482 
(1993). 
296. Wagner, K.-U. et al. Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res. 25, 
4323–4330 (1997). 
297. Diévart, A., Beaulieu, N. & Jolicoeur, P. Involvement of Notch1 in the development of mouse 
mammary tumors. Oncogene 18, 5973–5981 (1999). 
298. Burdon, T., Sankaran, L., Wall, R. J., Spencer, M. & Hennighausen, L. Expression of a whey 
acidic protein transgene during mammary development. Evidence  for different mechanisms of 
regulation during pregnancy and lactation. J. Biol. Chem. 266, 6909–6914 (1991). 
299. Chapman, R. S. et al. Suppression of epithelial apoptosis and delayed mammary gland involution 
in mice  with a conditional knockout of Stat3. Genes Dev. 13, 2604–2616 (1999). 
300. Boxer, R. B. et al. Isoform-specific requirement for Akt1 in the developmental regulation of 
cellular  metabolism during lactation. Cell Metab. 4, 475–490 (2006). 
301. Gallahan, D. et al. Expression of a truncated Int3 gene in developing secretory mammary 
epithelium  specifically retards lobular differentiation resulting in tumorigenesis. Cancer Res. 56, 
1775–1785 (1996). 
302. Wagner, K.-U. et al. An adjunct mammary epithelial cell population in parous females: its role in  
functional adaptation and tissue renewal. Development 129, 1377–1386 (2002). 
303. Bruno, R. D., Boulanger, C. A. & Smith, G. H. Notch-induced mammary tumorigenesis does not 
involve the lobule-limited epithelial  progenitor. Oncogene 31, 60–67 (2012). 
304. Alves-Guerra, M.-C., Ronchini, C. & Capobianco, A. J. Mastermind-like 1 Is a specific 
coactivator of beta-catenin transcription activation  and is essential for colon carcinoma cell 
survival. Cancer Res. 67, 8690–8698 (2007). 
305. Patrício, D. & Fardilha, M. The mammalian two-hybrid system as a powerful tool for high-
throughput drug screening. Drug Discov. Today 25, 764—771 (2020). 
306. Yau, E. H. & Rana, T. M. Next-Generation Sequencing of Genome-Wide CRISPR Screens. 
Methods Mol. Biol. 1712, 203–216 (2018). 
 
